Prostate Cancer (DBCOND0062462)

Identifiers

Synonyms
Cancer, Prostate / Prostate Ca / Prostatic Cancer / Cancer Prostate / Malignant Neoplasm of Prostate / Prostate Cancers / Cancer Of Prostate / Cancer of the Prostate / Prostatic neoplasms malignant / Prostate cancer / Prostate cancer NOS / Malignant tumor of prostate (disorder) / Carcinoma prostate / Carcinoma of prostate (disorder) / Prostate carcinoma / Prostatic carcinoma / Carcinoma prostatic / Primary malignant neoplasm of prostate (disorder)

Associated Data

Indicated Drugs and Targets
DrugDescriptionTargets
Capromab pendetide
A monoclonal anti-prostate specific membrane antigen antibody used in imaging kits to target radioactive agents to malignant prostate tissue.
Choline C-11
An imaging agent used in positron emission tomography imaging for suspected recurrent prostate cancer and non-informative bone scintigraphy, computerized tomography, or magnetic resonance imaging.
No drug targets
Estradiol
An estrogenic steroid used to treat vasomotor symptoms of vulvar and vaginal atrophy in menopause, hypoestrogenism, prevention of postmenopausal osteoporosis, treatment of breast cancer, and advanced androgen-dependent carcinoma of the prostate.
Etoposide
A podophyllotoxin derivative used to treat testicular and small cell lung tumors.
Flotufolastat F-18
A radiopharmaceutical diagnostic agent used in PET imaging to visualize PSMA-positive lesions in men with prostate cancer with suspected metastasis or recurrence.
Fluciclovine (18F)
A radiolabelled L-leucine derivative used to image tumors, especially in the prostate.
Gallium Ga-68 gozetotide
A radiopharmaceutical agent used in the diagnosis of prostate-specific membrane antigen (PSMA) positive lesions in male patients during positron emission tomography.
Piflufolastat F 18
A radiopharmaceutical diagnostic agent used with PET to image PSMA-positive lesions for the diagnosis of metastatic or recurrent prostate cancer.
Uracil
An antineoplastic agent used in combination with tegafur to treat various cancers, including breast, prostate, and liver cancer.
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT03615599
Plant-based Diets and Risk of Cancer in the Adventist Health Study-2No drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT04726319
Family History App in Personalized MedicineNo drug interventionsscreeningNot Availableactive_not_recruiting
NCT00385827
A Safety and Efficacy Study of Siltuximab (CNTO 328) in Male Subjects With Metastatic Hormone-Refractory Prostate Cancer (HRPC)treatment2terminated
NCT06582849
Enhanced Assistance During Radiotherapy for Unmet Essential NeedsNo drug interventionssupportive_careNot Availablenot_yet_recruiting
NCT06613100
Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancertreatment1not_yet_recruiting
NCT00034216
Collection of Blood From Patients With CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT00352924
Agriculture Health StudyNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT00451022
Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer StudiesNo drug interventionsNot AvailableNot Availablerecruiting
NCT00923221
Collection of Blood From Patients With Prostate CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT00984321
A Pilot Study of Geriatric Specific Interventions for Quality of Life in Elderly Patients With CancerNo drug interventionssupportive_careNot Availableactive_not_recruiting
NCT01231932
Characterizing Fatigue Experienced by Cancer Patients Receiving Primary Treatment and Cancer SurvivorsNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT01441089
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic AnalysisNo drug interventionsNot AvailableNot Availablerecruiting
NCT01542021
Androgen Deprivation Therapy Prior to Prostatectomy for Patients with Intermediate and High Risk Prostate CancertreatmentNot Availablecompleted
NCT01774071
Study of 89Zr-DFO-MSTP2109A in Patients With Prostate CancerNo drug interventionsdiagnostic1 / 2completed
NCT01794793
Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studiestreatment4completed
NCT01834001
Imaging Studies to Check the Local Response of Prostate Cancer to Radiation TherapyNo drug interventionsNot AvailableNot Availablerecruiting
NCT01990196
Neoadjuvant Phase 2 Study Comparing the Effects of AR Inhibition With/Without SRC or MEK Inhibition in Prostate Cancertreatment2active_not_recruiting
NCT02312401
Evaluation of Treatment Response Using Multiparametric MRI After Prostate RadiotherapyNo drug interventionsdiagnostic2active_not_recruiting
NCT02594202
Care of the Prostate Cancer Patient and Prospective Procurement of Prostate Cancer TissueNo drug interventionsNot AvailableNot Availablerecruiting
NCT02723734
Validation Study on the Impact of Decipher® Testing - VANDAAM StudyNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT02759744
Fusion Guided Focal Laser Ablation of Prostate CancerNo drug interventionsdevice_feasibilityNot Availablesuspended
NCT02769962
Trial of EP0057, a Nanoparticle Camptothecin With Olaparib in People With Relapsed/Refractory Small Cell Lung Cancertreatment1 / 2recruiting
NCT03031821
Metformin in Patients Initiating ADT as Prevention and Intervention of Metabolic Syndromeprevention3terminated
NCT03173924
18F-DCFPyL PSMA- Versus 18F-NaF-PET Imaging for Detection of Metastatic Prostate Cancerdiagnostic2active_not_recruiting
NCT03181867
18F-DCFPyL PET/CT in High Risk and Recurrent Prostate Cancerdiagnostic2enrolling_by_invitation
NCT03315871
Combination Immunotherapy in Biochemically Recurrent Prostate Cancertreatment2active_not_recruiting
NCT03354416
Profiling of Radiological Factors in Treatment and Outcomes in Prostate CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT03489057
Efficacy of a Couple-Focused mHealth Symptom Self-management ProgramNo drug interventionssupportive_careNot Availablecompleted
NCT03493945
Phase I/II Study of Immunotherapy Combination BN-Brachyury Vaccine, M7824, N-803 and Epacadostat (QuEST1)treatment1 / 2active_not_recruiting
NCT03574571
A Study to Test Radium-223 With Docetaxel in Patients With Prostate Cancertreatment3recruiting
NCT03808077
The Effect of Deep Versus Moderate Muscle Relaxants in Men During and After Robotic Surgery for Prostate Cancertreatment2recruiting
NCT03824652
WALNUTS for POWER: Polyphenols, Omega-3 Fatty Acids, Weight Loss, and EneRgyNo drug interventionstreatment2recruiting
NCT03830788
Erectile Dysfunction in Good Prognosis Prostate Cancer : Comparison Between Brachytherapy and Stereotactic Body RadiotherapyNo drug interventionstreatmentNot Availablerecruiting
NCT03976843
Prostate Specific Membrane Antigen (PMSA)-Based PET Imaging of High Risk Prostate Cancerdiagnostic2recruiting
NCT04243473
Biopsy Collection for Men Undergoing Brachytherapy for Prostate CancerNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT04465214
Mobile Sensor Technologies to Assess General Symptomology of People With CancerNo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT04541030
Integrated Genomic Prostate Score With MRI Targeted Prostate BiopsiesNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT04692675
Multiparametric Magnetic Resonance Imaging of the Prostate to Assess Disease Progression and Genomics in Patients Undergoing Active Surveillance for Prostate CancerNo drug interventionsotherNot Availablerecruiting
NCT04706663
Precision-Based Genomics in Prostate CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT04748042
Focal Radiation With Pulsed Systemic Therapy of Abiraterone, Androgen Deprivation Therapy (ADT), Lynparza Towards Castration Sensitive Oligometastatic Prostate Cancer (FAALCON)treatment2recruiting
NCT04808427
Pilot Study to Investigate Magnetic Resonance (MR) Image Guided Focal Therapy in Prostate CancerNo drug interventionstreatmentNot Availablerecruiting
NCT04887935
Neoadjuvant SGLT2 Inhibition in High-Risk Localized Prostate Cancertreatment1recruiting
NCT04993508
Randomized Prospective Multi Center Cohort Study for Primary Diagnosis of Clinically Significant Prostate Cancer with Combination of PSA/DRE and Multi Parametric Magnetic Resonance ImagingNo drug interventionsdiagnosticNot Availablenot_yet_recruiting
NCT05064111
Utility of Adding MR Fusion to Standard US Guided Prostate BiopsyNo drug interventionsNot AvailableNot Availablesuspended
NCT05079828
Head-to-head Comparison of 68Ga-PSMA-11 and 18F-PSMA-1007No drug interventionsdiagnosticNot Availableactive_not_recruiting
NCT05133440
A Study of Stereotactic Body Radiation Therapy and Radium (Ra-223) Dichloride in Prostate Cancer That Has Spread to the BonesNo drug interventionstreatment2active_not_recruiting
NCT05171387
Darolutamide + Androgen Deprivation Therapy (ADT) in Chinese Men With High Risk, Nonmetastatic Prostate Cancertreatment2active_not_recruiting
NCT05191680
TherApeutics in Early ProState Cancer (TAPS02)treatment3recruiting
NCT05245006
PET Imaging Study of 89Zr-DFO-YS5 in Men With Prostate CancerNo drug interventionsdiagnostic1recruiting
NCT05252390
NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumorstreatment1 / 2recruiting
NCT05448547
Immediate Curative Vs Conservative Treatment in Older Men with M0, High-risk Prostate CancerNo drug interventionstreatment3recruiting
NCT05588128
Prospective Monitoring of Subjects With Biochemically Recurrent Prostate Cancer Using 18FDCFPyLNot AvailableNot Availablerecruiting
NCT05616650
Focal Therapy With Stereotactic Body Radiation Therapy (SBRT) for Patients With a Single Prostate Tumortreatment2recruiting
NCT05617040
Prime-boost Immunotherapeutic Trial in Men With Biochemical Recurrence After Definitive Local Therapy for Prostate CancerNo drug interventionstreatment1 / 2active_not_recruiting
NCT05644821
Influence of Electronic Patient Reported Outcomes (ePROMs) in Surgical Therapy for Prostate Cancer on Postoperative OutcomeNo drug interventionsotherNot Availablerecruiting
NCT05759273
A Study to Observe Demography and the Outcome of Prostate Cancer Patients Treated With 6-month Triptorelin Formulation in ItalyNo drug interventionsNot AvailableNot Availablerecruiting
NCT06624813
Partial Prostatectomy for Prostate CancerNo drug interventionstreatmentNot Availablerecruiting
NCT06627530
COACTION Trial - COmbination Androgen bloCkade in inTermediate to hIgh-risk prOstate caNcertreatment4not_yet_recruiting
NCT06018311
Exercising Together for Hispanic Prostate Cancer Survivor-Caregiver DyadsNo drug interventionspreventionNot Availableactive_not_recruiting
NCT06096870
Enzalutamide and M9241 in PET Positive Recurrent Prostate Cancer (pprPC) Without Testosterone Lowering Therapytreatment2recruiting
NCT06280781
Imperial Prostate 9 - ATLAS (Approaches To Long-Term Active Surveillance)No drug interventionsotherNot Availablerecruiting
NCT06389097
SPECT Imaging for Pharmacokinetics and dosimEtry Towards TREATment OptimizationNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT06395753
A Dose Finding Study of Debio 4228 in Participants With Locally Advanced/Metastatic Prostate CancerNo drug interventionstreatment2recruiting
NCT06451614
SpaceIT Hydrogel System for Perirectal SpacingNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT06625970
Study Evaluating the Efficacy and Safety of Darolutamide and Stereotactic Dose Escalated Radiotherapy in Patients With Localized Prostate Cancer and High-risk Features of Relapsetreatment3not_yet_recruiting
NCT06626386
Determination of Prostate-specific Antigen in Capillary Blood (PSA-Cap)No drug interventionsNot AvailableNot Availablerecruiting
NCT06561230
Leveraging EA8191 to Assess AI-Augmented EHR AbstractionNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT04553926
'OLAP' (OLAparib Regulatory Post-marketing Surveillance)No drug interventionsNot AvailableNot Availablerecruiting
NCT04560452
Drug Intensive Monitoring Study of Olaparib in Clinical Practice Among Chinese PatientsNo drug interventionsNot AvailableNot Availablerecruiting
NCT04571840
Prostate Imaging Using MRI +/- Contrast EnhancementNo drug interventionsdiagnosticNot Availableactive_not_recruiting
NCT04576871
Re-treatment 225Ac-J591 for mCRPCtreatment0active_not_recruiting
NCT04644068
Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignanciestreatment1 / 2recruiting
NCT04672460
A Bioequivalence Study Between the Proposed and Current Talazoparib Capsule Formulation and Food Effect Study for the Proposed Talazoparib Capsule Formulation in Participants With Advanced Solid Tumorstreatment1completed
NCT04729114
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancertreatment1recruiting
NCT04733768
18F-PSMA-1007 PET/CT Imaging in Patients with Biochemically Recurrent or High-risk Prostate CancerNo drug interventionsdiagnostic2completed
NCT04751435
Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer PatientsNo drug interventionshealth_services_researchNot Availablerecruiting
NCT04782713
Smart Prostate Specific Antigen (PSA) Screening StudyNo drug interventionsscreeningNot Availableactive_not_recruiting
NCT04821622
Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPCtreatment3active_not_recruiting
NCT04852224
Strength, Aging, and Memory in Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT04895839
Predictors of Mental Health in Men With Prostate Cancer Undergoing a Patient Empowerment ProgramNo drug interventionssupportive_careNot Availablerecruiting
NCT04905069
Effectiveness of the SpaceOAR Vue System in Subjects With Prostate Cancer Being Treated With Stereotactic Body RadiotherapyNo drug interventionspreventionNot Availablerecruiting
NCT04981223
Predicting Location and Extent of Prostate Cancer Using Micro-Ultrasound ImagingNo drug interventionsdiagnosticNot Availablecompleted
NCT05000294
Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Typestreatment1 / 2recruiting
NCT05011188
FOR46 in Combination With Enzalutamide in Patients With Metastatic Castration Resistant Prostate Cancertreatment1 / 2recruiting
NCT05065944
Comparing Pre-Anesthesia Evaluation Via Telemedicine Versus in Person for Surgical Patients at Moffitt Cancer CenterNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT05079698
A Study of Stereotactic Body Radiotherapy and 177Lu-PSMA-617 for the Treatment of Prostate Cancertreatment1active_not_recruiting
NCT05100121
To Live Better After Prostate Cancer Treatment:No drug interventionssupportive_careNot Availablerecruiting
NCT05114746
Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer in JapanNo drug interventionstreatment2recruiting
NCT05141383
Comparative Study of Diagnostic and Prognosis Biomarkers of Prostate Cancer in Liquid BiopsyNo drug interventionsdiagnosticNot Availablecompleted
NCT05160480
A Pilot Study of Total-body PET Using FDA-approved Radiotracers Beyond 18F-FDGNo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT05162846
Methods for Increasing Genetic Testing Uptake in MichiganNo drug interventionshealth_services_researchNot Availablerecruiting
NCT05181800
FIRMAGON® Intensive Drug MonitoringNo drug interventionsNot AvailableNot Availablecompleted
NCT05202301
A Study Using Available Data to Learn to What Extent Patients With Prostate Cancer Who Received Second Generation Androgen Receptor Inhibitors Took Their Medication as Prescribed or Stopped Taking Their Medication CompletelyNot AvailableNot Availableactive_not_recruiting
NCT05223803
TERPS Trial for De Novo Oligometastic Prostate CancerNo drug interventionstreatment2recruiting
NCT05318131
Sleep, Exercise, Nutrition and Survivorship in Prostate CancerNo drug interventionssupportive_careNot Availablecompleted
NCT05328505
Molecular Imaging Informed Radiation Dose Escalation to Sites of Recurrent Disease and De-escalation to Uninvolved Areas in Salvage Radiotherapy for Prostate CancerNo drug interventionstreatmentNot Availablerecruiting
NCT05331638
Prostate Cancer Genius App Education and Home-based PSA Screening for African American MenNo drug interventionspreventionNot Availableactive_not_recruiting
NCT05375539
AGN-CognI.Q Acute Dose Safety and Pharmacokinetics Dose-Response in Prostate Cancer PatientsNo drug interventionstreatment1recruiting
NCT05478239
ArtemiCoffee in Patients With Rising PSANo drug interventionstreatment2recruiting
NCT05515978
Pragmatic Trial of Metformin for Glucose Intolerance or Increased BMI in Prostate Cancer Patientstreatment0recruiting
NCT05519449
Study of JANX007 in Subjects with Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)No drug interventionstreatment1recruiting
NCT05520255
18F-PSMA-1007 PET/CT in Prostate Cancer - Access Trial 2022 to 2028No drug interventionsdiagnostic3recruiting
NCT05546268
Study of Oral MRT-2359 in Selected Cancer Patientstreatment1 / 2recruiting
NCT05613023
A Trial of 5 Fraction Prostate SBRT Versus 5 Fraction Prostate and Pelvic Nodal SBRTNo drug interventionstreatment3recruiting
NCT05628363
Adaptive Stereotactic Body Radiation Therapy to the Prostate and Pelvic Nodes With Simultaneous Integrated Boost to the MR-detected Nodule for Patients With High-risk and Unfavorable Intermediate-risk Prostate CancerNo drug interventionstreatmentNot Availablerecruiting
NCT05668351
Stereotactic Ablative Radiation Therapy for Prostate CancerNo drug interventionstreatmentNot Availablerecruiting
NCT05679388
A Study of Extending Relugolix Dosing Intervals Through Addition of Itraconazole or Ritonavir in Prostate Cancer Patientstreatment1terminated
NCT05683691
Water Vapor Ablation for Localized Intermediate Risk Prostate CancerNo drug interventionstreatmentNot Availablerecruiting
NCT05707182
18F-rhPSMA-7.3 PET/MRI in Prostate Cancer Active Surveillance: a Pilot Studydiagnostic0withdrawn
NCT05735652
An Observational Study of Radiotherapy After Injection of SpaceOAR HydrogelNo drug interventionsNot AvailableNot Availablecompleted
NCT05753046
Laparoscopic TAP Block During Robotic Assisted Laparoscopic Radical Prostatectomy for Improvement in Postoperative PainNo drug interventionsother4enrolling_by_invitation
NCT05820932
Predicting Cognitive Decline From Androgen Deprivation TherapyNo drug interventionsNot AvailableNot Availablerecruiting
NCT05826509
SUrGery with or Without DARolutamide in High-risk And/or Locally Advanced Prostate Cancertreatment2recruiting
NCT05864144
A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumorstreatment1 / 2recruiting
NCT05929300
A Yoga Program for Patients Undergoing Prostate Cancer SurgeryNo drug interventionspreventionNot Availablewithdrawn
NCT05931419
High-Risk prostatE Cancer radiatiOn Versus surgERyNo drug interventionsNot AvailableNot Availablerecruiting
NCT05958082
Utilization of Educational Interventions in Completion of Genetic Testing in Black Patients with High-Risk Prostate CancerNo drug interventionshealth_services_researchNot Availablenot_yet_recruiting
NCT06037954
A Study of Mental Health Care in People With CancerNo drug interventionsotherNot Availablerecruiting
NCT06056830
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants with High-risk Prostate Cancer Prior to Radical ProstatectomyNo drug interventionsdiagnostic3recruiting
NCT06071195
All-in-One Prostate Cancer Staging with MRINo drug interventionsNot AvailableNot Availablerecruiting
NCT06072911
Continence, Sexual Function, Fitness and the Health of Men After Surgery for Prostate CancerNo drug interventionssupportive_careNot Availablerecruiting
NCT06085664
A Pilot Presurgical Trial of REGN5678 (Anti-PSMA x CD28) in Patients With High-risk, Localized Prostate Cancer Followed by Radical Prostatectomytreatment1 / 2recruiting
NCT06125145
Geriatric Assessment and Promotores (GAP) Pilot Feasibility StudyNo drug interventionssupportive_careNot Availablerecruiting
NCT06610474
Evaluation of an Online Prostate Cancer Screening Decision AidNo drug interventionsscreeningNot Availablenot_yet_recruiting
NCT06610825
Castrate Resistant Prostate Cancer Enhertu Therapytreatment2not_yet_recruiting
NCT06144619
Non-Invasive Biomarkers in Prostate Cancer Disease ManagementNo drug interventionsNot AvailableNot Availablerecruiting
NCT06215508
Geriatric Assessment and Technology Evaluation in Prostate CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT06218667
A Study of Copanlisib in Combination With Degarelix in People With Prostate Cancertreatment1 / 2recruiting
NCT06220435
Tumor-directed Radiation Therapy for Patients With the Highest Risk Category of Localized Prostate CancerNo drug interventionstreatmentNot Availablerecruiting
NCT06226129
Gadopiclenol in Contrast Enhanced MRI of the Prostatediagnostic4suspended
NCT06229366
[Ac-225]-PSMA-62 Trial in Oligometastatic Hormone Sensitive and Metastatic Castration Resistant Prostate CancerNo drug interventionstreatment1recruiting
NCT06235697
Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate TreatmentNo drug interventionstreatment3recruiting
NCT06238479
A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid TumorsNo drug interventionstreatment1recruiting
NCT06274047
PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation with Androgen Axis Suppression. a Phase III Multi-center Study for Men with Detectable PSA After Prostatectomy for Prostate Cancer.treatment3recruiting
NCT06296147
Virtual Reality Headset And/or Aromatherapy for Patients Undergoing a Transperineal Prostate BiopsyNo drug interventionssupportive_careNot Availablerecruiting
NCT06312670
Combining EPI-7386 with Enzalutamide and Androgen Deprivation Therapy for Metastatic Hormone-Sensitive Prostate Cancertreatment2recruiting
NCT06612047
Comparison of 5.0T and 3.0T Biparametric Magnetic Resonance Imaging in the Diagnosis of Prostate CancerNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT06347705
A Study of 2141-V11 in Combination With Standard Treatments in People With Prostate CancerNo drug interventionstreatment2recruiting
NCT06384222
Hyperpolarized (HP) 13C Pyruvate Magnetic Resonance Imaging (MRI) for Response Monitoring to Neoadjuvant Abirateronetreatment2not_yet_recruiting
NCT06399757
A Study to Investigate APL-5125 in Adults With Advanced Solid TumorsNo drug interventionstreatment1 / 2recruiting
NCT06402357
High Intensity Focused Ultrasound in Prostate CancerNo drug interventionstreatment2not_yet_recruiting
NCT06434649
Posterior Extra-fascial RARP in Intermediate or High Risk Prostate CancerNo drug interventionstreatmentNot Availablerecruiting
NCT06434909
CYTALUX™for the Intraoperative Imaging of Prostate CancerNo drug interventionsdiagnostic2recruiting
NCT06446401
The Case of "triple" Versus "double" Therapy for Patients with High Volume Metastatic Hormone Sensitive Prostate CancerNot AvailableNot Availablenot_yet_recruiting
NCT06457919
A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancertreatment1 / 2recruiting
NCT06458855
Nerve Grafting Technique to Restore Erectile Function Post Radical ProstatectomyNo drug interventionstreatmentNot Availablerecruiting
NCT06460454
PROnostic Interest of 18F-FDG PET/CT in Patients With Metastatic Castration-resistant Prostate Cancer (mCPRC) ProgressingNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT06463457
Comeback From Long coursE Androgen Deprivation Therapy (ADT) With RElugolix and Darolutamide (CLEARED)treatment2not_yet_recruiting
NCT06465069
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid TumorsNo drug interventionstreatment1recruiting
NCT06487507
Metabolic Impact and Compliance of Controlled, Varying, Mediterranean Diets in Pre-Surgical Prostate Cancer Populations (PROVISIONS)No drug interventionsbasic_scienceNot Availablenot_yet_recruiting
NCT06500741
Experiment to Assess Preferences for Novel Hormonal Therapy and Androgen-deprivation Therapy in Prostate Cancer PatientsNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT06521710
Nerve Grafting Technique to Preserve Erectile Function in Patients Undergoing Robotic Assisted Radical ProstatectomyNo drug interventionstreatmentNot Availablerecruiting
NCT06559007
Phase 1 Study to Evaluate PK, Safety, and Tolerability of HRS-5041 in Healthy Caucasian Male ParticipantsNo drug interventionstreatment1not_yet_recruiting
NCT06563388
Stereotactic Ablative Radiotherapy (SABR) for the Treatment of Patients With Metastatic Cancer, ID-COMET TrialNo drug interventionstreatment3recruiting
NCT06568094
A Study of HRS-5041 Tablets Combined With Antitumor Therapy in Subjects With Advanced Prostate Cancertreatment1 / 2recruiting
NCT06582446
Artificial Intelligence to Personalize Prostate Cancer Treatment (the HypoElect Trial)treatment2recruiting
NCT06589154
The Application of Multimodal Artificial Intelligence Systems in Prostate Cancer Diagnosis and Prognosis AnalysisNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT06614751
A PARG Inhibitor DAT-2645 Monotherapy in Patients with Advanced/Metastatic Solid Tumors Harboring BRCA1/2 Loss of Function Alterations And/or Other Defects in the DDR PathwayNo drug interventionstreatment1not_yet_recruiting
NCT06591819
Hypofractionated WPPT with HDR BoostNo drug interventionstreatment2not_yet_recruiting
NCT06594887
Rectal Spacers Use in Prostate Cancer Radiation TherapyNo drug interventionssupportive_careNot Availablerecruiting
NCT06594926
Working Out M0 Bipolar Androgen Therapytreatment2not_yet_recruiting
NCT06599476
Rectal Spacers in Prostate Cancer Patients Undergoing Radiation TherapyNo drug interventionssupportive_careNot Availablerecruiting
NCT06600698
Safety and Efficacy of AGN-INM176 in Prostate Patients With Rising PSANo drug interventionstreatment1 / 2not_yet_recruiting
NCT06601205
Finasteride and Flutamide in Pre-surgical Trial in Prostate Cancer.prevention2 / 3completed
NCT06604130
Plasma Exosome RNA to Diagnose Prostate CancerNo drug interventionsdiagnosticNot Availableenrolling_by_invitation
NCT06604247
The Association Between CBT-I Dose and Innate Immunity in Insomnia and Fatigue in Prostate Cancer PatientsNo drug interventionstreatmentNot Availablecompleted
NCT06604377
Model of Predicting Biochemical Recurrence After Radical Prostate Cancer Based on Pre-treatment PSMA PET / MR Image FeaturesNo drug interventionsNot AvailableNot Availablecompleted
NCT06604442
Intrapatient Comparison of Urinary Radioactivity Following Piflufolastat (18F) and Flotufolastat (18F) PET in Men with Low PSA Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomydiagnostic4not_yet_recruiting
NCT04278443
Fertility After Prostate BrachytherapyNo drug interventionsNot AvailableNot Availableunknown_status
NCT00036543
A Study of Atrasentan in Men With Metastatic, Hormone-Refractory Prostate Cancertreatment3completed
NCT01499043
Pilot Study of PLX3397 in Patients With Advanced Castration-Resistant Prostate Cancer (CRPC)treatment2terminated
NCT01950143
Effect of Sulforaphane on Prostate CAncer PrEventionNo drug interventionspreventionNot Availablecompleted
NCT01961843
Abiraterone Acetate for Castrate Resistant Prostate CancertreatmentNot Availableactive_not_recruiting
NCT05317143
Evaluation of Prostate Cancer MarginsNo drug interventionsNot AvailableNot Availablecompleted
NCT00004043
Calcitriol in Treating Patients With a Rising PSA Level Following Treatment for Prostate CancerNo drug interventionstreatment2completed
NCT01921803
Hypofractionated Radiotherapy as Primary Therapy for Prostate CancerNo drug interventionstreatment2completed
NCT05946603
IS-002 in Prostate CancerNo drug interventionsother2recruiting
NCT00001503
Follow-up Protocol for Patients With Cancer/AIDS/Skin DiseaseNo drug interventionsNot AvailableNot Availablecompleted
NCT01742403
Continuous Monitoring of Prostate Position During RadiotherapyNo drug interventionstreatmentNot Availablerecruiting
NCT03262103
Neoadjuvant Hiltonol® (PolyICLC) for Prostate Cancertreatment1completed
NCT00485303
An Efficacy and Safety Study of Abiraterone Acetate and Prednisone in Participants With Prostate Cancer Who Failed Androgen Deprivation and Docetaxel-Based Chemotherapytreatment2completed
NCT04428203
Epidiolex (CBD) in Patients With Biochemically Recurrent Prostate Cancertreatment1completed
NCT00970203
Dendritic Cell (DC)-Based Vaccines Loaded With Allogeneic Prostate Cell Lines in Combination With Androgen Ablation in Patients With Prostate Cancertreatment2completed
NCT03087903
A Study of Grape Seed Extract in Asymptomatic Non-Metastatic Prostate Cancer Patients With Rising PSANo drug interventionstreatmentNot Availableactive_not_recruiting
NCT02799303
MRI Versus PSA in Prostate Cancer ScreeningNo drug interventionsscreeningNot Availableunknown_status
NCT03832803
Less to Hold - A Comparison of Bladder Toxicities (Side Effects) in Patients Undergoing Prostate Radiotherapy Between Patients Treated With Empty Bladder and Those on a Drinking Protocol.No drug interventionsotherNot Availablecompleted
NCT03644303
Targeted Radiotherapy in Androgen-suppressed Prostate Cancer Patients.No drug interventionstreatmentNot Availableunknown_status
NCT05700903
Contributions to Hypertension With Androgen Deprivation Therapybasic_science4recruiting
NCT00002703
Radiation Therapy in Treating Patients With Stage I or Stage II Prostate CancerNo drug interventionstreatment3completed
NCT06027203
Transperineal Versus Transrectal Prostate BiopsyNo drug interventionsNot AvailableNot Availablecompleted
NCT01794403
Radiation Hypofractionation Via Extended Versus Accelerated Therapy (HEAT) For Prostate CancerNo drug interventionstreatmentNot Availablerecruiting
NCT00003103
Chemotherapy in Treating Patients With Solid Tumorstreatment1 / 2completed
NCT05381103
PSMA-PET to Guide ProstatectomyNo drug interventionsdiagnostic2 / 3recruiting
NCT00928603
Investigative Study of the Role of Focal Therapy for Prostate Cancer TreatmentNo drug interventionstreatment1unknown_status
NCT01803503
Docetaxel With or Without Low-dose, Short Course Sunitinib in Refractory Solid Tumorstreatment2unknown_status
NCT06397703
ADT and SBRT vs SBRT Alone for Unfavorable Intermediate Risk Prostate Cancertreatment3recruiting
NCT01795703
A Phase 2 Study to Evaluate Safety and Efficacy of Abiraterone in Participants With Prostate Cancer Who Have Received Docetaxeltreatment2completed
NCT00003290
Radiation Therapy in Treating Patients With Prostate CancerNo drug interventionstreatment3completed
NCT01685190
A Study of Prostate and pelvIs Versus prOsTate Alone Treatment for Locally Advanced Prostate CancerNo drug interventionstreatment2unknown_status
NCT00623090
Internet-Based Education for Prostate Cancer ScreeningNo drug interventionsscreening3completed
NCT03187990
Positron Emission Tomography / Magnetic Resonance Imaging (PET/MRI) Guided Biopsy in Men With Elevated PSANo drug interventionsdiagnosticNot Availablecompleted
NCT01917890
Radiosensitizing and Radioprotectve Effects of Curcumin in Prostate CancerNo drug interventionssupportive_careNot Availablecompleted
NCT04159090
Head- to Head Comparison of [68Ga]Ga-PSMA-11 With [18F]PSMA-1007 PET/CT in Staging Prostate Cancer Using Histopathology and Immunohistochemical Analysis as Reference-StandardNo drug interventionsdiagnosticNot Availableunknown_status
NCT01994590
Dovitinib (TKI258) and Abiraterone Acetate in Metastatic Castrate-Resistant Prostate Cancer (mCRPC)treatment2terminated
NCT00391690
Evaluation of Bone Markers as Diagnostic Tools for Early Detection of Bone Metastases in Patients With High Risk Prostate Cancertreatment4completed
NCT01630590
Cabozantinib and Androgen Ablation in Patients With Androgen-Dependent Metastatic Prostate Cancertreatment2completed
NCT01748890
A Pilot Trial of Sonoelastography for Planning Tumor-targeted Prostate BiopsyNo drug interventionsdiagnosticNot Availableterminated
NCT00769990
Genistein in Treating Patients Undergoing External-Beam Radiation Therapy for Bone MetastasesNo drug interventionstreatment1 / 2withdrawn
NCT01434290
Radiation Therapy in Treating Patients With Prostate CancerNo drug interventionstreatment2completed
NCT02255890
Registry of Irreversible Electroporation for the Ablation of Prostate Cancer With Use of Nanoknife DeviceNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT05403190
The Performance of da Vinci SP System on Extraperitoneal Approach Radical ProstatectomyNo drug interventionstreatmentNot Availableunknown_status
NCT00416390
Lycopene in Treating Patients With Prostate Cancer or Benign Prostatic HyperplasiaNo drug interventionstreatmentNot Availablecompleted
NCT02093390
A Phase 1 Study to Evaluate the Effects of Fluconazole and Atorvastatin on the Pharmacokinetics of TAK-385 in Healthy Subjectstreatment1completed
NCT00003690
Flavopiridol Plus Cisplatin or Carboplatin in Treating Patients With Advanced Solid Tumorstreatment1completed
NCT02141490
Study of Ferumoxytol Enhanced MRI for Detecting Lymph Node Metastases in Prostate, Bladder, and Kidney Cancersdiagnostic2completed
NCT05755490
PROWESS (PROstate Cancer Wearables Exercise and Structured Supports): A Pilot Supportive Care InterventionNo drug interventionssupportive_careNot Availablenot_yet_recruiting
NCT00480090
A Phase II Study of Ara-C (Cytarabine) in Men With Androgen Independent Prostate Cancertreatment2completed
NCT06101290
Locally Ablative TherapY in Oligo-ProgressiVe GEnitourinary TumoRs (LAYOVER)No drug interventionstreatmentNot Availablerecruiting
NCT03511664
Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancertreatment3completed
NCT00587964
Phase II Trial of Stereotactic Radiosurgery Boost Following Surgical Resection for Brain MetastasesNo drug interventionstreatment2completed
NCT00997464
An Exploration of Genetic Testing for Prostate Cancer SusceptibilityNo drug interventionsNot AvailableNot Availableunknown_status
NCT00853164
A Pilot Study of Physical Activity for Improving Quality of Life in Prostate Cancer Patients on Androgen Deprivation Therapy (ADT)No drug interventionstreatmentNot Availablecompleted
NCT00741364
Vitamin D Effects on Prostate PathologyNo drug interventionstreatment2unknown_status
NCT03232164
PSMA-based 18F-DCFPyL PET/CT and PET/MRI Pilot Studies in Prostate Cancerdiagnostic0recruiting
NCT02037464
CAPSAICIN Trial: Assessing Capsaicin as a Chemopreventive Agent for Prostate CancerNo drug interventionsbasic_science2unknown_status
NCT01852864
Degarelix Before Radical Prostatectomybasic_science0unknown_status
NCT02114164
Study of Carbon Dioxide Exchange Patterns During Robotic ProstatectomiesNo drug interventionssupportive_careNot Availablecompleted
NCT00217464
Fulvestrant in Treating Patients With Recurrent Prostate Cancertreatment2terminated
NCT05605964
Randomized Study to Evaluate MACE in Patients With Prostate Cancer Treated With Relugolix or Leuprolide Acetatetreatment3active_not_recruiting
NCT02362464
Long-Term TARP Vaccination Using a Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Previously Vaccinated Men on NCI 09-C-0139No drug interventionstreatment2completed
NCT02088164
Long-Term Outcome of Subjects With Elevated PSA in Healthy Taiwanese MenNo drug interventionsNot AvailableNot Availablecompleted
NCT02485964
A Pilot Study to Assess the Immunogenicity of Candidate PSA Peptides for a Prostate Cancer VaccineNo drug interventionsotherNot Availablecompleted
NCT05647564
PET/CT Characterization of Treatment ResistanceNo drug interventionsdiagnosticNot Availablerecruiting
NCT03321864
Capture of Prostatic Trans-rectal Ultrasound Scans for ResearchNo drug interventionsbasic_scienceNot Availablesuspended
NCT06449664
Training for Men Undergoing Androgen Deprivation Therapy.No drug interventionssupportive_careNot Availablerecruiting
NCT04019964
Nivolumab in Biochemically Recurrent dMMR Prostate Cancertreatment2recruiting
NCT04698564
Utility of Hyperpolarized 13C-pyruvate Metabolic Magnetic Resonance ImagingNo drug interventionstreatment2recruiting
NCT00339664
Analyses of Human Samples Collected in Clinical TrialsNo drug interventionsNot AvailableNot Availablecompleted
NCT06168864
Development of Artificial Intelligence Models for Segmentation and Characterization of Prostate Cancer: a Single-center Retrospective Observational Study.No drug interventionsNot AvailableNot Availablecompleted
NCT01006564
Multifunctional Magnetic Resonance (MR) for Radiotherapy Planning in Prostate CancerNo drug interventionsdiagnosticNot Availableunknown_status
NCT01715064
Acute Effects of Exercise on the Cortical Silent Period in Prostate Cancer PatientsNo drug interventionssupportive_care2 / 3completed
NCT01344564
Initiation of Androgen Deprivation Therapy for Prostate Cancer Using Degarelix Followed by LeuprolidetreatmentNot Availablecompleted
NCT06359964
Infective Complications in TP Biopsy Without Antibiotic ProphylaxisNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT00084864
Calcitriol and Dexamethasone Before Radical Prostatectomy in Treating Patients With Localized Adenocarcinoma (Cancer) of the Prostatetreatment2terminated
NCT01254864
Maximal Androgen Depletion Followed by Randomization of Maximal Androgen Ablation With Molecular Targeted Therapiestreatment2completed
NCT01262664
A First-in-Man, Phase I Evaluation of A Single Cycle of Prohibitin Targeting Peptide 1 in Patients With Metastatic Prostate Cancer and ObesityNo drug interventionstreatment1terminated
NCT03223064
Accuracy of Lymph Node Imaging in Prostate Cancer: PSMA PET-CT and Nano-MRINo drug interventionsdiagnosticNot Availableunknown_status
NCT04773821
Performance of Prostate MRI and Following Biopsy to Detect Prostate Cancer Recurrence After Focal TherapyNo drug interventionsdiagnosticNot Availablerecruiting
NCT01990521
Prostate Screening Study Using MRI in BRCA CarriersNo drug interventionstreatmentNot Availablerecruiting
NCT02494921
LEE011 (Ribociclib) in Combination With Docetaxel Plus Prednisone in mCRPCtreatment1 / 2completed
NCT00849121
Two-Arm Study of a DNA Vaccine Encoding Prostatic Acid Phosphatase (PAP) in Patients With Non-Metastatic Castrate-Resistant Prostate Cancertreatment2completed
NCT04535921
Fear of Cancer Recurrence in Genitourinary CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT06353321
Non-significant Risk (NSR) Study of [68Ga]-PSMA-11 (Illuccix) as a BgRT BioGuide on RefleXion X1No drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT03271502
Effect of Anesthesia on Optic Nerve Sheath Diameter in Patients Undergoing Robot-assisted Laparoscopic ProstatectomyNo drug interventionsotherNot Availablecompleted
NCT04575402
Digitally Captured Activity Data and PROs to Monitor Physical Function in Prostate Cancer PatientsNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT05926102
The Prostate Cancer, Genetic Risk, and Equitable Screening Study (ProGRESS)No drug interventionsscreeningNot Availablerecruiting
NCT01812902
Prospective Study Comparing Extended With Limited Pelvic Lymphadenectomy in Intermediate and High Risk Prostate Cancer Patients Undergoing Radical ProstatectomyNo drug interventionshealth_services_researchNot Availablecompleted
NCT06165302
Exercise in Prostate CancerNo drug interventionsotherNot Availablenot_yet_recruiting
NCT01716702
A Feasibility Study of an Online Intervention for Sexual Rehabilitation in Prostate CancerNo drug interventionssupportive_careNot Availablecompleted
NCT00824902
Evaluation Ultrasound Elasticity/Tissue Strain-Hardening Imaging for Prostate Cancer Patients Undergoing Radical ProstatectomyNo drug interventionstreatmentNot Availableterminated
NCT00126802
The Role of Tomotherapy in Hypofractionated/Dose Escalated Conformal Radiation Treatment for High Risk Prostate CancerNo drug interventionstreatment1 / 2unknown_status
NCT01594502
Validation of Digital Morphometry for Cancer Risk in Benign Prostate BiopsiesNot AvailableNot Availablecompleted
NCT00295802
Ablatherm Integrated Imaging High Intensity Focused Ultrasound for the Indication of Low Risk, Localized Prostate CancerNo drug interventionstreatment2 / 3unknown_status
NCT00421902
Acupuncture Treatment for Hot Flashes StudyNo drug interventionstreatmentNot Availablecompleted
NCT00964002
Efavirenz in Treating Patients With Metastatic Prostate Cancertreatment2completed
NCT00433602
Incidence of Blood Clots in Patients Undergoing Chemotherapy for Solid TumorsNo drug interventionsNot AvailableNot Availablecompleted
NCT04420702
Diffusion Basis Spectrum Imaging of the ProstateNo drug interventionsdiagnosticNot Availablerecruiting
NCT05389202
Study of Prostate Perfusion Before Embolization in Patients With Symptomatic Prostate AdenomaNo drug interventionstreatmentNot Availableunknown_status
NCT03853902
Mindfulness Online for Symptom Alleviation and Improvement in Cancer of the ProstateNo drug interventionssupportive_careNot Availablecompleted
NCT00077402
Fenretinide In Treating Patients With Advanced or Metastatic Hormone-Refractory Prostate Cancertreatment2completed
NCT04825002
Detection of Clinically Significant Prostate Cancer Using a Urinary Multimarker SensorNo drug interventionsdiagnosticNot Availableunknown_status
NCT02440802
Evaluation and Predictive Value of Genetic Polymorphisms in the Management of Hormonal Treatment of Prostate CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT00856102
Exercise and Cognitive-psychosocial Functions in Men With Prostate Cancer Receiving Androgen Depletion TherapyNo drug interventionstreatmentNot Availablecompleted
NCT04015102
A Registry for Hereditary Cancer Risk Assessment and Genetic TestingNo drug interventionsNot AvailableNot Availablecompleted
NCT00241384
Low Dose Supplemental External Radiation With Pd-103 Versus Pd-103 Alone for Prostate CancerNo drug interventionstreatment3completed
NCT01694784
Understanding and Discouraging Overuse of Potentially Harmful Screening TestsNo drug interventionspreventionNot Availablecompleted
NCT05923684
NLP-Based Feedback to Improve Risk Comms and Informed Shared Decision MakingNo drug interventionshealth_services_researchNot Availablerecruiting
NCT04809584
18F-DCFPyL PET/MRI in Regional Nodal&Distant Metastases Detection in Intermediate &HR Prostate CancerNot AvailableNot Availabletemporarily_not_available
NCT05109884
Comparison of PET Imaging Patterns With PSMA and AR Expression in Prostate Cancer and Bladder CancerNo drug interventionsdiagnosticNot Availablecompleted
NCT00342784
Identification of Prostate Cancer GenesNo drug interventionsNot AvailableNot Availablecompleted
NCT00258284
Capecitabine and Docetaxel in Treating Patients With Metastatic Prostate Cancertreatment2completed
NCT03284684
Kinetics of Perioperative Circulating DNA in Cancer SurgeryNo drug interventionsNot AvailableNot Availablecompleted
NCT00303784
Prostate Adenocarcinoma TransCutaneous Hormonestreatment3unknown_status
NCT06122584
Diagnostic Performance of [18F]PSMA-1007 PET/CT Imaging in Patients With Newly-Diagnosed Prostate CancerNo drug interventionsdiagnostic3recruiting
NCT00899184
DNA Changes in Patients With Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT06274684
Feasibility of Virtual Reality Assistance in Prostate Biopsy Under Local Anesthesia.No drug interventionstreatmentNot Availablenot_yet_recruiting
NCT03028584
Survivorship Care Plans in a Community Oncology PracticeNo drug interventionsNot AvailableNot Availablecompleted
NCT02721784
Serial mpMRI (Multi Parametric Magnetic Resonance Imaging) Scanning in Prostate Cancer After Androgen Deprivation Therapy and RadioTherapyNo drug interventionsdiagnostic1 / 2unknown_status
NCT02621684
Physical Activity Intervention in African American Men After Radical ProstatectomyNo drug interventionssupportive_careNot Availablewithdrawn
NCT00523484
Casodex/Zoladex Hormonal therApy Study for assessMent of Correlation Between PSA & BAI in prOstate Cancer patieNtsNo drug interventionsNot AvailableNot Availablecompleted
NCT05840484
Comprehensive Monitoring of Men With Prostate Cancer Cared for by "Active SurveillanceNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT03739684
Study of 18F-DCFPyL PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancerdiagnostic3completed
NCT01673984
GP Extended Action Triptorelintreatment4terminated
NCT02483884
PET/CT Imaging Study of the Safety and Diagnostic Performance of [68Ga]RM2 in Patients With Primary Prostate Cancerdiagnostic1 / 2terminated
NCT02968784
Focal ExAblate MR-Guided Focused Ultrasound Treatment for Management of Organ-Confined Intermediate Risk Prostate CancerNo drug interventionstreatmentNot Availableterminated
NCT00765479
Soy Protein in Preventing Recurrent Cancer in Patients Who Have Undergone Surgery for Stage II Prostate CancerNo drug interventionstreatment2 / 3completed
NCT02274779
Salvage Radiotherapy Combined With Hormonotherapy in Oligometastatic Pelvic Node Relapses of Prostate Cancertreatment2active_not_recruiting
NCT05383079
Combination of Radium-223 and Lutetium-177 PSMA-I&T in Men With Metastatic Castration-Resistant Prostate Cancertreatment1 / 2recruiting
NCT00004879
Monoclonal Antibody ABX-EGF in Treating Patients With Renal (Kidney), Prostate, Pancreatic, Non-Small Cell Lung, Colon or Rectal, Esophageal, or Gastroesophageal Junction Cancertreatment1completed
NCT04271579
Early Prostate Cancer Recurrence With PSMA PET Positive Unilateral Pelvic Lesion(s)No drug interventionstreatmentNot Availablerecruiting
NCT04478279
A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumorstreatment1 / 2active_not_recruiting
NCT03634579
MRI Guided Prostate Cancer Focal Laser AblationNo drug interventionstreatmentNot Availableterminated
NCT06237179
Behavioral Exercise Training to Reduce Cardiovascular Disease RiskNo drug interventionssupportive_care1 / 2recruiting
NCT05099679
Pilot Study for Black Men With Prostate Cancer: Optimization Of Mental and Heart Health, the BOOM-Heart StudyNo drug interventionssupportive_careNot Availablerecruiting
NCT01607879
Use of β-hydroxy-β-methylbutyrate to Counteract Muscle Loss in Men With Prostate Cancer on Androgen Ablationsupportive_care2completed
NCT00911079
Pilot Study of a Catheter-based Ultrasound Hyperthermia SystemNo drug interventionsdevice_feasibilityNot Availableterminated
NCT03602079
Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 GeneNo drug interventionstreatment1 / 2completed
NCT02190279
18F-DCFBC PET/CT in Prostate Cancerdiagnostic0completed
NCT01025479
Prevalence of Osteoporosis in Korean Prostate Cancer Patients Who is Receiving LHRH Agonist and/or Anti-androgen AgentNo drug interventionsNot AvailableNot Availablecompleted
NCT02584179
Biparametric MRI for Detection of Significant Prostate CancerNo drug interventionsdiagnosticNot Availablecompleted
NCT04304079
A Novel Augmented Reality System (ARssist) for the Assistant Surgeon in Robotic Assisted SurgeryNo drug interventionstreatmentNot Availablewithdrawn
NCT02278679
Digital Rectal Exam Proficiency ToolNo drug interventionsNot AvailableNot Availableunknown_status
NCT06584279
Diagnostic Value of MRI-targeted Plus Index-lesion-ipsilaterally Systematic Biopsy for Biopsy-naive Men at Risk of Prostate Cancer: a Prospective, Multicenter, Paired, Non-inferiority TrialNo drug interventionsNot AvailableNot Availablerecruiting
NCT02454543
Impact of Radical Prostatectomy as Primary Treatment in Patients With Prostate Cancer With Limited Bone MetastasesNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT03793543
Test-Retest Reproducibility of 18F-DCFPyL PET/CT in the Evaluation of Patients With Metastatic Prostate Cancerdiagnostic1completed
NCT00732043
Extension to Study of Effects of Pomegranate Extract on Rising PSA Levels After Primary Therapy for Prostate CancerNo drug interventionsprevention2unknown_status
NCT04060043
Pilot Study to Evaluate the Effects of a Generic Goserelin Acetate in Patients With Prostate Cancertreatment0completed
NCT03529643
Effect of Anesthetic Method on Optic Nerve Sheath Diameter in Patients Undergoing RALPotherNot Availablecompleted
NCT05209243
START-MET HS Prostate Cancer. : SbrT & Androgen Receptor Therapy METastatic HSPCNo drug interventionstreatmentNot Availablerecruiting
NCT04555343
Intravesical Antifibrinolytic for Patients With Hematuria and Clot Retentiontreatment1 / 2completed
NCT01059643
A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Necktreatment2completed
NCT06270043
Focal Therapy for Localized Prostate CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT00136487
Celecoxib (Celebrex) Versus Placebo in Men With Recurrent Prostate Cancertreatment2 / 3completed
NCT03572387
A Pilot Study of 5-AZA and ATRA for Prostate Cancer With PSA-only Recurrence After Local Treatmenttreatment2completed
NCT00633087
A Phase I/II Trial of 2-Deoxyglucose (2DG) for the Treatment of Advanced Cancer and Hormone Refractory Prostate Cancertreatment1 / 2terminated
NCT04321187
Influence of Prostate Cancer Radiation on AgingNo drug interventionsNot AvailableNot Availablecompleted
NCT01320787
18-F-Fluoroacetate as PET Imaging Agentdiagnostic1withdrawn
NCT04718987
Potency pReservation In Prostate cAncer Patients Treated With UltraSound-guided Low-dose Rate BrachytherapyNo drug interventionspreventionNot Availablerecruiting
NCT05279287
Video Analysis of Errors and Technical Performance Within Minimally Invasive Surgery Short Title: Video Analysis in Minimally Invasive Surgery (VAMIS)No drug interventionsNot AvailableNot Availablerecruiting
NCT00798187
Efficacy of Cancer Support Programs: A Social Comparison Theory AnalysisNo drug interventionsNot AvailableNot Availableterminated
NCT02420587
AMG 208 Tumor Microenvironment in Metastatic Castration Resistant Prostate Cancer (mCRPC)treatment2withdrawn
NCT01692587
Does Protein Restriction Inhibit Prostrate Cancer GrowthNo drug interventionsbasic_scienceNot Availablecompleted
NCT02680587
Stereotactic Body Radiation for Prostate OligometastasesNo drug interventionstreatment2completed
NCT05787587
A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid TumorsNo drug interventionstreatment1recruiting
NCT01188187
Comparison of Docetaxel/Prednisone to Docetaxel/Prednisone in Combination With OGX-011 in Men With Prostate Cancertreatment3completed
NCT01286987
Study of Talazoparib, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumorstreatment1completed
NCT00828633
Health-Related Quality of Life in Gay Men With Localized Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT02620033
Impact of Yoga As Complementary Therapy in Patients Undergoing Radical ProstatectomyNo drug interventionssupportive_careNot Availablecompleted
NCT00003633
Combination Chemotherapy in Treating Patients With Advanced Prostate Cancertreatment1unknown_status
NCT03920033
Salvage Hypofractionated Accelerated Versus Standard Radiotherapy for Biochemical Failure After ProstatectomyNo drug interventionstreatmentNot Availablerecruiting
NCT02623933
MRI Assisted Focal Boost With HDR Monotherapy for Prostate Cancer PatientsNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT01681433
OGX-427 in Metastatic Castrate-Resistant Prostate Cancer With Prostate-Specific Antigen Progression While Receiving Abirateronetreatment2terminated
NCT00937833
Return of Continence Following Robot-Assisted Radical Prostatectomy With or Without a Urethrovesical SlingNo drug interventionspreventionNot Availablecompleted
NCT00519233
AGS-1C4D4 in Patients With Advanced Hormone Refractory Prostate Cancertreatment1completed
NCT03029533
Phase 1 Study to Evaluate the Pharmacokinetics and Safety Following SC Administration of DWJ108J in Patients With Prostate Cancertreatment1unknown_status
NCT02146833
SHIP (Selinexor in Hormone Insensitive Prostate Cancer)treatment2terminated
NCT00685633
Bicalutamide With or Without Enzastaurin in Treating Patients With Prostate Cancertreatment2withdrawn
NCT01513733
The CATCH Prostate Cancer Trial: Cabazitaxel And Tasquinimod in Men With Prostate Cancertreatment1completed
NCT02243033
Phase II Laser Focal Therapy of Prostate CancerNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT03169933
Combined, Intensified and Modulated Adjuvant Therapy in Prostate CarcinomaNo drug interventionstreatmentNot Availablecompleted
NCT00002633
Hormone Therapy With or Without Surgery or Radiation Therapy in Treating Patients With Prostate Cancertreatment3completed
NCT01643954
Retrospective/Prospective Analysis of Surgical Outcomes of Robotic Prostatectomy at The JamesNo drug interventionsotherNot Availableactive_not_recruiting
NCT00780754
Prevention of Prostate Cancer With Dutasteride in Case of High Grade PIN Neoplasiaprevention3completed
NCT03436654
Multi-arm Multi-modality Therapy for Very High Risk Localized and Low Volume Metastatic Prostatic Adenocarcinomatreatment2active_not_recruiting
NCT03740854
The Effects of Two Different Ventilation Strategies on Lung Ventilation: An Ultrasonographic Evaluation.No drug interventionsdiagnosticNot Availableunknown_status
NCT00087854
Study of Individualized Amonafide to Treat Prostate Cancertreatment1 / 2completed
NCT04249154
Postop Hypofractionated Radiation Therapy and LHRH in Patients With Prostate Cancertreatment2recruiting
NCT00242554
Open-label Phase IV Clinical Trial to Evaluate the Safety and Tolerability of Zoledronic Acid in Patients With Prostate Cancer and Bone Metastasestreatment4completed
NCT02111954
Ga-68-NODAGA-MJ9 Compared to F-18-FCH PET/CT for Prostate Cancer PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT04115254
Stereotactic Magnetic Resonance Guided Radiation TherapyNo drug interventionstreatmentNot Availablesuspended
NCT00020254
Vaccine Therapy Plus Sargramostim and Interleukin-2 Compared With Nilutamide Alone in Treating Patients With Prostate Cancertreatment2completed
NCT02342054
Single Fraction Real-time High-Dose-Rate Brachytherapy in Patients With Low and Intermediate Risk Prostate CancerNo drug interventionstreatment2unknown_status
NCT02275754
Redes III Patient Navigator Qol StudyNo drug interventionssupportive_careNot Availablecompleted
NCT00678054
Study of Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) for Patients With Rising Prostate-Specific Antigen (PSA)No drug interventionstreatment2completed
NCT03579654
Study of Proscavax Vaccine in Patients With Localized Prostate Cancer vs Active SurveillanceNo drug interventionstreatment2unknown_status
NCT04194554
A Multi-Center Trial of Androgen Suppression With Abiraterone Acetate, Leuprolide, PARP Inhibition and Stereotactic Body Radiotherapy in Prostate Cancertreatment1 / 2recruiting
NCT03062254
Metabolic Change in Prostate Cancer Bone Metastases on 68Ga-HBED-CC-PSMA PET/CT Following Radium-223 Therapybasic_science2completed
NCT04424654
Biomarker Analysis of Castration-resistant Prostate Cancer Undergoing Bipolar Androgen Therapytreatment2completed
NCT00134654
Two Doses of Conjugated Estrogen (Premarin) in Patients With Androgen-Independent Prostate Cancertreatment2completed
NCT04302454
Androgen Deprivation Therapy for Oligo-recurrent Prostate Cancer in Addition to radioTherapytreatment3recruiting
NCT02895854
LDR Brachytherapy Versus SBRT for Low and Intermediate Risk Prostate Cancer PatientsNo drug interventionstreatmentNot Availableunknown_status
NCT03440554
Non-contrast MR Imaging for Whole Body Cancer Detection and CharacterizationNo drug interventionsdiagnosticNot Availableunknown_status
NCT01727154
Immune Monitoring Protocol in Men With Prostate Cancer Enrolled in a Clinical Trial of Sipuleucel-TNot AvailableNot Availableterminated
NCT01354951
Assessing the Potential for Reduced Toxicity Using Focal Brachytherapy in Early Stage, Low Volume Prostate CancerNo drug interventionstreatment2terminated
NCT02391051
Focal Brachytherapy in Patients With Selected "Low-risk" Prostate Cancer - a Phase-II-trialNo drug interventionstreatment2recruiting
NCT00734851
Multimodality Phase II Study in Prostate Cancertreatment2terminated
NCT06250751
Behavioral Exercise TRaining for Men Undergoing Androgen Depr Therapy for Prostate CaNo drug interventionssupportive_careNot Availablerecruiting
NCT04953351
MRI-Ultrasound Fusion or Cognitive Registration in MR-targeted Prostate BiopsyNo drug interventionsdiagnosticNot Availableunknown_status
NCT01902251
Relative Bioavailability Study of Enzalutamide in Prostate Cancer Patientsbasic_science1completed
NCT05886751
Randomized Trial of Trust in Online Videos About Prostate CancerNo drug interventionsotherNot Availablecompleted
NCT03999151
Diet and Exercise Interventions Among Men With Prostate Cancer (Prostate 8-II)No drug interventionspreventionNot Availableactive_not_recruiting
NCT04478851
EXCEL: Exercise for Cancer to Enhance Living WellNo drug interventionssupportive_careNot Availablerecruiting
NCT03389451
68Ga PSMA PET for Patients With Biochemical Recurrence of Prostate Cancerdiagnostic2 / 3completed
NCT03675451
PSMA Imaging of Localized Prostate Cancerdiagnostic2completed
NCT00507351
Ambulatory Cancer Pain Management: A Feasibility StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT02362451
Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Men With Stage D0 Prostate CancerNo drug interventionstreatment2terminated
NCT01275651
Biomarkers in Bone Marrow and Blood Samples From Patients With Prostate Cancer Treated With KetoconazoleNo drug interventionsNot AvailableNot Availablewithdrawn
NCT06271551
Transdermal Estradiol and Exercise in Mitigating Adverse Effects of Androgen Deprivation Therapy for Prostate Cancer Radiation Therapytreatment2not_yet_recruiting
NCT01834651
A Phase II Study of Cabozantinib (XL184) Therapy in Castrate Resistant Prostate Cancer (CRPC) With Visceral Metastasestreatment2completed
NCT03770351
Early Prostate Cancer: Predicting Treatment ResponseNo drug interventionsNot AvailableNot Availableunknown_status
NCT05596851
Radio-guided Surgery With DROP-IN Beta Probe for 68Ga-PSMA, in High-risk Prostate Cancer Patients Eligible for Robotic-assisted Radical Prostatectomy.No drug interventionsNot AvailableNot Availablerecruiting
NCT00002651
SWOG-9346, Hormone Therapy in Treating Men With Stage IV Prostate Cancertreatment3completed
NCT00695851
Dose-Seeking Trial of PCK3145 in Asymptomatic, Castrate Metastatic Prostate Cancer Patients.treatment1completed
NCT01492751
Effectiveness of Localized Prostate Cancer TreatmentsNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT03802851
HoLEP Prior to Radiation Therapy for Patients With LUTS/Retention and Concurrent Prostate CancerNo drug interventionstreatmentNot Availablerecruiting
NCT04889651
A Study to Compare the Pharmacokinetics and Safety Between BR9004 and BR9004-1 in Healthy Male Volunteerstreatment1completed
NCT02918253
HDR Focal: Feasibility StudyNo drug interventionstreatmentNot Availablerecruiting
NCT00246753
Lapatinib in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapytreatment2completed
NCT01717053
Abiraterone, Radiotherapy and Short-Term Androgen Deprivation in Unfavorable Localized Prostate Cancertreatment2completed
NCT03650153
Randomized Controlled Trial of MRI Target Biopsy: Transrectal vs. TransperinealNo drug interventionsdiagnosticNot Availablecompleted
NCT01412853
Spectro-IRM and Evaluation Response to Prostatic RadiotherapyNo drug interventionsdiagnosticNot Availablecompleted
NCT02702453
True NTH Sexual Recovery Intervention for Prostate Cancer Survivors and Their PartnersNo drug interventionssupportive_careNot Availablecompleted
NCT04089553
An Open-label, Phase II Study of AZD4635 in Patients With Prostate Cancertreatment2completed
NCT01366053
Hormone Sensitive Prostate Cancer Patients Switched to Degarelix Therapy After Failing on GnRH AgonistsNo drug interventionsNot AvailableNot Availablecompleted
NCT04172753
Feasibility of Online MR-guided Radiotherapy on a 1.5T MR-LinacNo drug interventionstreatmentNot Availablerecruiting
NCT05073653
A Study of 68Ga-GRP PET/CT for Imaging in Low and Intermediate Risk Prostate CancerNo drug interventionsdiagnosticNot Availableunknown_status
NCT03724253
[68Ga]-NeoBOMB1 Imaging in Patients With Malignancies Known to Overexpress Gastrin Releasing Peptide Receptor (GRPR)No drug interventionsdiagnostic2terminated
NCT00714753
Internal Radiation Therapy With or Without External-Beam Radiation Therapy in Treating Patients With Localized Prostate CancerNo drug interventionstreatment2completed
NCT06014853
A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of SOL-804 in Healthy Male Subjectstreatment1completed
NCT01533753
Quality of Life Study Using Gabapentin Versus Venlafaxine in Treating Hot Flashes in Patients With Prostate Cancertreatment2terminated
NCT04136353
Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the Prostatetreatment3active_not_recruiting
NCT01741753
BKM120+Abiraterone Acetate for Metastatic CRPCtreatment1terminated
NCT01835977
Multi-Center Randomized Clinical Trial Irreversible Electroporation for the Ablation of Localized Prostate CancerNo drug interventionstreatment2active_not_recruiting
NCT00002677
Tributyrin in Treating Patients With Refractory Prostate Cancer or Other Solid Tumorstreatment1completed
NCT03857477
The BARCODE 1 Study (Full Study): The Use of Genetic Profiling to Guide Prostate Cancer Targeted Screening.No drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT05539677
Biobank and Register of Patients With Agresive Tumors for Translational and Analytical ResearchNo drug interventionsNot AvailableNot Availablerecruiting
NCT05955677
Head-to-head Comparison of [68Ga]Ga-PSMA-D5 With [68Ga]Ga-PSMA-11 PET/CT in PCa Diagnosis, Recurrence, and MetastasisNo drug interventionsdiagnostic0recruiting
NCT00030277
High-Intensity Focused Ultrasound in Treating Patients With Locally Recurrent Prostate CancerNo drug interventionstreatment1completed
NCT01717677
Evaluation of Four Treatment Modalities in Prostate Cancer With Low or "Early Intermediate" RiskNo drug interventionstreatmentNot Availableterminated
NCT05239377
MiProstate - Information Hub for the Prostate Cancer Care FlowNo drug interventionsNot AvailableNot Availablecompleted
NCT00958477
A Study to Determine the Safety, Tolerability, Pharmacokinetics and Dynamic Effects of Different Doses of the Study Drug EMD 525797 in Prostate Cancertreatment1completed
NCT00054977
Safety of GM-CT-01 With and Without 5-Fluorouracil in Patients With Solid Tumorstreatment1completed
NCT05056077
Improving Nutrition and Physical Activity for Cancer Survivors (Tools To Be Fit)No drug interventionssupportive_careNot Availablerecruiting
NCT04794777
Comparing "Salvage" Radiotherapy and Individualized PSMA PET/CT Targeted Treatment in With Relapsing Prostate CancerNo drug interventionstreatment3recruiting
NCT04146077
Active Surveillance for Low Risk Prostate CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT05001477
Customized TULSA-PRO Ablation RegistryNo drug interventionsNot AvailableNot Availablerecruiting
NCT03458247
Study of Dose Escalation of Abiraterone Actetate in Prostate Cancertreatment2completed
NCT00270647
Physicians' Health Study IINo drug interventionspreventionNot Availablecompleted
NCT06385847
To Assess The Patient Preference for Goserelin Microsphere Versus Goserelin Implant in Patients With Prostate Cancerother2recruiting
NCT04281147
Study to Gather Information About the Use of Healthcare Services and the Way the Disease is Cared for in Canadian Patients With Prostate Gland Cancer Which Spread Throughout the BodyNot AvailableNot Availablecompleted
NCT01968447
Effect of Neuromuscular Block and Arterial PCO2 on Surgical Rating Scale (SRS), Following Reversal With SugammadexNo drug interventionstreatmentNot Availablecompleted
NCT00151047
Docetaxel Plus Capecitabine in Newly Diagnosed Localized or Locally Advanced Prostate Cancertreatment2completed
NCT00305747
Diindolylmethane in Treating Patients With Nonmetastatic Prostate Cancer That Has Not Responded To Previous Hormone Therapytreatment1completed
NCT05323747
Prospective Evaluation of a Commercially Available Hydrogel SpacerNo drug interventionsNot AvailableNot Availablecompleted
NCT04320147
MR-target Biopsy vs. TRUS-biopsy in Men With Suspicious Prostate CancerNo drug interventionsdiagnosticNot Availableunknown_status
NCT02623647
A Phase I-II Study on Stereotactic Body Radiotherapy in 3 Fractions for Low/Int Risk Prostate CancerNo drug interventionstreatmentNot Availableunknown_status
NCT00087347
Magnetic Resonance Imaging of Lymph Nodes Using Ferumoxytol in Patients With Primary Prostate or Breast CancerNot AvailableNot Availablecompleted
NCT00041847
Gene-Environment Interaction in Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT02033447
Magnetic Nanoparticle Thermoablation-Retention and Maintenance in the Prostate:A Phase 0 Study in MenNo drug interventionsother0completed
NCT06565247
Evaluation of PSMA-PET and mpMRI in High-risk Prostate Cancer - Using Histopathologic ValidationNo drug interventionsdiagnostic3not_yet_recruiting
NCT02462447
Carbon-11 Labeled Sarcosine in Prostate CancerNot AvailableNot Availablecompleted
NCT05574647
Imperial Prostate 7 - Prostate Assessment Using Comparative Interventions - Fast Mri and Image-fusion for CancerNo drug interventionsdiagnosticNot Availablerecruiting
NCT00005847
Chemotherapy With or Without Biological Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapytreatment2completed
NCT00004045
Chemotherapy in Treating Patients With Prostate Cancertreatment2completed
NCT03070145
Exercise Intervention Among Men With Prostate Cancer Initiating Androgen Deprivation TherapyNo drug interventionssupportive_careNot Availablecompleted
NCT02135445
Safety and Efficacy of TAK-385 for Patients With Localized Prostate Cancertreatment2completed
NCT00078845
Amifostine in Treating Peripheral Neuropathy Caused by Paclitaxel in Patients With Solid Tumorssupportive_care2completed
NCT04340245
Exploiting Risk-Based Risk Stratification in Early Prostate Cancer to Discriminate Progressors From Non-ProgressorsNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT00992745
A Phase I Pilot Study Comparing 123I MIP 1072 Versus 111In Capromab Pendetide in Subjects With Metastatic Prostate Cancerdiagnostic1completed
NCT03386045
Optimal Prostate StudyNo drug interventionstreatmentNot Availablerecruiting
NCT04322045
Combined Prostate-specific Antigen, Multi-parametric MRI and Targeted Prostate Biopsy for Prostate Cancer ScreeningNo drug interventionsscreeningNot Availableunknown_status
NCT00090545
A Phase II Study of BAY 43-9006 (Sorafenib) in Metastatic, Androgen-Independent Prostate Cancertreatment2completed
NCT03465345
Study of Metformin Plus Oligomeric Procyanidin Complex for Pharmacologic Manipulation of AGE (Advanced Glycation Endproducts) Levels in Prostate Cancer Patientstreatment1withdrawn
NCT00767845
Symptom Management in African-American Men With Localized Prostate CancerNo drug interventionsNot AvailableNot Availablewithdrawn
NCT03193645
Observational Prospective Study Describing the Global Patient Care and Follow-up of Prostate Cancer Patients Treated With DegarelixNot AvailableNot Availablecompleted
NCT04489745
Stereotactic Body Radiotherapy (SBRT) for Localized Prostate CancerNo drug interventionstreatment2active_not_recruiting
NCT00052845
Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapytreatment2completed
NCT02451345
Decision Support Tools for Men With Prostate Cancer- Clinical & Lifestyle ModelNo drug interventionsotherNot Availablecompleted
NCT06451445
A Pan-Canadian, Investigator Initiated Clinical Trial With Focal IRE Directed to Intermediate-Risk Prostate CancerNo drug interventionstreatmentNot Availablerecruiting
NCT00003045
Hyperthermia Plus Radiation Therapy in Treating Patients With Nonmetastatic Advanced Prostate CancerNo drug interventionstreatmentNot Availablecompleted
NCT00321698
Radiation Therapy and Docetaxel in Treating Patients Who Are Undergoing Surgery for Localized Prostate Cancertreatment1 / 2terminated
NCT04995198
PROMISE Registry: A Prostate Cancer Registry of Outcomes and Germline Mutations for Improved Survival and Treatment EffectivenessNo drug interventionsNot AvailableNot Availablerecruiting
NCT01171898
Safety, Pharmacokinetic and Proof-of-Concept Study of ARN-509 (Apalutamide) in Castration-Resistant Prostate Cancer (CRPC)No drug interventionstreatment1 / 2active_not_recruiting
NCT05772598
Validating the 'Sexual Minorities and Prostate Cancer Scale' to Gold Standard QuestionnairesNo drug interventionsNot AvailableNot Availablecompleted
NCT02886598
Safety and Efficacy of Firmagon® (Degarelix) for InjectionNot AvailableNot Availablecompleted
NCT02796898
Study of the Efficacy, Safety, and Pharmacokinetics of SM88 in Patients With Prostate CancerNo drug interventionstreatment1 / 2completed
NCT01448798
Athermal Nerve-sparing During Robotic-assisted Radical Prostatectomy Using a Hemostatic Matrix.No drug interventionstreatmentNot Availableunknown_status
NCT01960998
Perioperative Post-Prostatectomy Incontinence Home Telehealth ProgramNo drug interventionstreatmentNot Availablecompleted
NCT00348998
Bevacizumab, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancertreatment2unknown_status
NCT00511498
Effect of Nightly Versus Prn Sildenafil on Early Return of Erectile Function Following Laparoscopic Radical ProstatectomyNot AvailableNot Availablecompleted
NCT04507698
INTERVAL - Intense Exercise Trial for Men With Metastatic Castrate-Resistant Prostate CancerNo drug interventionsbasic_scienceNot Availableunknown_status
NCT05762198
Comparing Water Vapour Thermal Therapy (Rezūm) and TURPNo drug interventionstreatmentNot Availablerecruiting
NCT03182998
Decision Aids to Improve Knowledge in Patients With Prostate CancerNo drug interventionsotherNot Availablecompleted
NCT00887198
Abiraterone Acetate in Asymptomatic or Mildly Symptomatic Patients With Metastatic Castration-Resistant Prostate Cancertreatment3completed
NCT04558398
Impact of Exercise on Mitochondria in Cancer Patients.No drug interventionsbasic_scienceNot Availableactive_not_recruiting
NCT01710098
Treatment of Prostate Cancer With Firmagon®Not AvailableNot Availablecompleted
NCT05940298
Molecular Imaging of Gastrin Releasing Peptide Receptors Using Labeled Technetium-99m DB8No drug interventionsdiagnostic1recruiting
NCT04220398
Neoadjuvant Chemo-hormonal Therapy Combined With Radical Prostatectomy for Locally Advanced Prostate CancerNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT00244998
Fulvestrant in Treating Patients With Advanced Prostate Cancertreatment2completed
NCT02313298
Stereotactic Body Radiotherapy for Organ Confined Prostate CancerNo drug interventionstreatment2unknown_status
NCT03652298
Effects of a Neuroscience-based Technique on Cancer Patients Announced of a Palliative Disease Progression and PartnersNo drug interventionsprevention2terminated
NCT02518698
Treatment Patterns in Castrate Resistant Prostate Cancer Patients With Bone Metastases in a Medicare PopulationNot AvailableNot Availablecompleted
NCT05324098
Leveraging Technology to Achieve Equity for Men With Prostate Cancer on Androgen Deprivation TherapyNo drug interventionshealth_services_researchNot Availablecompleted
NCT02324998
Study of Olaparib (± Degarelix) Given to Men With Intermediate/High Risk Prostate Cancer Before Prostatectomyother1completed
NCT03810105
A Study of Olaparib and Durvalumab in Prostate Cancertreatment2terminated
NCT05129605
Prostate Cancer Genetic Risk Evaluation and Screening StudyNo drug interventionsNot AvailableNot Availablerecruiting
NCT00751205
Prevention of Sagopilone-induced Neurotoxicity With Acetyl-L-Carnitine (ALC)treatment2completed
NCT01230905
Study to Monitor the Effects of Androgen Suppression Treatment on the HeartNo drug interventionsscreening4completed
NCT02302105
Randomized Trial of Prostate Only or Pelvic RT in High Risk Prostate CancerNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT05764005
Optimizing Active Surveillance in Low-Risk Prostate Cancer: a Pilot StudyNo drug interventionshealth_services_researchNot Availablecompleted
NCT00684905
Leuprolide, Bicalutamide, and Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer After External-Beam Radiation Therapytreatment2completed
NCT03457805
Prostatic Artery Embolization in Advanced Prostate CancerNo drug interventionstreatmentNot Availableunknown_status
NCT06183905
Multi-parametric Ultrasound Versus Multi-parametric MRI for Prostate Cancer DetectionNo drug interventionsdiagnosticNot Availablenot_yet_recruiting
NCT01531205
Neoadjuvant Chemohormonal Therapy Followed by Salvage Surgery for High Risk PSAtreatment2terminated
NCT01692405
Semi-automatic Download of Prostate Biopsy Cores While Keeping the Orientation, Unfolding and Unity of the SampleNo drug interventionsdiagnosticNot Availablecompleted
NCT03381105
From PSA to Stockholm3: Study Part 1No drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT04536805
Relapse in Previously Irradiated Prostate Bed : Stereotactic Ablative Reirradiation Potentiated by Metformintreatment1 / 2recruiting
NCT02543905
The PROFILE Study: Germline Genetic Profiling: Correlation With Targeted Prostate Cancer Screening and TreatmentNo drug interventionsNot AvailableNot Availablerecruiting
NCT01160705
Biomarkers of Response to Taxotere in HRPC. ICORG 08-08, V2Not AvailableNot Availablecompleted
NCT01303705
Anti-OX40, Cyclophosphamide (CTX) and Radiation in Patients With Progressive Metastatic Prostate Cancertreatment1completed
NCT02993497
Respiratory Measurement Using Infrared Camera and Respiratory Volume Monitor (ExSpiron 1Xi) for Sedation in Patients Undergoing TURP/TURB Under Spinal AnesthesiaNo drug interventionssupportive_careNot Availablecompleted
NCT01753297
A Study of Immediate 9 Months Adjuvant Hormone Therapy With Triptorelin 11.25 mg Versus Active Surveillance After Radical Prostatectomy in High Risk Prostate Cancer Patients.treatment4completed
NCT01605097
High Dose Rate Prostate Brachytherapy: Dose Escalation to Dominant Intra-prostatic NoduleNo drug interventionstreatmentNot Availablecompleted
NCT03432897
BrUOG 337: Olaparib Prior to Radical Prostatectomy For Advanced Prostate Cancer Defects in DNA Repair Genestreatment2terminated
NCT05163197
Transperineal Laser Ablation Treatment (TPLA) for Prostate Cancer (PCa) RegistryNo drug interventionsNot AvailableNot Availablerecruiting
NCT00433797
Dietary Intervention With Phytochemicals and Polyunsaturated Fatty Acids in Prostate Cancer PatientsNo drug interventionstreatment1 / 2completed
NCT02555397
Phase 1 Trial of Interleukin 12 Gene Therapy for Locally Recurrent Prostate CancerNo drug interventionstreatment1unknown_status
NCT04832997
Micro-ultrasound for Prostate Cancer DiagnosisNo drug interventionsdiagnosticNot Availablerecruiting
NCT05644197
Multidisciplinary Care After ProstatectomyNo drug interventionssupportive_careNot Availablenot_yet_recruiting
NCT05146297
Diversity and Inclusion in Research Underpinning Prevention and Therapy TrialsNo drug interventionshealth_services_researchNot Availablerecruiting
NCT00329797
Zoledronate in Preventing Osteoporosis and Bone Fractures in Patients With Locally Advanced Nonmetastatic Prostate Cancer Undergoing Radiation Therapy and Hormone TherapyNo drug interventionssupportive_care3completed
NCT04176497
PSMA-PET/MRI Unfavorable-Risk Target Volume Pilot StudyNo drug interventionstreatment2active_not_recruiting
NCT03365297
Therapeutics in Active Prostate Cancer Surveillancetreatment2completed
NCT00035997
Open-label Trial on the Effect of I.V. Zoledronic Acid 4 mg on Bone Density in Hormone Sensitive Prostate Cancer Patients With Bone Metastasistreatment4completed
NCT00853697
Exogenous Testosterone Plus Dutasteride for the Treatment of Castrate Metastatic Prostate CancerNo drug interventionstreatment2completed
NCT02499497
A Selective Androgen Receptor Modulator for Symptom Management in Prostate Cancersupportive_care2completed
NCT01144897
PET Acetate for Castrate-Resistant Prostate Cancer on Chemotherapydiagnostic1completed
NCT00498797
E3-Hormone Refractory Prostrate Cancer Taxotere Combinationtreatment2completed
NCT02199197
Radium Ra 223 With Enzalutamide Compared to Enzalutamide Alone in Men With Metastatic Castration Refractory Prostate Cancertreatment2completed
NCT06451497
Phase 1 Trial of ZM008 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid TumorsNo drug interventionsother1recruiting
NCT05910697
Clinical Utility of MyProstateScore 2.0 P2No drug interventionsdiagnosticNot Availableterminated
NCT06408597
Mannitol Versus Nitroglycerin for Kidney Injury Prevention in Robotic-assisted Radical Prostatectomy or CystectomyNo drug interventionssupportive_careNot Availablerecruiting
NCT04299997
Evaluation of the PI-RADS v2.1 Score Using Multiple ReadersNo drug interventionsNot AvailableNot Availablecompleted
NCT00003183
Mitoxantrone and G-CSF in Treating Patients With Metastatic Prostate Cancertreatment1 / 2unknown_status
NCT01558583
Online Study of Colorectal Cancer and Prostate Cancer Screening Decision MakingNo drug interventionshealth_services_researchNot Availablecompleted
NCT06172283
Intermittent Fasting in Prostate Cancer Patients Receiving Androgen Deprivation TherapyNo drug interventionstreatmentNot Availablerecruiting
NCT04298983
Abemaciclib in Combination With Androgen Deprivation Therapy for Locally Advanced Prostate Cancertreatment2active_not_recruiting
NCT00188383
Effects of N-Methyl-D-Aspartate (NMDA)-Receptor Antagonism on Hyperalgesia, Opioid Use, and Pain After Radical Prostatectomyeducational_counseling_training1 / 2unknown_status
NCT02163083
Detection of Lymphnodes Using ICG During RARPNo drug interventionspreventionNot Availablecompleted
NCT01331083
A Phase II Study of PX-866 in Patients With Recurrent or Metastatic Castration Resistant Prostate Cancertreatment2completed
NCT02365883
Transrectal Photoacoustic Imaging of the ProstateNo drug interventionsNot AvailableNot Availableterminated
NCT04009083
Axumin PETMRI Imaging Following Focal Cryo-ablation (FCA)No drug interventionsdiagnosticNot Availablecompleted
NCT06052683
A Trial Evaluating Toxicity of SBRT and LDRB in Localized Prostate Cancer.No drug interventionstreatmentNot Availablerecruiting
NCT02759783
Conventional Care Versus Radioablation (Stereotactic Body Radiotherapy) for Extracranial OligometastasesNo drug interventionstreatment2 / 3active_not_recruiting
NCT02618161
Timing of HDR With EBRT in Localised Prostate Cancer,Toxicity and Quality of Life AssessmentNo drug interventionstreatmentNot Availablecompleted
NCT04742361
Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate CancerNo drug interventionsdiagnostic3active_not_recruiting
NCT02917161
Prostatic Artery Embolization Before Radical Prostatectomy in Prostate Cancer: A Proof-of-concept StudyNo drug interventionstreatmentNot Availablecompleted
NCT02091661
Radical Retropubic Prostatectomy Versus Conventional External Beam Radiotherapy for Clinically Localized Prostate CancerNo drug interventionstreatment3suspended
NCT05899361
A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of InterestNo drug interventionsdiagnosticNot Availablerecruiting
NCT01376661
Outcome Assessment of an Active Surveillance Program for Low Risk Prostate Cancer: An Observational StudyNo drug interventionsNot AvailableNot Availableterminated
NCT03725761
Sacituzumab Govitecan in Patients With Metastatic Castration-Resistant Prostate Cancer Progressing on Second Generation AR-Directed Therapytreatment2active_not_recruiting
NCT05710861
Cost-utility of Focal HIFU vs ProstatectomyNo drug interventionstreatmentNot Availablerecruiting
NCT00379561
PSA-Activated PSA-PAH1 for Locally Recurrent Prostate Cancertreatment1completed
NCT02706561
Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer SurgeryNo drug interventionssupportive_careNot Availablerecruiting
NCT01325961
Medico-economic Evaluation Comparing Intensity-Modulated Radiation Therapy (IMRT) Performed by Helical Tomotherapy and Dynamic Arc Therapy in Prostate, Cervical and Anal Canal CancersNo drug interventionsotherNot Availablecompleted
NCT06575361
Comprehensive Evaluation of MRI-AI in Prostate Cancer DiagnosisNo drug interventionsdiagnosticNot Availablerecruiting
NCT01777061
Clinical Management Decisions for Recurrent Prostate Cancer Patients Based on [11C]Acetate PET ScanNot AvailableNot Availableno_longer_available
NCT01656161
Study on Efficacy, Pharmacokinetics, and Safety of Two Subcutaneous Injections of Triptorelin Embonate 6 Month Formulation in Patients With Advanced Prostate Cancertreatment3completed
NCT01617161
Proton Therapy vs. IMRT for Low or Intermediate Risk Prostate CancerNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT00453661
Cancer Prevention and Treatment Demonstration for Ethnic and Racial MinoritiesNo drug interventionsNot AvailableNot Availablecompleted
NCT00483561
Gefitinib and Etoposide in Treating Patients With Advanced Prostate Cancer That Did Not Respond to Hormone Therapytreatment2terminated
NCT02425228
Prospective Assessment of Image Registration for the Diagnosis of Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT00564928
A Phase 2 Study to Investigate the Clinical Activity of IPI-504 in Patients With Hormone-resistant Prostate Cancertreatment2completed
NCT01538628
SpaceOAR System Pivotal StudyNo drug interventionstreatment3completed
NCT03093428
Study Evaluating the Addition of Pembrolizumab to Radium-223 in mCRPCtreatment2active_not_recruiting
NCT01478828
Pre-Prostatectomy Lovastatin on Prostate CancertreatmentNot Availableterminated
NCT05161728
PSMA Response in Metastasized Hormone Sensitive Prostate CancerNo drug interventionsdiagnosticNot Availablerecruiting
NCT02404428
Utilizing MRI to Study the Effect of Sulforaphane on Prostate CancerNo drug interventionsNot AvailableNot Availableterminated
NCT00103428
Intravenous CG7870 in Combination With Docetaxel in Patients With Metastatic Hormone-Refractory Prostate Cancertreatment1 / 2terminated
NCT04992728
Prostate Assessment With Restriction Spectrum Imaging (RSI) MRINo drug interventionsNot AvailableNot Availablerecruiting
NCT03541928
Phase II High Risk Prostate Cancer Trial Using Gene & Androgen Deprivation Therapies, Radiotherapy, & Surgerytreatment2unknown_status
NCT02149628
The Effect of Propofol Based Total Intravenous Anesthesia on Oxidative Stress and Nitric Oxideprevention4completed
NCT03447028
Effect of TyG Index on Outcomes of Radical ProstatectomyNo drug interventionsNot AvailableNot Availablecompleted
NCT00931528
Tadalafil in Preventing Erectile Dysfunction in Patients With Prostate Cancer Treated With Radiation Therapysupportive_care3completed
NCT00005828
Green Tea Extract in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone TherapyNo drug interventionstreatment2completed
NCT05471128
MRI Fusion Biopsy vs. Micro-Ultrasound Guided BiopsyNo drug interventionsNot AvailableNot Availablerecruiting
NCT02858128
WB-DW-MRI vs CHOLINE-PET/CT for Selecting Treatments in Recurrent Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT05225428
Video Education With Result Dependent dIsclosureNo drug interventionshealth_services_researchNot Availablerecruiting
NCT04081428
Using Breath, Cell Free DNA and Image Analysis to PRedIct Normal TissUe and Tumour Response During Prostate Cancer SBRTNo drug interventionsNot AvailableNot Availablerecruiting
NCT02643511
Hemiablative Focal Brachytherapy Pilot StudyNo drug interventionstreatment2recruiting
NCT03604211
SBRT for Oligometastatic Lymph Node Recurrence in Prostate Cancer: a Single Institution ExperienceNo drug interventionsNot AvailableNot Availablecompleted
NCT00698711
Vaccination of Prostate Cancer Patients With MUC-2-KLH Conjugate Plus the Immunological Adjuvant QS21treatment1completed
NCT02224911
Use of Laser Interstitial Thermal Therapy in the Focal Treatment of Localized Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT01672411
Predictive Value of Prostate-specific Antigen Isoform p2psa and Its Derivates in the Diagnosis of Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT00002511
Radiation Therapy Compared With No Further Treatment Following Surgery in Treating Patients With Prostate CancerNo drug interventionstreatment3completed
NCT03232411
Biobank for African American Prostate Cancer Research in FloridaNo drug interventionsNot AvailableNot Availablecompleted
NCT05188911
Analysis of Next Generation PET and Liquid Biopsy to Monitor mCRPC Treated With Abiraterone: ANGELA TrialNot AvailableNot Availableunknown_status
NCT03513211
Phase I/II Study of Hydroxychloroquine With Itraconazole With Biochemically Recurrent Prostate Cancertreatment1 / 2completed
NCT05381311
Survey Based Discrete Choice Experiment Study in Prostate Cancer (DECIDER) StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT00963911
Validation of a Screening Tool in Geriatric OncologyNo drug interventionsscreeningNot Availablecompleted
NCT00450411
Ultrasound-Guided Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer Previously Treated With External-Beam Radiation TherapyNo drug interventionstreatment2completed
NCT02919111
Gallium-68 PSMA-11 PET in Intermediate to High-risk Preprostatectomy Patientsdiagnostic2 / 3completed
NCT06193993
Effect of Low-dose 500 mg Abiraterone Acetate in Treatment of Metastatic Prostate Cancer Patientstreatment1active_not_recruiting
NCT06206993
Effects of Kieser Resistance Training Plus Kieser Pelvic Floor Training vs. Kieser Resistance Training Plus Traditional Pelvic Floor Exercise on Urinary Incontinence in Prostate Cancer Patients After Radical ProstatectomyNo drug interventionssupportive_careNot Availablecompleted
NCT00193193
Weekly Paclitaxel, Low-Dose Estramustine, and Carboplatin in the Treatment of Hormone Refractory Prostate Carcinomatreatment2completed
NCT05761093
Patient and Physician Benefit/ Risk Preferences for Treatment of mPC in Hong Kong: a Discrete Choice ExperimentNo drug interventionsNot AvailableNot Availablerecruiting
NCT06177093
De-escalated Dose SBRT in Localized Prostate Cancer (DESTINATION-MRL)No drug interventionstreatmentNot Availablerecruiting
NCT04854993
Recovery From dNMB Using Different Sugammadex Doses in Elderly Patients Undergoing Robot-assisted Prostatectomytreatment3completed
NCT01620593
Castration Compared to Castration Plus Metformin as First Line Treatment for Patients With Advanced Prostate Cancertreatment2completed
NCT02821793
Expectations and Priorities of Elderly Patients for a First Medical Treatment for CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT05081193
Safety and Efficacy of Oral Testosterone Undecanoate Followed by Enzalutamide as Therapy for Men With Metastatic Castrate Resistant Prostate Cancertreatment2recruiting
NCT06141993
ARCTIC: Liquid Biomarkers in the Prospective Androgen Receptor Signaling Inhibitors (ARSI) Resistance Clinical TrialsNo drug interventionsNot AvailableNot Availablerecruiting
NCT03630393
Ultralow Versus Standard Pneumoperitoneum PressureNo drug interventionstreatmentNot Availableterminated
NCT03909893
A Study of Adaptive Radiation Therapy for Pelvic Genitourinary CancerNo drug interventionstreatmentNot Availablewithdrawn
NCT00176293
Randomized Phase II Trial of Doxil With or Without Dexamethasone for Metastatic Hormone Refractory Prostate Cancertreatment2terminated
NCT00278993
Evaluating E7389 in Patients With Hormone Refractory Prostate Cancer With Advanced and/or Metastatic Disease Stratified by Prior Chemotherapytreatment2completed
NCT00980993
Quantification of Respiratory-induced Prostate MotionNo drug interventionsNot AvailableNot Availablewithdrawn
NCT00345293
Dendritic Cell Vaccine Study (DC/PC3) for Prostate CancerNo drug interventionstreatment1 / 2completed
NCT00016393
BMS-247550 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapytreatment2completed
NCT01987193
Feasibility Study of Tumor Blood Flow Measurement by Detection of Positron Activation Post Proton Therapy (DS01)No drug interventionsNot AvailableNot Availableterminated
NCT02139371
Evaluation of a New Radiotracer (64Cu-DOTA-AE105) for Diagnosing Aggressive Cancer With Positron Emission TomographyNo drug interventionsdiagnostic0completed
NCT02001571
A Study to Assess the Effect of Abiraterone Acetate in Male Participants With Mild or Moderate Hepatic Impairment Compared to Matched Control Participants With Normal Hepatic Functiontreatment1completed
NCT00523471
Blood Test to Measure DNA Damage in BloodNo drug interventionsNot AvailableNot Availableterminated
NCT00006371
A Phase II Trial of Early Medical Adrenalectomy for "D0.5" Prostate Cancertreatment2terminated
NCT00342771
An Epidemiological Study of Genetic Risk Factors for Prostate Cancer in African-American and Caucasian MalesNo drug interventionsNot AvailableNot Availablecompleted
NCT02015871
An Extension Long-term Safety and Tolerability Trial of Degarelix in Chinese Patients With Prostate Cancertreatment3completed
NCT02022371
Prostate Cancer Genomic HeterogeneityNo drug interventionsdiagnostic1 / 2completed
NCT02414971
Relationship of Mitochondrial Enzymes With Cancer Related FatigueNo drug interventionsNot AvailableNot Availablecompleted
NCT06435871
Developing Inclusive Support and Intervention for Spanish-speaking Latiné Prostate Cancer SurvivorsNo drug interventionssupportive_careNot Availablenot_yet_recruiting
NCT01491971
Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancertreatment2completed
NCT03712371
Study of Chitosan for Pharmacologic Manipulation of AGE (Advanced Glycation Endproducts) Levels in Prostate Cancer PatientsNo drug interventionstreatment1 / 2terminated
NCT02456571
CTC Immune CheckpointNo drug interventionsNot AvailableNot Availablecompleted
NCT00219271
Effect Of Zoledronic Acid On Circulating And Bone Marrow-Residing Prostate Cancer Cells In Patients With Clinically Localized Prostate Cancertreatment4completed
NCT00823771
A Pilot Study to Assess the Follow-up of Prostate Cancer Patients Who Have Undergone Radiotherapy TreatmentNo drug interventionsNot AvailableNot Availableterminated
NCT00004071
Mitoxantrone and Prednisone With or Without Leflunomide in Treating Patients With Stage IV Prostate Cancertreatment2 / 3completed
NCT00293371
Docetaxel, Prednisone, and Vatalanib in Treating Patients With Advanced Prostate Cancertreatment1 / 2terminated
NCT01083771
Med Diet Prevention Metabolic Syndrome Men Undergoing Androgen Deprivation Therapy Prostate CancerNo drug interventionspreventionNot Availablecompleted
NCT00223171
Duration of Androgen Blockade Combined With Pelvic Irradiation in Prostate CancersNo drug interventionstreatment3unknown_status
NCT00003871
PSA Vaccine Therapy in Treating Patients With Advanced Prostate CancerNo drug interventionstreatment2completed
NCT05766371
Pembrolizumab Plus 177Lu-PSMA-617 in Patients With Castration Resistant Prostate Cancertreatment2recruiting
NCT01354171
Active Surveillance Magnetic Resonance Imaging StudyNo drug interventionsdiagnostic3unknown_status
NCT04745871
Diagnostic Performance of PSMA PET/CT for Pre-operative Lymph Node Assessment in Intermediate and High-risk Non-metastasic Prostate Cancer (PREOP-PSMA ).No drug interventionsdiagnosticNot Availablerecruiting
NCT05896371
A Phase 1/2 Study of Personalized PSMA Radiopharmaceutical Therapytreatment1 / 2not_yet_recruiting
NCT00553878
Comparing 0.5 mg Dutasteride vs Placebo Daily in Men Receiving Androgen Ablation Therapy for Prostate Cancerprevention2 / 3completed
NCT04296578
Study Evaluating Sodium Selenite in Combination With Abiraterone in Castrate Resistant Prostate Cancer Progressing on Abirateronetreatment1withdrawn
NCT06429878
The Long Term Effect of MRI Before Radical Prostatectomy.No drug interventionsdiagnosticNot Availableactive_not_recruiting
NCT02789878
Neoadjuvant Androgen Deprivation Therapy Plus Abiraterone With or Without Apalutamide for High-Risk Prostate Cancertreatment2completed
NCT03572478
Rucaparib and Nivolumab in Patients With Prostate or Endometrial Cancertreatment1 / 2terminated
NCT03809078
68Ga PSMA 11 PET/MRI and 68Ga RM2 PET/MRI for Biopsy Guidance in Patients With Suspected Prostate Cancerdiagnostic2completed
NCT03196778
Low Dose Hemi-body Radiation For Recurrent Prostate CancerNo drug interventionstreatmentNot Availablecompleted
NCT00080678
Docetaxel With or Without Imatinib Mesylate in Treating Patients With Androgen-Independent Prostate Cancer and Bone Metastasestreatment2completed
NCT06505278
The Impact of Medication Timing Adjustment on the Effect of Novel Hormonal Therapytreatment2not_yet_recruiting
NCT06172478
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid TumorsNo drug interventionstreatment2recruiting
NCT03253978
SPORT High-Risk Trial Evaluating SABR in Prostate CancerNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT00006078
Lycopene In Preventing of Prostate CancerNo drug interventionsprevention1completed
NCT00483678
Couples Therapy to Enhance Intimacy Between Patients With Advanced or Recurrent Prostate Cancer and Their PartnersNo drug interventionsotherNot Availablecompleted
NCT02882178
Consensus Method to Evaluate the Conformity of Prescription of a ChemotherapyNo drug interventionsNot AvailableNot Availablecompleted
NCT02766478
Genistein Supplementation to Mitigate Cardiometabolic Dysfunction in Patients Undergoing Androgen Deprivation Therapy for Prostate Cancerprevention2terminated
NCT01905488
Perioperative Changes of Cognitive Function According to Jugular Vein Insufficiency in Robot-assisted ProstatectomyNo drug interventionsNot AvailableNot Availablecompleted
NCT03525288
PSMA-PET Guided RadiotherapyNo drug interventionstreatment2 / 3active_not_recruiting
NCT05454488
An Evidence-Based Focal Cryotherapy Protocol for Focal Ablation of Intermediate Risk Prostate CancerNo drug interventionstreatment2recruiting
NCT00110188
Ridaforolimus (AP23573/MK-8669) in Participants With Taxane-Resistant Androgen-Independent Prostate Cancer (AIPC)(MK-8669-017)treatment2completed
NCT04894188
Neoadjuvant Hormone and Radiation Therapy Followed by Radical Prostatectomy in Patients With High-Risk Prostate CancertreatmentNot Availablerecruiting
NCT06029088
Risk-adapted Strategy Including Magnetic Resonance Imaging and Prostate-specific Antigen Density in Blood for Biopsy Decision in Patients With Lesions Suspicious for Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT04638088
Comparison of Radical Prostatectomy Performed by Robot-assisted Laparoscopy or Conventional Laparoscopy or by LaparotomyNo drug interventionsNot AvailableNot Availablerecruiting
NCT00644488
A Phase I Study of BMS-641988 in Japanese Patients With Castration Resistant Prostate CancerNo drug interventionstreatment1completed
NCT01368588
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate CancerNo drug interventionstreatment3active_not_recruiting
NCT02772588
AASUR in High Risk Prostate Cancertreatment2active_not_recruiting
NCT00667888
A Phase III Intensity Radiotherapy Dose Escalation for Prostate Cancer Using HypofractionationNo drug interventionstreatment3unknown_status
NCT01510288
Phase 1 Trial of Ipilimumab and GVAX in Patients With Metastatic Castration-resistant Prostate Cancertreatment1terminated
NCT05596188
Anxiety Before Non-cardiac Surgery in AdultsNo drug interventionsNot AvailableNot Availablerecruiting
NCT00208988
A Randomized Controlled Trial to Promote Physician-Patient Discussion of Prostate Cancer ScreeningNo drug interventionseducational_counseling_trainingNot Availablecompleted
NCT00605488
The Biodistribution and Potential Diagnostic Ability of 18F FACBC in Patients With Head and Neck, Breast, and Prostate CancerNo drug interventionsdiagnosticNot Availablecompleted
NCT00127088
Study of Peri-Operative Docetaxel Plus Laparoscopic Radical Prostatectomy in Prostate Cancer Patientstreatment2suspended
NCT04350788
Enhancing Survivorship Care Planning for Patients With Localized Prostate Cancer Using A Couple-focused Web-based Tailored Symptom Self-management ProgramNo drug interventionssupportive_careNot Availablecompleted
NCT00414388
Sorafenib to Overcome Resistance to Systemic Chemotherapy in Androgen-independent Prostate Cancertreatment1 / 2completed
NCT04287088
bpMRI and Risk Based Shared Clinical Decision Making in Prostate Cancer DiagnosisNo drug interventionsdiagnosticNot Availablerecruiting
NCT04037488
Changes in Body Composition With Patients Under Androgen Deprivation TherapyNo drug interventionsNot AvailableNot Availableunknown_status
NCT01553188
AMG 386 and Abiraterone for Advanced Prostate Cancertreatment2completed
NCT00258388
Docetaxel and Prednisone With/Out OGX-011 in Recurrent or Metastatic Prostate Cancer That Did Not Respond to Previous Hormone Therapytreatment2completed
NCT04831307
68Ga-HTK03149 for Use as a Diagnostic RadiopharmaceuticalNo drug interventionsotherNot Availableunknown_status
NCT03418207
The Accuracy of Modified TTMB in the Spatial Distribution of Prostate CancerNo drug interventionsdiagnosticNot Availableunknown_status
NCT04692207
Prostate Biopsies With Target Lesion on MRINo drug interventionsNot AvailableNot Availablecompleted
NCT02438007
A Study of Galeterone Compared to Enzalutamide In Men Expressing Androgen Receptor Splice Variant-7 mRNA (AR-V7) Metastatic CRPCtreatment3terminated
NCT02106507
ARN 509 Plus Everolimus in Men With Progressive Metastatic Castration-Resistant Prostate Cancer After Treatment With Abiraterone Acetatetreatment1completed
NCT00924807
Safety Study of Sorafenib With Androgen Deprivation and Radiotherapy to Treat Prostate Cancertreatment1 / 2terminated
NCT05295407
Performance of Inherited Risk Assessment for Predicting Prostate Cancer From Prostate BiopsyNo drug interventionsNot AvailableNot Availablerecruiting
NCT02328807
Focal Prostate Radio-Frequency AblationNo drug interventionstreatmentNot Availablecompleted
NCT00263107
Postoperative Telerounding: A Multi-Center Prospective Randomized Assessment of Patient Outcomes and Satisfaction.No drug interventionsNot AvailableNot Availablecompleted
NCT00482807
Radiation Therapy, Docetaxel, and Hormone Therapy in High-Risk Locally Advanced Metastasized Prostate Cancertreatment1completed
NCT03413007
Correlation Between iXip and Final Pathology Specimen From Radical Prostatectomy: a Multicenter Prospective TrialNo drug interventionsNot AvailableNot Availableunknown_status
NCT00788307
Gene Therapy and Radioactive Iodine in Treating Patients With Locally Recurrent Prostate Cancer That Did Not Respond to External-Beam Radiation Therapytreatment1terminated
NCT05580107
MDPK67b in Patients With Prostate CancerNo drug interventionstreatment1recruiting
NCT04516707
Evaluation of Tolerance and Efficacy Retrospective Data of XOFIGONo drug interventionsNot AvailableNot Availablecompleted
NCT00196807
Prostate Cancer Screening: Fostering Informed DecisionsNo drug interventionsscreening3completed
NCT00433407
T-Cell Response in Patients Receiving Trastuzumab and/or Chemotherapy for HER2-Positive Solid TumorstreatmentNot Availablecompleted
NCT03861507
Needle Localization During Prostate Brachytherapy Using Power Doppler UltrasoundNo drug interventionsdiagnosticNot Availablerecruiting
NCT00003607
Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Prostate CancerNo drug interventionstreatment3completed
NCT00003307
Radiation Therapy Plus Amifostine in Treating Patients With Primary Prostate Cancertreatment2completed
NCT06334809
INSIDE: Identification of Genomic Screening Pathways in Cancer Patients With DNA Repair AlterationsNo drug interventionsNot AvailableNot Availablerecruiting
NCT00215709
Bi-Weekly Administration of Docetaxel for Older Men With Hormone Refractory Prostate Cancertreatment1completed
NCT01260909
Real-Time MV/kV Image Guided Radiation TherapyNo drug interventionsNot AvailableNot Availablewithdrawn
NCT04687709
To Investigate the Role of Gut Microbiome in ADT Related Metabolic Changes in Prostate Cancer PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT01045109
Vitamin D3 Supplementation in Participants Diagnosed With Early-Stage Prostate Cancer Who Decide to Undergo Active Surveillance Treatment Regimen.No drug interventionstreatment2completed
NCT04098809
Impact of Catheter Size on Peri-Operative Pain After Robotic Assisted Laparoscopic ProstatectomyNo drug interventionsotherNot Availablecompleted
NCT04552509
TRUEBEAM Stereotactic Body Radiotherapy for Localized Prostate CancerNo drug interventionstreatmentNot Availablerecruiting
NCT02516709
Linear Source Registry for Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT03580109
Spa Therapy for Upper or Lower Limb LymphoedemaNo drug interventionsotherNot Availablerecruiting
NCT04581109
Detection of Viable CTCs Using the EPIDROP Technology in Metastatic Prostate Cancer (EPIDROP)No drug interventionsdiagnosticNot Availableunknown_status
NCT02811809
Apalutamide Plus Intermittent Hormone Therapy Versus Intermittent Hormone Therapy Alone in Prostate Cancertreatment2withdrawn
NCT02200809
MR-guided Focal Laser Ablation of the ProstateNo drug interventionstreatmentNot Availablecompleted
NCT06047509
Focal Laser Ablation of Prostate Cancer: A Feasibility Study Using MRI/US Image Fusion for GuidanceNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT00063609
The Effect of Zoledronic Acid on Bone Loss in Prostate Cancer Patients Undergoing Androgen Deprivation Therapyprevention4completed
NCT02966509
Engagement of Patients With Advanced CancerNo drug interventionshealth_services_researchNot Availablecompleted
NCT04848909
Stereotactic Body Radiotherapy (SBRT) Post ProstatectomyNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT00049309
Low-Fat Diet and/or Flaxseed in Preventing Prostate CancerNo drug interventionstreatment2completed
NCT03264209
Smart After-Care in Patients With Prostate CancerNo drug interventionssupportive_careNot Availableunknown_status
NCT04262609
Faecal Incontinence in Prostate Cancer Survivors Treated Whith RadiotherapyNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT04534309
Behavioral Weight Loss Program for Cancer Survivors in MarylandNo drug interventionspreventionNot Availablecompleted
NCT02853409
Quality of Life of Patients With Locally Advanced and Metastatic Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT00582556
Zometa on Bone Mineral Density in Prostate Cancer Patients Undergoing Androgen Ablation Therapytreatment2completed
NCT06505356
Characterization of Microbiological and Genetic Features in Prostate Cancer and Their Association With Disease StageNo drug interventionsdiagnosticNot Availablenot_yet_recruiting
NCT00943956
Everolimus, Bicalutamide, and Leuprolide Acetate in Treating Patients Undergoing Radiation Therapy For High-Risk Locally Advanced Prostate Cancertreatment1completed
NCT03787056
Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer PatientsNo drug interventionsdiagnosticNot Availablerecruiting
NCT03212456
Evaluation of Post-operative Biochemical Recurrence in Patients Submitted to Radical Prostatectomy Under General Opioid-free Anesthesia Compared to Conventional General AnesthesiaNo drug interventionstreatmentNot Availableunknown_status
NCT00003256
Flavopiridol in Treating Patients With Recurrent Prostate Cancertreatment2completed
NCT04582656
Efficacy Assessment of a Novel 3D Cartography-based Targeted Focal Microwave Therapy in Men With Localized Intermediate-risk Prostate CancerNo drug interventionstreatmentNot Availableunknown_status
NCT05458856
Effects of Triptorelin When Given Every 6-months Under the Skin to Adult Males With Cancer in the Prostatetreatment3completed
NCT04177056
Stereotactic Body Radiotherapy for Osseous Low Alpha-Beta Resistant Metastases for Pain ReliefNo drug interventionstreatmentNot Availableunknown_status
NCT04732156
Detection of ISUP≥2 Prostate Cancers Using Multiparametric MRI: Prospective Multicenter Comparison of the PI-RADS Score and an Artificial Intelligence SystemNo drug interventionsdiagnosticNot Availablerecruiting
NCT02702856
Clinical Validation of a Urinary Exosome Gene Signature in Men Presenting for Suspicion of Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT06003556
PSMA-Guided Ablation of the ProstateNo drug interventionsdiagnostic2recruiting
NCT04045756
Focal Laser Ablation for the Treatment of Focal Low-Intermediate Risk Prostate CancerNo drug interventionstreatmentNot Availableunknown_status
NCT00819156
Dose Finding Trial With a New Treatment (Degarelix) for Prostate Cancertreatment2completed
NCT02635256
Hypofractionated Radiosurgery for Localised Prostate CancerNo drug interventionstreatmentNot Availablecompleted
NCT00707356
Study of WST11 in Patients With Localized Prostate Cancertreatment2completed
NCT00014456
Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumorstreatment1completed
NCT04400656
PROState Pathway Embedded Comparative TrialNo drug interventionsNot AvailableNot Availablecompleted
NCT00377156
Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain MetastasesNo drug interventionstreatment3completed
NCT04625556
Development of Urologic Registry for Personalized Medicine in Patients With Urologic Malignant Diseases by Analyzing MicrobiomeNo drug interventionsNot AvailableNot Availablerecruiting
NCT00577356
Docetaxel and Immunotherapy Prior to Prostatectomy for High-Risk Prostate Cancertreatment2terminated
NCT06491056
Prospective Asian Multicenter Prostate Cancer Focal Therapy Study (ProAMFocal)No drug interventionsNot AvailableNot Availablerecruiting
NCT01444456
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced AnaemiaNo drug interventionsNot AvailableNot Availablecompleted
NCT00664456
Luteinizing Hormone-Releasing Hormone Agonist Therapy and Iodine I 125 Implant in Treating Patients With Previously Untreated Prostate CancerNo drug interventionstreatment3completed
NCT00134056
S0421, Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapytreatment3completed
NCT00516256
CHESS: Human and Computer Mentors for Prostate Cancer PatientsNo drug interventionssupportive_careNot Availablecompleted
NCT00669656
Herbal Therapy for Treatment of Recurrent Prostate Cancertreatment2completed
NCT01762956
Pelvic Floor Muscles Training in Men Undergoing Radiotherapy for Prostate Cancer: Randomized Controlled TrialNo drug interventionspreventionNot Availableterminated
NCT03692585
Ethnographic Study of the Everyday Life of Men With Prostate Cancer, Focusing on Diet, Activities and Digital BehaviorNo drug interventionsNot AvailableNot Availablecompleted
NCT03315585
The Efficacy and Safety of Composite Steep-pulse Treatment Apparatus Used in Prostate Cancer Focal TherapyNo drug interventionstreatmentNot Availablecompleted
NCT01437085
A Study to Measure Needle Bending and Changes in Prostate Shape During a Prostate Seed ImplantNo drug interventionsNot AvailableNot Availableunknown_status
NCT02971085
Seoul National University Prospectively Enrolled Registry for Prostate Cancer With Active SurveillanceNo drug interventionsNot AvailableNot Availablerecruiting
NCT03709485
Evaluation of Gut Microbiome in Patients With Prostate CancerNo drug interventionsbasic_scienceNot Availableunknown_status
NCT04186585
Recommended Dose Estimation of BP-C2other1recruiting
NCT00402285
Lycopene or Omega-3 Fatty Acid Nutritional Supplements in Treating Patients With Stage I or Stage II Prostate CancerNo drug interventionstreatmentNot Availablecompleted
NCT01937585
Trial of Print Messages to Support the Role of Partners in Promoting Provider Discussions About Prostate Cancer Screening Among AA MenNo drug interventionspreventionNot Availablecompleted
NCT00841685
The Implantation Under Echography of Fiducial Markers in the Intraprostatic Lesion and ProstateNo drug interventionsotherNot Availablecompleted
NCT01304485
PET Imaging Characteristics of C11-Acetate in Patients With Recurrent Prostate Carcinomadiagnostic2completed
NCT01187485
A Randomized Study of Testosterone Replacement in Patients With Low Risk Hormone Refractory Prostate Cancertreatment1completed
NCT00114985
Prostate Immobilization Device Used During Radiation Treatments to Decrease Rectal BleedingNo drug interventionstreatment2completed
NCT02934685
IG-VMAT for Localized Prostate CancerNo drug interventionstreatment3unknown_status
NCT02083185
A Phase 2 Study to Evaluate the Safety and Efficacy of TAK-385, Together With a Leuprorelin Observational Cohort, in Participants With Prostate Cancertreatment2completed
NCT01355185
Seed Movement in Prostate Brachytherapy Implants: Clinical Measurement and Dosimetric ConsequencesNo drug interventionsNot AvailableNot Availableunknown_status
NCT00363285
Cyproterone Acetate in Treating Patients With Newly Diagnosed Stage III or Stage IV Prostate Cancertreatment3unknown_status
NCT01028885
MRI-Guided Radiation Therapy in Treating Patients Who Have Undergone Surgery to Remove the ProstateNo drug interventionstreatment1completed
NCT00900185
Study of a Polymorphism in Patients With Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT03660085
Prostate Cancer - Patient Empowerment ProgramNo drug interventionssupportive_careNot Availablecompleted
NCT06470685
Prophylactic Prostatectomy for Prostate Cancer (PPPC)No drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT03297385
Dynamics of Androgen Receptor Genomics and Transcriptomics After Neoadjuvant Androgen Ablationtreatment2completed
NCT03149185
Technology Based Psychosocial Intervention for Symptom Management and HRQOL in Men Living With Advanced Prostate CancerNo drug interventionssupportive_careNot Availablecompleted
NCT00078585
PROSTVAC®-VF/TRICOM™ Vaccine for the Treatment of Metastatic Prostate Cancer After Failing Hormone TherapyNo drug interventionstreatment2completed
NCT03419585
The "PC-LIGHT" StudyNo drug interventionspreventionNot Availablecompleted
NCT00104715
Hormone Therapy and Docetaxel or Hormone Therapy Alone in Treating Patients With Metastatic Prostate Cancertreatment3completed
NCT02559115
68Ga-RM2 for PET/CT of Gastrin Releasing Peptide Receptor (GRPr) Expression in Prostate CancerNo drug interventionsdiagnostic2completed
NCT05361915
Study to Assess Abivertinib in Combination With Abiraterone in Metastatic Castration Resistant Prostate Cancertreatment2suspended
NCT03124615
Effect of Enzalutamide Dose Reduction on Fatigue, Cognition, and Drug Trough Levels in Patients With Prostate Cancertreatment2unknown_status
NCT01620515
Two-Dose Level Evaluation of NX-1207 for the Treatment of Low Risk, Localized (T1c) Prostate Cancertreatment2completed
NCT00753415
A Study of V934/V935 Vaccine in Cancer Participants With Selected Solid Tumors (V934-002)No drug interventionstreatment1completed
NCT00003115
Epidural Hydromorphone Compared With Hydromorphone Infusion in Treating Patients With Prostate Cancer Undergoing Radical Prostatectomysupportive_care3completed
NCT00562315
FACBC PET/CT for Recurrent Prostate Cancerdiagnostic2completed
NCT00054015
3-AP in Treating Patients With Advanced Prostate Cancertreatment2completed
NCT04861415
SBRT vs. Conventional Fractionation With HDR Boost for Prostate CancerNo drug interventionstreatmentNot Availablerecruiting
NCT00067015
Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancertreatment3completed
NCT05533515
Circulating Tumour Cells as Biomarkers to Predict Prostate Cancer Metastasis for Treatment Stratification of CancerNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT00581815
Spectroscopy With Surface Coils and DecouplingNo drug interventionsdiagnostic1completed
NCT05744115
Ga-68-PSMA-11 in Men With Prostate CancerNo drug interventionsdiagnostic3terminated
NCT00941915
Stereotactic Body Radiotherapy (SBRT) for Prostate CancerNo drug interventionstreatmentNot Availablecompleted
NCT05131815
The BurnAlong Pilot Study for Adolescent and Young Adult Cancer SurvivorsNo drug interventionssupportive_careNot Availableactive_not_recruiting
NCT00895115
Vitamin E Supplements in Preventing Cancer in Patients at Risk of Prostate Cancer or Who Have Prostate CancerNo drug interventionsprevention1completed
NCT00557037
A Phase II Trial of Phenoxodiol in Patients With Castrate and Non-Castrate Prostate Cancertreatment2completed
NCT01751737
Choline PET/CT and MRI for Targeted Prostate BiopsyNo drug interventionsdiagnosticNot Availablecompleted
NCT01454037
Immune Profiles and Circulating Tumor Cell Status Following Prostate CryotherapyNo drug interventionsNot AvailableNot Availableunknown_status
NCT02282137
68Ga-PSMA PET-CT Scan for Diagnosis and Management of Prostate CancerNo drug interventionsdiagnostic2unknown_status
NCT05568537
Prostate MRI and Pylarify PSMA PET/CTtreatment4not_yet_recruiting
NCT03961737
Study of the Response to Irradiation on Prostatic Explants ex Vivo, as a Predictive Factor of the Clinical Response to Irradiation of Prostate CancersNo drug interventionsotherNot Availableunknown_status
NCT03987737
Rectal Gas Removal Through Small Catheter Placement Prior to MRI of the ProstateNo drug interventionsdiagnosticNot Availableunknown_status
NCT02046837
An Exercise Trial and Economic Analysis in Men With Prostate CancerNo drug interventionssupportive_care2completed
NCT00199537
Bone Loss in Men on Androgen Blockade as Adjuvant Therapy for Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT02477137
Effects of an Interactive ICT-Platform for Assessment and Management of Symptoms in Patients Treated for Prostate CancerNo drug interventionssupportive_careNot Availablecompleted
NCT00183937
Study of Bortezomib and Docetaxel for Patients With Hormone Refractory Prostate Cancertreatment2completed
NCT00798837
Intraprostatic MAXimal Simultaneous BoostNo drug interventionstreatmentNot Availableterminated
NCT00585637
Vitamin D for Chemopreventionprevention1completed
NCT00002637
Biological Therapy in Treating Patients With Prostate Cancertreatment1 / 2completed
NCT02057237
A Safety and Feasibility Study of Mitotane in Prostate Cancertreatment1completed
NCT03606837
68Ga-RM2 Compared to 68Ga-PSMA-617 PET/CT for Intermediate Risk Prostate Cancer ImagingNo drug interventionstreatment2recruiting
NCT00164437
CD-ROM Intervention for Prostate Cancer ScreeningNo drug interventionseducational_counseling_training2 / 3completed
NCT06066437
NeoAdjuvant Theranostic Lutetium Study: The Nautilus Trialtreatment1 / 2recruiting
NCT03164837
68Ga-NOTA-RM26 PET/CT in Prostate Cancer PatientsNo drug interventionsdiagnostic1unknown_status
NCT02538432
Phase II Trial of EP4 Receptor Antagonist, AAT-007 (RQ-07; CJ-023,423) in Advanced Solid Tumorstreatment2withdrawn
NCT00354432
Soy Protein/Effexor Hormone Therapy for Prostate Cancersupportive_care3terminated
NCT03120832
Phase 1 Trial of PAN-301-1 (SNS-301) in Cancer PatientsNo drug interventionstreatment1completed
NCT05978232
NAVAH Impact on Radiation Therapy Completion in Black Breast & Prostate Cancer PatientsNo drug interventionssupportive_careNot Availablerecruiting
NCT00607932
Brassica Vegetables or Indole-3-Carbinol in Treating Patients With PSA Recurrence After Surgery for Prostate CancertreatmentNot Availablecompleted
NCT01642732
Study of Everolimus Added to Combined Hormonal and Radiation Therapy for High Risk Prostate CancerNo drug interventionstreatment1terminated
NCT05472532
Evaluation of an Automated System to Culture Metastatic Patient Circulating Tumor Cells in Embryonated Chicken Eggs (in Ovo Culture)No drug interventionsotherNot Availablerecruiting
NCT02704832
Role of Geriatric Intervention in Treatment of Older Patients With Cancer (PREPARE)No drug interventionsother3unknown_status
NCT05324332
68Ga-P16-093 and 68Ga-PSMA-11 PET/CT Imaging in the Same Group of Primary Prostate Cancer PatientsdiagnosticNot Availableunknown_status
NCT00441532
Study On Lidocaine Vs. Placebo Pain Control During Transrectal Ultrasound Guided Prostate BiopsytreatmentNot Availablecompleted
NCT00082732
Behavior-Based Dietary Intervention in Treating Patients With Hormone-Refractory Prostate CancerNo drug interventionstreatment1completed
NCT00584532
Effects of a Genistein Concentrated Polysaccharide (GCP) for Prostate Cancer on Active Surveillance.treatment2 / 3completed
NCT00882232
Cross-linked Hyaluronan Gel Reduces Rectal Toxicity Due to Radiation Therapy for Prostate CancerNo drug interventionstreatment1completed
NCT04700332
PyL in Patients With High Risk and Biochemically Recurrent Prostate CancerNo drug interventionsdiagnostic2recruiting
NCT05720832
Feasibility of Technology-Based SSIP in Prostate Cancer PatientsNo drug interventionssupportive_careNot Availableactive_not_recruiting
NCT01985932
Functional MRI Use in Prostate Radiation Treatment PlanningNo drug interventionsdiagnosticNot Availablecompleted
NCT00688532
Study of Coronary Heart Disease (CHD) & Heart Failure (HF) Risk in Prostate Cancer Patients, Taking Casodex or NotNo drug interventionsNot AvailableNot Availablecompleted
NCT05888532
64Cu-GRIP B in Patients With Advanced Malignanciesdiagnostic1 / 2recruiting
NCT02758132
Denosumab Plus Enzalutamide, Abiraterone and Prednisone Compared to Denosumab Plus Enzalutamide Alone for Men With Castrate Resistant Prostate Cancer (CRPC) With Bone Metastasestreatment2terminated
NCT00003232
Combination Chemotherapy in Treating Pain in Hormone Refractory Metastatic Prostate Cancertreatment3completed
NCT00005632
Vaccine Therapy Plus QS21 in Treating Patients With Prostate CancerNo drug interventionstreatment1completed
NCT05327452
Testing Home-based Exercise Strategies in Underserved Minority Cancer Patients Undergoing Chemotherapy: the THRIVE StudyNo drug interventionssupportive_careNot Availablerecruiting
NCT02735252
PROMOTE: Identifying Predictive Markers of Response for Genitourinary CancerNo drug interventionsbasic_scienceNot Availableactive_not_recruiting
NCT00769652
Medical Nutrition Therapy or Standard Care in Treating Patients With Lung Cancer, Pancreatic Cancer, or Stage III or Stage IV Prostate CancerNo drug interventionssupportive_careNot Availableterminated
NCT01801852
Autologous Natural Killer T Cells Infusion for the Treatment of CancerNo drug interventionstreatmentNot Availableunknown_status
NCT00777452
A Prospective Longitudinal Study of Health-Related Quality of Life in Men With Clinically Localized Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT01660152
Vacuum Erection Device in Improving Recovery of Erectile Function in Patients With Prostate Cancer Undergoing SurgeryNo drug interventionssupportive_careNot Availablecompleted
NCT01705652
Study to Assess the Activity of Nexrutine® in Prostate Cancer Patientstreatment2terminated
NCT04863352
Health Status, Quality of Life and Function in Survivors After Radical Treatment for Prostate Cancer. Part I and IIANo drug interventionsNot AvailableNot Availablecompleted
NCT03103152
A Study to Examine the Effectiveness of Aspirin and/or Vitamin D3 to Prevent Prostate Cancer Progressionprevention2 / 3completed
NCT05597852
Using Rectal Hydrogel Spacer for Salvage SABR in Prostate CancerNo drug interventionsdevice_feasibilityNot Availablerecruiting
NCT00763152
CMT-07-08: The PROstate Bed Evaluation StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT00084552
Intensity-Modulated Radiation Therapy With or Without Decreased Radiation Dose to Erectile Tissue in Treating Patients With Stage II Prostate CancerNo drug interventionstreatmentNot Availablecompleted
NCT05610852
Single-Port Transvesical Partial Prostatectomy Versus High Intensity Focused UltrasoundNo drug interventionstreatmentNot Availablerecruiting
NCT00284752
Phase II Trial of Abraxane in Front Line Therapy of Hormone Refractory Metastatic Prostate Cancertreatment2completed
NCT00014352
Combination Chemotherapy Plus Warfarin in Treating Patients With Prostate Cancertreatment2completed
NCT03525652
Therapeutic Vaccine Plus PD-1 Knockout in Prostate Cancer TreatmentNo drug interventionstreatment1 / 2unknown_status
NCT02840552
The Safety and Efficacy of 18F-Fluoromethylcholine (18F-FCH) PET/CT in Prostate Cancerdiagnostic3completed
NCT00122252
Biological Imaging for Optimising Clinical Target Volume (CTV) and Gross Tumour Volume (GTV) Contouring in Prostate Cancer to Improve the Possibilities for Intensity Modulated RadioTherapy (IMRT) Dose EscalationNo drug interventionsNot AvailableNot Availableterminated
NCT05627752
Docetaxel Alone or in Combination With Enzalutamide for mCRPC Previously Treated With Abiraterone at mHSPC Stagetreatment2 / 3recruiting
NCT04377152
Expanded Access 68Gallium-PSMA-11 PET for Prostate CancerNot AvailableNot Availableapproved_for_marketing
NCT03957252
Validation of ClarityDX Prostate as a Reflex Test to Refine the Prediction of Clinically-significant Prostate CancerNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT02070952
CyberKnife Stereotactic Radiosurgery for Low and Intermediate Risk Prostate CancerNo drug interventionstreatmentNot Availableunknown_status
NCT01996852
Improving Erectile Function and Quality of Life After Prostate Cancer Treatmentsupportive_careNot Availableterminated
NCT06402552
Comparing Bp-MRI and Mp-MRI for Prostate Cancer Screening AccuracyNo drug interventionsdiagnosticNot Availablerecruiting
NCT03211052
A Study of Neoadjuvant TAK-700 and Leuprorelin Acetate Followed by Surgery Versus Surgery Alonetreatment2terminated
NCT05123300
PRISMA-PET - Primary Staging of Prostate Cancer With PSMANo drug interventionsdiagnosticNot Availablerecruiting
NCT04037800
An RCT to Compare Early Continence Recovery After RARP With or Without Sustainable Functional Urethral ReconstructionNo drug interventionstreatmentNot Availablecompleted
NCT05614700
Prostate Reirradiation Toxicity Outcomes Feasibility StudyNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT01943500
Collection of Blood Specimens for Circulating Tumor Cell AnalysisNo drug interventionsNot AvailableNot Availablecompleted
NCT05306600
Onco-Genomas Brasil: Mapping Breast and Prostate Cancer in the Brazilian Public Health SystemNo drug interventionsNot AvailableNot Availablerecruiting
NCT02130700
Oral VT-464 in Patients With Castration-Resistant Prostate Cancer Previously Treated With Enzalutamide, Androgen Receptor Positive Triple-Negative Breast Cancer Patients, and Men With ER Positive Breast Cancertreatment2completed
NCT00003400
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Prostate Cancertreatment2completed
NCT00963300
MRI in Assessing Hypoxia in Patients With Localized Prostate Cancer Undergoing Stereotactic Body Radiation TherapyNo drug interventionsdiagnosticNot Availablewithdrawn
NCT00548600
Radical Radiotherapy by External Beam Radiation Versus Radical Radiotherapy With Temporary Iridium Implant Plus External Beam Radiation in Carcinoma of the ProstateNo drug interventionstreatment3completed
NCT05539300
PSMA Response in Metastasized Hormone Sensitive Prostate Cancer - EnzalutamideNo drug interventionsdiagnosticNot Availablerecruiting
NCT03809000
A Study of Salvage Radiotherapy With or Without Enzalutamide in Recurrent Prostate Cancer Following Surgerytreatment2active_not_recruiting
NCT05705700
Biomarker Study of in Men With PSA Progression on Abi for CR or CS PC (Bio-STAMP)treatment2withdrawn
NCT00754000
The AIM Study: Assessing the Impact of Margin ReductionNo drug interventionsNot AvailableNot Availablecompleted
NCT05600400
Improving Sexual Quality of Life - Randomized Trial of Two vs Five MRI Guided SABR Treatments for Prostate CancerNo drug interventionstreatmentNot Availablerecruiting
NCT00052000
A Trial of MLN2704 in Subjects With Metastatic Androgen Independent Prostate Cancertreatment1completed
NCT00925600
Evaluation of New or Worsening Lens Opacifications in Men With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Losssupportive_care3completed
NCT05010200
The Safety and Tolerability of PGV001-based Personalized Multi-peptide Vaccines in the Adjuvant Setting.prevention1recruiting
NCT01567800
Prostate Hypoxia FAZANo drug interventionsdiagnosticNot Availablerecruiting
NCT01748500
Pantoprazole and Docetaxel for Men With Metastatic Castration-Resistant Prostate Cancertreatment2completed
NCT04124900
Telomere Associated Variables (TAVs) in Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT00133900
Circulating Tumor Cells and Survival in Hormone Refractory Prostate Cancer (HRPC) Patients Receiving ChemotherapyNo drug interventionsNot AvailableNot Availableunknown_status
NCT00140400
Prime-Boost Dose Scheduling Trial for Human GM-CSF Gene Transduced Irradiated Prostate Allogeneic Cancer Vaccine (Allogeneic Prostate GVAX®) in Patients With Hormone-Refractory Prostate CancerNo drug interventionstreatment1 / 2completed
NCT04742959
Study of TT-00420 (Tinengotinib) Tablet as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumorstreatment1 / 2completed
NCT02608359
A Post-marketing Surveillance to Assess Safety of Abiraterone Acetate (Zytiga) in Indian Participants With Metastatic, Castration Resistant Prostate CancerNot AvailableNot Availablewithdrawn
NCT00959959
ARMOR1: Study of TOK-001 to Treat Castration Resistant Prostate Cancertreatment1completed
NCT05582759
Sleep Hygiene Education, ReadiWatchTM Actigraphy, and Telehealth Cognitive Behavioral Training for Insomnia Effect, on Symptom Relief for Men With Prostate Cancer Receiving Androgen Deprivation TherapyNo drug interventionssupportive_careNot Availablecompleted
NCT00006359
Androgen Suppression Plus Radiation Therapy in Treating Patients With Prostate CancerNo drug interventionstreatment2completed
NCT02271659
Medical and Economic Evaluation for Intermediate-risk Prostate CancerNo drug interventionstreatmentNot Availableunknown_status
NCT05078359
Optimizing Positive Predicting Value of Prostate MRINo drug interventionsNot AvailableNot Availableunknown_status
NCT03177759
Living With Prostate Cancer (LPC)No drug interventionsNot AvailableNot Availablecompleted
NCT00081159
Hormone Ablation Therapy, Doxorubicin, and Zoledronate With or Without Strontium 89 in Treating Patients With Androgen-Dependent Prostate Cancer and Bone Metastasestreatment2completed
NCT00027859
Hormone Therapy Compared With Combination Chemotherapy in Treating Patients With Prostate Cancertreatment3completed
NCT06200259
Reduction of Gastrointestinal Toxicity in Prostate Cancer by Proton Spot PlacementNo drug interventionstreatmentNot Availablerecruiting
NCT03327675
High Precision Imaging of Prostate Specific Membrane Antigen for Personalized Treatment in Prostate CancerNo drug interventionsdiagnosticNot Availablerecruiting
NCT02268175
Enzalutamide/Leuprolide +/- Abiraterone/Pred in Prostatetreatment2completed
NCT00005075
Ultrasound in Treating Patients With Recurrent Stage I or Stage II Prostate CancerNo drug interventionstreatment3terminated
NCT00303875
Exercise and Dietary Counseling in Improving Physical Activity, Nutrition, and Quality of Life in Older Long-Term Cancer Survivors Who Are OverweightNo drug interventionsother2completed
NCT04116775
Fecal Microbiota Transplant and Pembrolizumab for Men With Metastatic Castration Resistant Prostate Cancer.treatment2unknown_status
NCT05116475
Evaluation of dAroLutamide Addition to anDrogen Deprivation Therapy and radIatioN Therapy in Newly Diagnosed Prostate Cancer With Pelvic Lymph Nodes Metastasestreatment3recruiting
NCT06313775
Comparison of Spinal Anesthesia and Spermatic Cord Block for Bilateral OrchiectomyNo drug interventionstreatmentNot Availableenrolling_by_invitation
NCT06424275
Prostate Cancer Awareness and Initiative for Screening in the European UnionNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT02035475
Prevention of Lymphoceles After Robotic PLNDNo drug interventionspreventionNot Availablecompleted
NCT02132975
Motorised Probe Holder Assisting Prostate BiopsiesNo drug interventionsNot AvailableNot Availablecompleted
NCT02825875
Study of the Clinical Utility of PSMA Imaging in the Evaluation of Men With Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT00241475
Gefitinib in the Treatment of the First Relapse of Prostate Cancer Beyond Prostatectomy or Radiotherapytreatment2completed
NCT01191775
A Study of PNT2258 in Patients With Advanced Solid Tumorstreatment1completed
NCT04441775
Artificial Intelligence for Prostate Cancer Treatment PlanningNo drug interventionsNot AvailableNot Availablecompleted
NCT01505075
Safety and Efficacy Study of Hypofractionated Radiotherapy and Androgen Deprivation Therapy for Prostate CancerNo drug interventionstreatment1 / 2unknown_status
NCT02742675
Androgen Deprivation Therapy or Androgen Deprivation Therapy Plus Definitive Treatment (Radiation or Surgery)treatment2unknown_status
NCT02070575
Evaluation of Molecular Forms of PSA and Human Kallikrein 2 in a Cohort of Patients With Locally Resected Prostate Cancer But Biochemical RecurrenceNo drug interventionsNot AvailableNot Availablecompleted
NCT02105675
Phase II Study of DCVAC/PCa Added to Standard Chemotherapy for Men With Metastatic Castration Resistant Prostate Cancertreatment2completed
NCT05350475
Protons vs. Photons for High-risk Prostate CancerNo drug interventionstreatmentNot Availablerecruiting
NCT05167175
The Study of Olaparib Combined With Abiraterone and Prednisone in mHSPC Patients With HRR Gene Mutationtreatment2recruiting
NCT00423475
Radiation Therapy With or Without Goserelin in Treating Patients Who Have Undergone Surgery for Recurrent or Refractory Prostate Cancertreatment3completed
NCT00036075
Study Using CP-461 to Treat Advanced Prostate CancerNo drug interventionstreatment2completed
NCT01480375
A Novel 3D Navigation Technology for Improved TRUS Prostate BiopsyNo drug interventionsdiagnosticNot Availablecompleted
NCT00683475
A Study of IMC-A12 or Ramucirumab Plus Mitoxantrone and Prednisone in Prostate Cancertreatment2completed
NCT05938270
A Study to Investigate the Biological Effects of Saruparib (AZD5305), Darolutamide, and in Combination in Men With Newly Diagnosed Prostate Cancer.basic_science1recruiting
NCT00073970
Celecoxib in Treating Patients With Relapsed Prostate Cancer Following Radiation Therapy or Radical Prostatectomytreatment2terminated
NCT05700370
MyProstateScore Equivalency With and Without DRENo drug interventionsscreeningNot Availableenrolling_by_invitation
NCT03543670
Evaluation of Oncoxin-Viusid® in Prostate CancerNo drug interventionssupportive_care2completed
NCT00450970
Expanded Access Study of Satraplatin Plus Prednisone in Patients With Hormone Refractory Prostate Cancer (HRPC)treatment3terminated
NCT03862170
Antibiotic Prophylaxis for HDR Brachytherapy in the Treatment of Prostate Cancerprevention3suspended
NCT06217770
Retrospective Study to Assess Real-Life Use of The Long Acting GnRH Agonist as Prostate Cancer TreatmentNo drug interventionsNot AvailableNot Availablecompleted
NCT01964170
A Study to Compare the Effect of ASP3550 With Goserelin in Patients With Prostate Cancertreatment3completed
NCT02724670
Study of MR-based IGRT for Prostate CancerNo drug interventionstreatmentNot Availablerecruiting
NCT02237170
Immune Monitoring on Sipuleucel-TNo drug interventionsNot AvailableNot Availablecompleted
NCT00072670
A Phase 2 Study of Trabectedin (Yondelis) in Adult Male Participants With Advanced Prostate Cancertreatment2completed
NCT03933670
Hyperpolarized Pyruvate (13C) MR Imaging in Monitoring Patients With Prostate Cancer on Active SurveillanceNo drug interventionsdiagnostic2recruiting
NCT02185170
DEPORRA-CoProst: Assessment of New Fluorescence Imagery Techniques Using Prostate Chips From Transurethral ResectionsNo drug interventionsdiagnosticNot Availableterminated
NCT06398470
Study to Evaluate a New Method to Detect Residual Tumours During Surgery for Prostate Cancer Using Confocal MicroscopyNo drug interventionsdevice_feasibility1 / 2recruiting
NCT01410942
Multimodal Therapy for the Treatment of Fatigue in Patients With Prostate Cancer Receiving Radiotherapy With Androgen Deprivation Therapytreatment2active_not_recruiting
NCT01394042
Prostate Cancer Imaging With Radioactive Tracer and Ultrasound Detector Compared to MRI and ProstaScintNo drug interventionsdiagnostic0unknown_status
NCT04035642
Phase II Study of Single-Dose Image-Guided Radiotherapy (SDRT) for Prostate CancerNo drug interventionstreatmentNot Availablerecruiting
NCT02747342
A Phase 1 Trial of SHR3680 With or Without SHR3162 in Prostate Cancertreatment1completed
NCT05366842
Patient-Reported Erectile Recovery and Quality of Life Outcomes With Lyopreserved Placental Tissue Applied Directly Over Neurovascular Bundle During Nerve Sparing Radical Prostatectomy Versus Standard of CareNo drug interventionstreatment2recruiting
NCT01729442
Assessment of HIFU-induced Prostate Necrosis With Shear-wave Ultrasound ElastographyNo drug interventionsdiagnosticNot Availablecompleted
NCT03496142
Perineal Versus Rectal Approach for Prostate Biopsy to Prevent Iatrogenic InfectionsNo drug interventionspreventionNot Availableunknown_status
NCT01737242
UK Genetic Prostate Cancer Study: Epidemiology and Molecular Genetics StudiesNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT01802242
Tumor TARGET Prostate CancerNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT04053842
Multi-modality Imaging (PCa) Using Sodium MRI and PSMA PET in Men Pre-prostatectomyNo drug interventionsdiagnostic2recruiting
NCT01901042
Efficacy of Symbiotic in the Reduction of Acute Radiation Proctitis SymptomsNo drug interventionsprevention2 / 3completed
NCT00312442
Phase II/III Study of WST09 in Prostate Cancer After Radiation TherapyNo drug interventionstreatment2 / 3terminated
NCT04430842
Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072SNo drug interventionstreatment1completed
NCT04107142
Haplo / Allogeneic NKG2DL-targeting Chimeric Antigen Receptor-grafted γδ T Cells for Relapsed or Refractory Solid TumourNo drug interventionsother1unknown_status
NCT01959542
Early Changes In Multiparametric MRI In Prostate CancerNo drug interventionsdiagnosticNot Availablecompleted
NCT05613842
Copper-64 SAR Bombesin in PSMA Negative Prostate Cancer (BOP)diagnostic2completed
NCT04889742
Hyperthermia Enhanced Re-irradiation of Loco-regional Recurrent TumorsNo drug interventionstreatment2not_yet_recruiting
NCT01050842
Bicalutamide and Raloxifene in Treating Patients With Metastatic or Hormone-Refractory Prostate Cancertreatment0completed
NCT00129142
Toremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer on Androgen Deprivation Therapyprevention3completed
NCT04221542
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancertreatment1recruiting
NCT00216099
Pemetrexed as Second-Line Therapy in Treating Patients With Hormone Refractory Prostate Cancertreatment2completed
NCT03689699
Nivolumab and BMS-986253 for Hormone-Sensitive Prostate Cancer (MAGIC-8)treatment1 / 2active_not_recruiting
NCT04239599
Trial of Hypofractionated IMRT Boost Versus Conventional IMRT Boost for Localized High Risk Prostate CancerNo drug interventionstreatmentNot Availableunknown_status
NCT03700099
Biomarker Analysis of Castration-resistant Prostate Cancer Undergoing Treatment With Docetaxel Followed by Enzalutamidetreatment2active_not_recruiting
NCT00691899
A Study to Assess the Effects of MK0822 in Prolonging Time to First Bone Metastasis in Men With Castration-Resistant Prostate Cancer (0822-030)prevention3withdrawn
NCT01191099
Comprehensive Analysis of Hypoxia in Prostate Cancer: Diagnostic Markers and Prognostic SignificanceNo drug interventionsNot AvailableNot Availableunknown_status
NCT01132599
Comparing PET-CT Using C-11 Choline and 18F-Fluoromethylcholine in Patients With Metastatic Prostate CancerNo drug interventionsdiagnostic2withdrawn
NCT00027599
APC8015 and Bevacizumab in Treating Patients With Prostate Cancertreatment2completed
NCT02463799
Study of Sipuleucel-T W/ or W/O Radium-223 in Men With Asymptomatic or Minimally Symptomatic Bone-MCRPCtreatment2completed
NCT00630799
Efficacy and Safety Study of a New Leuprolide Acetate 17 mg Depot to Treat Prostate Cancer Patientssupportive_care3terminated
NCT05690399
Evaluation of Clinical and Pathological Characteristics and Routine Treatment of Patients With Prostate CancerNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT00022399
Celecoxib Compared With No Treatment Before Surgery in Treating Patients With Localized Prostate Cancerprevention2completed
NCT01083199
Global Performance Evaluation of the AMS CONTINUUM™ DeviceNo drug interventionstreatment4completed
NCT00313599
Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumorstreatment1completed
NCT01844999
Personal Patient Profile - Prostate (P3P) II: Effectiveness-Implementation Trial in Diverse Health Care NetworksNo drug interventionsotherNot Availablecompleted
NCT04337099
A Single Patient Compassionate Use of MBM-02 (Tempol) for the Treatment of Prostate CancerNot AvailableNot Availableavailable
NCT02844699
A Multicenter Randomized Double-blind Placebo-controlled Pilot Study of Safety, Pharmacodynamics and Efficacy of Different Treatments of Immunotherapeutic Drug Mobilan (M-VM3) in Patients With Diagnosed Prostate Cancertreatment1 / 2unknown_status
NCT06144099
Prothrombin Complex Concentrate vs Fresh Frozen Plasma in Goal-directed Bleeding Management in Non-cardiac Surgerytreatment4not_yet_recruiting
NCT03911999
Exosomal microRNA in Predicting the Aggressiveness of Prostate Cancer in Chinese PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT00122499
A Study to Assess the Efficacy of Tadalafil to Treat Erectile Dysfunction After Radiotherapy of Prostate Cancertreatment3completed
NCT06235099
Copper Cu 64 PSMA I&T PET Imaging in Men With Suspected Recurrence of Prostate Cancerdiagnostic3recruiting
NCT05518799
CYP3A4 Activity in Patients With Prostate Cancer Versus Male Patients With Other Solid TumoursotherNot Availablecompleted
NCT03518606
Metronomic Oral Vinorelbine Plus Anti-PD-L1/Anti-CTLA4 ImmunothErapy in Patients With Advanced Solid Tumourstreatment1 / 2active_not_recruiting
NCT00032006
Hormone Therapy Followed By Internal Radiation Therapy in Treating Patients With Locally Recurrent Prostate CancerNo drug interventionstreatment2completed
NCT06450106
Study of STM-416p Administered to Patients Undergoing Radical ProstatectomyNo drug interventionstreatment1not_yet_recruiting
NCT02799706
Trial Comparing Irradiation Plus Long Term Adjuvant Androgen Deprivation With GnRH Antagonist Versus GnRH Agonist Plus Flare Protection in Patients With Very High Risk Localized or Locally Advanced Prostate Cancertreatment3active_not_recruiting
NCT00578006
Internet-based System for Cancer Patients to Self-report ToxicityNo drug interventionsNot AvailableNot Availablecompleted
NCT00601406
Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological CancerNo drug interventionstreatmentNot Availableunknown_status
NCT03380806
Prostate Boost Irradiation With Stereotactic Body RT (SBRT)treatment2unknown_status
NCT05525806
Clinical Utility Study for MyProstateScore+No drug interventionsdiagnosticNot Availablecompleted
NCT05252806
Quantitative mpMRI to Predict Metastatic Potential of Prostate CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT00255606
Docetaxel and Prednisone in Treating Patients With Hormone-Refractory Metastatic Prostate Cancertreatment3completed
NCT01423006
Pilot Study on Focal Prostate Radio-Frequency AblationNo drug interventionstreatmentNot Availablecompleted
NCT06179706
11C-choline PET/CT Based Helical Tomotherapy as Innovative Treratment Approach for Bone Metastases in Prostate Cancer Patients.No drug interventionsNot AvailableNot Availablecompleted
NCT03982706
Examination of Focal Therapies- MRI-Fusion, HIFU, NanoKnife and CryotherapyNo drug interventionsNot AvailableNot Availableunknown_status
NCT04293406
pCHIP: Prostate Cancer Health Impact ProgramNo drug interventionsNot AvailableNot Availableterminated
NCT05819606
Positron Emission Radiomics With PSMA Radioligands on Newly Diagnosed Prostate Cancer PatientsNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT03011606
Robotic Surgery After Focal Ablation TherapyNo drug interventionstreatmentNot Availablecompleted
NCT00282906
FDG Positron Emission Tomography and Computed Tomography (PET-CT) in Metastatic Prostate CancerNo drug interventionsdiagnosticNot Availablecompleted
NCT02218606
Multicenter Trial of Abiraterone Acetate With or Without Cabazitaxel in Treatment of Metastatic Castration Resistant Prostate Cancertreatment2completed
NCT04147806
A Pilot Study of Ultra-High-Dose Hypofractionated or Single-Dose Radiotherapy for Intermediate Risk Prostate Cancertreatment2active_not_recruiting
NCT01615406
A Phase 1 Pilot Study of 99mTc-MIP-1404 SPECT/CT Imaging to Histology in Men With Prostate Cancerdiagnostic1completed
NCT00374049
MUC1 Vaccine in Conjunction With Poly-ICLC in Patients With Recurrent and/or Advanced Prostate CancerNo drug interventionstreatment1completed
NCT06430749
Targeted Microwave Tissue Coagulation for Prostate CancerNo drug interventionstreatmentNot Availablerecruiting
NCT04638049
Intestinal Microbiota in Prostate Cancer Patients as a Biomarker for Radiation-INduced Toxicity (IMPRINT)No drug interventionsbasic_scienceNot Availablecompleted
NCT02311049
Hypofractionated Radiotherapy for Prostate CancerNo drug interventionstreatment2completed
NCT02009449
A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumorstreatment1active_not_recruiting
NCT02295449
Quantitative Prostate Cancer Contrast-enhanced UltrasoundNo drug interventionsdiagnosticNot Availableunknown_status
NCT00117949
Study Investigating the Pharmacokinetics, Pharmacodynamics and Safety of FE200486treatment2completed
NCT00537849
Investigational Study For the Treatment of Localized (T1c/T2a) Prostate Cancer With High Intensity Focused Ultrasound (HIFU) Using the Sonablate 500 (SB-500) System in CanadaNo drug interventionstreatmentNot Availablewithdrawn
NCT01521949
Study of Acai Juice in Asymptomatic or Minimally Symptomatic Prostate Cancer Patients With Rising PSANo drug interventionstreatment2completed
NCT00744549
Study of Antioxidants on MRI Detectable Early Stage Prostate Cancer Among Men on Active SurveillanceNo drug interventionstreatment2completed
NCT02911649
Reducing Sedentary Behaviour With TechnologyNo drug interventionssupportive_careNot Availablecompleted
NCT04658849
Insulin Resistance Following ADT for Prostate CAtreatment0withdrawn
NCT02564549
MRI-Based Active Surveillance to Avoid the Risks of Serial Biopsies in Men With Low-Risk Prostate CaNo drug interventionsdiagnosticNot Availableterminated
NCT02460549
Feasibility Study of an Intervention Therapeutic Education for Patients Treated With Androgen DeprivationNo drug interventionssupportive_careNot Availablecompleted
NCT03639649
STHLM3 - Prostate Cancer Diagnostic TrialNo drug interventionsdiagnosticNot Availablecompleted
NCT01477749
Sipuleucel-T Manufacturing Demonstration StudyNot Available2completed
NCT00458549
Polyunsaturated Fatty Acids in Treating Patients With Prostate Cancer Undergoing Prostate Biopsy and/or SurgeryNo drug interventionsbasic_scienceNot Availableterminated
NCT02957149
Platelet Rich Plasma During Radical ProstatectomyNo drug interventionssupportive_careNot Availablecompleted
NCT02110849
Prostate Cancer Parameters for Patients Receiving Proton TreatmentNo drug interventionsNot AvailableNot Availablewithdrawn
NCT06433349
A Multi-center Investigation of Family Health.No drug interventionsNot AvailableNot Availablerecruiting
NCT00207636
Community Interventions in Non-Medical Settings to Increase Informed Decision Making for Prostate Cancer ScreeningNo drug interventionseducational_counseling_training3unknown_status
NCT02911636
5 Fractions of Pelvic SABR With Intra Prostatic SABRNo drug interventionstreatmentNot Availableunknown_status
NCT04891536
Salvage Cryotherapy for Recurrent Prostate Cancer After Radiation TherapyNo drug interventionstreatmentNot Availablerecruiting
NCT02043236
Strategies to Improve Bone Health in Men on ADTNo drug interventionspreventionNot Availablecompleted
NCT06355336
Real World Prostate Cancer RegistryNo drug interventionsNot AvailableNot Availablerecruiting
NCT03098836
Apalutamide and Abiraterone Acetate in African American and Caucasian Men With Metastatic Castrate Resistant Prostate Cancertreatment2active_not_recruiting
NCT06549036
Veteran Peer Navigators to Promote Shared Decision Making for PSA ScreeningNo drug interventionsscreeningNot Availablenot_yet_recruiting
NCT01794936
Pilot Study of VTI Doppler Probe Use to Identify Neurovascular Bundle During Prostate SurgeryNo drug interventionsdiagnosticNot Availableterminated
NCT01667536
A Phase 2 Study With MIP-1404 in Men With High-Risk PC Scheduled for RP and EPLND Compared to Histopathologydiagnostic2completed
NCT04563936
Efficacy and Safety of LY01005 in Patients With Prostate Cancer Compared to ZOLADEX®treatment3completed
NCT01644136
Microspheres in Preventing Lymphatic Fluid Collection After Surgery in Patients With Prostate CancerNo drug interventionssupportive_careNot Availableterminated
NCT02470936
Web-based Lifestyle Trial Among Men With Prostate Cancer: Prostate 8No drug interventionssupportive_careNot Availablecompleted
NCT05455736
STereotactic sAlvage Radiotherapy for Macroscopic Prostate Bed Recurrence After prostatectomy-a Prospective Observational StudyNo drug interventionsNot AvailableNot Availableunknown_status
NCT01655836
High-Dose Rate Brachytherapy and Stereotactic Body Radiation Therapy in Treating Patients With Prostate CancerNo drug interventionstreatment1active_not_recruiting
NCT01733836
Prostate Cancer Active Surveillance Metformin Trialtreatment2withdrawn
NCT06573736
Stockholm3 Use Prior to MRI for Prostate Cancer Detection in a Clinical Care Pathway: a Multi-centered ValidationNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT01009736
Effects of Tomato-Soy Juice on Biomarkers in Patients With Prostate Cancer Undergoing ProstatectomyNo drug interventionstreatment1 / 2completed
NCT00214136
Intensity Modulated Radiation Therapy (IMRT) Radiotherapy for Treating Prostate Pelvic NodesNo drug interventionstreatment2completed
NCT04452136
Expanded Access Protocol of 68Ga PSMA 11 PET Imaging of Prostate CancerNot AvailableNot Availableapproved_for_marketing
NCT00686036
Trial Assessing Zactima Against Placebo in Prostate Cancer Subjects Undergoing Intermittent Androgen Deprivation Hormonal Therapytreatment2terminated
NCT00544336
Family Quality of Life Among Families With a Member Who is a Cancer PatientNo drug interventionsNot AvailableNot Availablecompleted
NCT05343936
Evaluation of an Active Surveillance Protocol for Prostate Cancer in the Brazilian PopulationNo drug interventionsNot AvailableNot Availablerecruiting
NCT04982536
Assessment of VMCore Biopsy Versus Standard of Care BiopsyNo drug interventionsdiagnosticNot Availableunknown_status
NCT02059213
A Phase II Study of Androgen Deprivation Therapy With or Without Palbociclib in RB-Positive Metastatic Prostate Cancertreatment2completed
NCT01827813
Comparison Of Effectiveness of Transrectal Ultrasonography-Guided Saturation Biopsy And 10-12 Core Biopsy In Repeated Prostate BiopsiesNo drug interventionsdiagnosticNot Availablecompleted
NCT04832113
Impact of Patient's Therapeutic Education in APA and Dietetic on Radiotherapy Reproducibility Sessions for Prostate CancerNo drug interventionsotherNot Availablerecruiting
NCT06398613
Preoperative PSMA PET/CT as Triage for ePLND in Patients Scheduled for RALP (PrePSMA)No drug interventionstreatmentNot Availablerecruiting
NCT01371513
Korean Practice Patterns for Screening PCA(Prostate Cancer)No drug interventionsNot AvailableNot Availablecompleted
NCT02514213
Trial to Evaluate Safety and Immunogenicity of INO-5150 Alone or With INO-9012 in Men With Prostate Cancertreatment1completed
NCT01619813
Reolysin Combined With Docetaxel and Prednisone or Docetaxel and Prednisone Alone in Metastatic Castration Resistant Prostate Cancertreatment2completed
NCT05879913
ASCVD Management Using CCTA in Prostate Cancer Patients on ADTNo drug interventionsdiagnosticNot Availablerecruiting
NCT02108613
Living Well on Androgen Deprivation TherapyNo drug interventionssupportive_careNot Availablewithdrawn
NCT01215513
Long-Term Safety and Tolerability of Degarelix One-Month Dosing Regimen in Korean Patientstreatment3completed
NCT03857113
Technetium Based Radioguided Surgery for Prostate Cancer (TRACE) StudyNo drug interventionsNot AvailableNot Availableunknown_status
NCT06303713
LuCarbo - a Study of 177Lu-PSMA-617 Plus Carboplatin in Metastatic Castrate-resistant Prostate Cancertreatment1recruiting
NCT03084913
Olive Oil v Prostate Cancer Foundation Diet for Treatment of Prostate CancerNo drug interventionstreatmentNot Availablecompleted
NCT00345813
Soy Supplements in Treating Patients Undergoing Surgery for Localized Prostate CancerNo drug interventionstreatment2completed
NCT01176513
GE-148-002: A Phase 2, Open-label, Single-Center Study to Assess GE-148 (18F) Injection PET Imaging to Detect Localized Prostate Cancerdiagnostic2terminated
NCT01059513
Hypo-fractionated Stereotactic Body Radiotherapy for Localized Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT02726113
Vitamin D and Prostate Cancer: A Clinical Study Enrolling Subjects Undergoing Prostatectomybasic_science2completed
NCT03031613
Effects of PEEP on Intracranial and Intraocular Pressure in Robot-assisted Laparoscopic Radical ProstatectomyNo drug interventionspreventionNot Availableunknown_status
NCT01995513
Safety Study of Continued Enzalutamide Treatment In Prostate Cancer Patientstreatment4completed
NCT03424213
Race-related Alternative Splicing: Novel Targets in Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT02494713
Hormonal Therapy and Chemotherapy Followed by Prostatectomy in Patients With Prostate Cancertreatment2terminated
NCT01072513
Semen Analysis After Proton Therapy for Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT03502213
Study In Urology Practices Looking At Impact Of OncotypeDX GPS Test On Men Choosing And Remaining On Active SurveillanceNo drug interventionsNot AvailableNot Availablecompleted
NCT05790213
Focal Prostate Ablation With Androgen Deprivation and Novel Hormonal Therapy for Intermediate Risk Prostate Cancertreatment2suspended
NCT01119118
ZD4054 With Positron Emission Tomography/Magnetic Resonance Imaging (PET/MRI) for Prostate Cancertreatment2terminated
NCT01745718
Clinical Study Evaluating Targeted Biopsies and Cytological Imprints in Prostate CancerNo drug interventionsdiagnosticNot Availablewithdrawn
NCT06059118
Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancertreatment2recruiting
NCT00967018
A Long Term Safety Study of Degarelix in Patients With Prostate Cancertreatment3completed
NCT00911118
Dose Escalation Study Using Ultra-Hypofractionated, Image-Guided, Intensity-Modulated Radiotherapy in Prostate CancerNo drug interventionstreatment1active_not_recruiting
NCT02036918
Dendreon Lymph Node Biopsy in Metastatic Castrate-Resistant Prostate Cancerother1completed
NCT01851018
Toxicity Comparison Between Hypofractionated Radiotherapy With HDR Brachytherapy Boost Versus Standard TreatmentNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT05982418
Improvement of RARP Outcomes Via 3D Printed/Virtual Prostate ModelsNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT06440018
INSPIRE: A Multi-Cancer Early Detection StudyNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT00808418
A Study to Determine the Maximum Tolerated Dose of Elesclomol Sodium Given With a Fixed Dose of Docetaxel and Prednisone in Patients With Metastatic Prostate Cancertreatment1completed
NCT04599218
MR/TRUS Fusion Guided Prostate Biopsy - An Improved Way to Detect and Quantify Prostate CancerNo drug interventionsdiagnosticNot Availablerecruiting
NCT04924218
Evaluation of the Effect of Endoscopic Urethral Procedures Applied After Radical Prostatectomy on Urinary IncontinenceNo drug interventionspreventionNot Availablecompleted
NCT00922818
Study of Anatomic Nerve Sparing Radical Perineal ProstatectomyNo drug interventionsNot AvailableNot Availablewithdrawn
NCT00111618
Study of AS1404 With Docetaxel in Patients With Hormone Refractory Metastatic Prostate Cancertreatment2completed
NCT01229618
Hyperpolarized Pyruvate Injection in Subjects With Prostate Cancerdiagnostic1completed
NCT04882618
Use of Indocyanine Green During Pelvic Lymph Node Dissection in Prostate Cancer.treatment4unknown_status
NCT00554918
Docetaxel and Prednisolone With or Without Zoledronic Acid and/or Strontium Chloride Sr 89 in Treating Patients With Prostate Cancer Metastatic to Bone That Has Not Responded to Hormone Therapytreatment2completed
NCT02905318
Palbociclib in Patients With Metastatic Castration-Resistant Prostate Cancertreatment2active_not_recruiting
NCT01314118
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigentreatment2active_not_recruiting
NCT00106418
A Research Study for Patients With Prostate Cancertreatment2completed
NCT00510718
A Phase 1 Study of MDV3100 in Patients With Castration-Resistant (Hormone-Refractory) Prostate Cancertreatment1completed
NCT02489318
A Study of Apalutamide (JNJ-56021927, ARN-509) Plus Androgen Deprivation Therapy (ADT) Versus ADT in Participants With mHSPCtreatment3active_not_recruiting
NCT05804318
Daily Adaptive Radiation Therapy Using an Individualized Approach for Prostate CancerNo drug interventionstreatmentNot Availablerecruiting
NCT00925418
Evaluation of the Cryotherapy in the Prevention of Nails Toxicity Induced by Taxotere® in Breast or Prostate CancerNo drug interventionsprevention3completed
NCT02570919
Phase II Study of Ultra-high-dose Hypofractionated vs. Single-dose Image-Guided Radiotherapy for Prostate CancerNo drug interventionstreatmentNot Availablecompleted
NCT00003819
Vaccine Therapy Plus QS21 in Treating Patients With Progressive Prostate Cancertreatment1completed
NCT03388619
Highly Conformal, Hypofractionated, Focally Dose Escalated Post-Prostatectomy RadiotherapyNo drug interventionstreatment1active_not_recruiting
NCT00006019
Phenylbutyrate Plus Azacitidine in Treating Patients With Acute Myeloid Leukemia, Myelodysplasia, Non-Hodgkin's Lymphoma, Multiple Myeloma, Non-small Cell Lung Cancer, or Prostate Cancertreatment2completed
NCT00984919
Biomarker 11-dh-TXB2 in Blood and Urine Samples From Patients With Prostate Cancer and Healthy VolunteersNo drug interventionsNot AvailableNot Availablecompleted
NCT00450619
153Sm-EDTMP With or Without a PSA/TRICOM Vaccine To Treat Men With Androgen-Insensitive Prostate Cancertreatment2completed
NCT01411319
MRI-Guided Lattice Extreme Ablative Dose Radiotherapy For Prostate CancerNo drug interventionstreatmentNot Availablecompleted
NCT05702619
Hypoxia-driven Prostate Cancer Genomics (HYPROGEN)Not AvailableNot Availablerecruiting
NCT00219219
Zoledronic Acid in the Prevention of Skeletal-related Events in Hormone Refractory and Hormone-sensitive Prostate Cancer Patients With Bone Metastasestreatment4completed
NCT03500419
Penile Length Maintenance Post-ProstatectomyNo drug interventionstreatmentNot Availablecompleted
NCT05285319
Trial Comparing Radical Radiotherapy to Prostate Only VS Prostate And Pelvic Lymph Nodes in Intermediate And High Risk Prostate CancerNo drug interventionstreatment2unknown_status
NCT06001619
Prostate Medication, Metabolism and Gut Microbiotaother4recruiting
NCT03588819
Stereotactic MRI-Guided Radiation for Localized Prostate CancerNo drug interventionstreatmentNot Availableunknown_status
NCT02353819
Stereotactic Ablative Radiotherapy (SABR) of Pelvis and Prostate Targets For High Risk Prostate CancerNo drug interventionstreatment1active_not_recruiting
NCT04595019
Hypofractionated Expedited Radiotherapy for Men With localisEd proState CancerNo drug interventionstreatmentNot Availablerecruiting
NCT00949819
Active Surveillance for Cancer of the Prostate (ASCaP)No drug interventionsNot AvailableNot Availablerecruiting
NCT06509919
Application of a Novel Biomarker Based on Plasma cfDNA Assay in the Early Diagnosis of Prostate CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT00879619
Taxotere/Prednisone Plus Sunitinib in Chemotherapy-Naïve, Hormone Refractory Prostate Cancer Patientstreatment1 / 2terminated
NCT01520441
BOTOX in Men With Prostate Cancer With Lower Urinary Tract Symptoms(LUTS)/Benign Prostatic Hyperplasia (BPH)diagnostic0withdrawn
NCT00048841
Prevention of Osteoporosis in Men With Prostate Cancerprevention3completed
NCT00562341
Effect of Lap-Band Induced Weight Loss on Serum PSA LevelsNo drug interventionsNot AvailableNot Availablewithdrawn
NCT03410641
Long-term Cancer Risk in the Randomised Oslo Diet and Antismoking StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT02680041
18F Fluciclovine (FACBC) PET/CT in Patients With Rising PSA After Initial Prostate Cancer Treatmentdiagnostic3completed
NCT04831541
68Ga-PSMA-11 PET/CT in Patients With Various Types of Cancerdiagnostic0recruiting
NCT04243941
PSMA-PET/MRI Low- and Intermediate-Risk Prostate CancerNo drug interventionstreatment2withdrawn
NCT05751941
Study of Sipuleucel-T With or Without Continuing New Hormonal Agents in Metastatic Prostate Cancertreatment2recruiting
NCT03569241
PEACE V: Salvage Treatment of OligoRecurrent Nodal Prostate Cancer MetastasesNo drug interventionstreatment2active_not_recruiting
NCT00667641
Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumorstreatment1completed
NCT03783741
The Biopsychosocial Burden of Prostate BiopsyNo drug interventionsNot AvailableNot Availablecompleted
NCT06511141
Sacral Neuromodulation for Male Overactive Bladder (MOAB)No drug interventionstreatmentNot Availablenot_yet_recruiting
NCT05489341
Artificial Intelligence and Radiologists at Prostate Cancer Detection in MRI: The PI-CAI ChallengeNo drug interventionsNot AvailableNot Availablecompleted
NCT04292041
Fasting Mimicking Diet in Prostate Cancer and Metabolic SyndromeNo drug interventionsNot AvailableNot Availableunknown_status
NCT00850941
Radiation Therapy for Rising Prostate Specific Antigen (PSA) Post-prostatectomyNo drug interventionsNot AvailableNot Availableunknown_status
NCT00182741
Calcitriol, Mitoxantrone, and Prednisone in Treating Patients With Metastatic Prostate Cancertreatment2completed
NCT06579417
ART-Pro: Clinical Trial Evaluating Biparametric MRI and Advanced, Quantitative Diffusion MRI for Detection of Prostate CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT02003417
Cardiovascular Risk and Preventive Care in Prostate Cancer Patients Receiving Radiation and Hormone TherapyNo drug interventionsNot AvailableNot Availablecompleted
NCT00035217
Follow-Up Study for Men Diagnosed With Prostate Cancer Through Participation in a Prostate Specific Antigen Screening ProgramNo drug interventionsNot AvailableNot Availablecompleted
NCT05781217
Short Versus Long-term Androgen Deprivation Therapy With Salvage Radiotherapy in Prostate Cancer. URONCOR 0624treatment3recruiting
NCT04045717
Hypofractionated Focal Lesion Ablative Microboost in prostatE Cancer 2.0No drug interventionstreatment2active_not_recruiting
NCT00617617
The Specific Role of Isoflavones in Reducing Prostate Cancer RiskNo drug interventionsprevention2completed
NCT06150417
MDRT in Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA)No drug interventionstreatment2recruiting
NCT00877617
Quality of Life in Men With High Risk Localized Prostate CancerNo drug interventionsNot AvailableNot Availablewithdrawn
NCT00400517
GM-CSF and Thalidomide in Treating Patients Undergoing Surgery for High-Risk Prostate Cancertreatment2completed
NCT01250717
Docetaxel Followed by Radical Prostatectomy in Patients With High Risk Localized Prostate Cancertreatment2completed
NCT03554317
COMbination of Bipolar Androgen Therapy and Nivolumabtreatment2completed
NCT04769817
ProsTIC Registry of Men Treated With PSMA TheranosticsNo drug interventionsNot AvailableNot Availablerecruiting
NCT02220517
Randomized Study Comparing MR-guided in Bore Versus MRI/US Fusion-guided Prostate BiopsyNo drug interventionsdiagnosticNot Availablecompleted
NCT04242017
Long-term Better Than Short-term ADT With Salvage RTtreatment2 / 3recruiting
NCT04357717
ExoDx Prostate Evaluation in Prior Negative Prostate Biopsy SettingNo drug interventionsNot AvailableNot Availableterminated
NCT00003717
Paclitaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancertreatment2unknown_status
NCT03949517
68-Ga PSMA 11 PET/MRI and 68-Ga RM2 PET/MRI for Evaluation of Prostate Cancer Response to HIFU Therapytreatment1 / 2completed
NCT06504017
FUS-TB VS COG-TB in Small Lesions of Prostate CancerNo drug interventionsdiagnosticNot Availablenot_yet_recruiting
NCT02344017
Safety and Pharmacokinetics of ODM-204 in Patients With Metastatic Castration-Resistant Prostate Cancertreatment1 / 2completed
NCT06582017
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myelomatreatment1recruiting
NCT05555017
Tracer-Guided Surgery for Recurrent Prostate CancerNo drug interventionstreatment2recruiting
NCT03961217
Return to Work Among Cancer Survivors With Treatment-induced Survivorship SyndromesNo drug interventionsNot AvailableNot Availablecompleted
NCT04158817
68Ga-THP-PSMA PET/CT in Prostate Cancer: Clinical Stage and RestageNo drug interventionsdiagnostic0completed
NCT00313534
Nordihydroguaiaretic Acid in Treating Patients With Nonmetastatic Relapsed Prostate Cancertreatment1terminated
NCT00003734
Combination Hormone Therapy Followed by Radiation Therapy in Treating Patients With Prostate Cancertreatment3unknown_status
NCT00005634
Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapytreatment1completed
NCT00425334
Safety Study of Hemospan® in Prostatectomy Patientstreatment2completed
NCT06523634
Salvage Stereotactic Body Radiotherapy of the Prostate Bed for Biochemical Recurrence After Radical Prostatectomy.No drug interventionstreatmentNot Availablenot_yet_recruiting
NCT05751434
A Study on the Effects of Exercise Therapy on Signs of Prostate CancerNo drug interventionstreatment2recruiting
NCT03458234
RAD 1801: Pilot Study of Intra-Urethral Radiotransponder Beacon Guided Focal Prostate Stereotactic Body RadiotherapyNo drug interventionstreatmentNot Availableterminated
NCT00335634
Sexual Dysfunction and Adaptation in Couples Affected by Prostate Cancer SurgeryNo drug interventionsNot AvailableNot Availablecompleted
NCT00928434
A Study of Degarelix in Patients With Prostate Cancertreatment3completed
NCT03753334
Effects of EPA in Men With Biochemical Recurrence or Progression of Prostate Cancer.treatment2recruiting
NCT03308734
Effects of 6 Week Reduced Exertion High Intensity Interval Training Protocol in Patients With Prostate CancerNo drug interventionssupportive_careNot Availablewithdrawn
NCT00339534
Survey of Prostate Cancer in Accra, GhanaNo drug interventionsNot AvailableNot Availablecompleted
NCT00336934
Pomegranate Extract in Treating Patients With Rising Prostate-Specific Antigen Levels After Surgery or Radiation Therapy for Localized Prostate CancerNo drug interventionstreatmentNot Availablecompleted
NCT04936334
The Role of 68Ga-PSMA-11 PET (Prostate Specific Membrane Antigen) in Surgery Guidance in Prostate CancerNo drug interventionsdiagnostic2completed
NCT03927924
High-intensity Focused Ultrasound StudyNo drug interventionstreatmentNot Availableterminated
NCT00464724
3T Perfluorocarbon-Filled Endorectal Magnetic Resonance Spectroscopic Imaging of ProstateNo drug interventionsdiagnosticNot Availableterminated
NCT00039624
Magnetic Resonance-Guided High-Dose Brachytherapy (Short-Range Radiation Therapy) for Prostate CancerNo drug interventionstreatment2completed
NCT00462124
Evaluation of the Safety and Efficacy of the BioProtect Balloon in Prostate Cancer Subjects Undergoing RadiotherapyNo drug interventionspreventionNot Availablecompleted
NCT01040624
Docetaxel, Androgen Deprivation and Proton Therapy for High Risk Prostate CancerNo drug interventionstreatmentNot Availablecompleted
NCT00203424
Treatment of Prostate Cancer With Adjuvant Bevacizumab Plus Erlotinibtreatment2completed
NCT02232724
Choline PET/CT vs. Dual Time Point FDG PET/CT in Prostate CancerNo drug interventionsdiagnosticNot Availablecompleted
NCT05156424
A Comparison of Aerobic and Resistance Exercise to Counteract Treatment Side Effects in Men With Prostate CancerNo drug interventionshealth_services_research1 / 2unknown_status
NCT03296124
Prognostic Value of Androgen Receptor Expression and Mutations Within Oncogenes and Tumor Suppressor Genes in Patients Treated for High Risk Prostate Cancer With Proton Therapy (PRX32)No drug interventionsNot AvailableNot Availablewithdrawn
NCT00455624
Prospective Study of Insulin Resistance and Cardiovascular Disease Risk During Androgen Deprivation Therapy for Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT03492424
Ablative Therapy in the Management of Prostate CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT05497024
Older Men's Decision Making About Active Surveillance for Prostate Cancer - Aim 3: Decision Aid Cognitive and Usability TestingNo drug interventionsNot AvailableNot Availablerecruiting
NCT00003124
Hormone Therapy Plus Radiation Therapy in Treating Patients With Prostate Cancertreatment2completed
NCT00002924
Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone TherapyNo drug interventionsNot AvailableNot Availablecompleted
NCT03784924
EDRN Prostate MRI Biomarker StudyNo drug interventionsNot AvailableNot Availablerecruiting
NCT06167824
Assessment of Predictive Role of [11C] Choline PET/CT on Survival in Prostate Cancer Patients With Biochemical Failure Without Androgen Deprivation TherapyNo drug interventionsNot AvailableNot Availablecompleted
NCT00228124
PR.7 Companion Trial: Effect of Intermittent Versus Continuous Androgen Suppression on Bone Loss and Body CompositionNo drug interventionsNot AvailableNot Availableunknown_status
NCT02003924
Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancertreatment3active_not_recruiting
NCT00167024
Application of Genetic Polymorphisms of DNA Repair in The Prediction of Prostate Cancer Susceptibility and Its Clinical OutcomeNo drug interventionsNot AvailableNot Availableunknown_status
NCT01867424
Gadoxetate Enhanced Imaging Study to Detect Prostate Cancerdiagnostic2completed
NCT04694924
Prospective Prostate Cancer and Patient-reported Outcomes RegistryNo drug interventionsNot AvailableNot Availablerecruiting
NCT04341324
Effect of ADT in Chinese Male With Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT00004124
S9921, Hormone Therapy With or Without Mitoxantrone and Prednisone in Patients Who Have Undergone Radical Prostatectomy for Prostate Cancertreatment3completed
NCT04763824
KanSurvive: Testing a Model for Improving Cancer Survivorship Care in Rural PracticeNo drug interventionshealth_services_researchNot Availablecompleted
NCT03383016
Diet, Physical Activity and Related Candidate Biomarkers in Relation to Prostate Cancer Risk (BIOCaPPE)No drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT03869216
Fostering Shared Decision-making About Prostate Cancer Screening Among Clinicians and African American MenNo drug interventionspreventionNot Availablecompleted
NCT02818816
Preoperative Brimonidine on IOP of Patients Undergoing RALPtreatment4completed
NCT04556916
Early Detection of Prostate CancerNo drug interventionsdiagnosticNot Availablerecruiting
NCT00685516
Green Tea, Black Tea, or Water in Treating Patients With Prostate Cancer Undergoing SurgeryNo drug interventionstreatmentNot Availablecompleted
NCT03080116
Neoadjuvant Degarelix With or Without Apalutamide (ARN-509) Followed by Radical Prostatectomytreatment2active_not_recruiting
NCT02055716
Sulforadex in Healthy Human Males MADtreatment1completed
NCT00923416
Trans-Rectal Ultrasound-Guided (TRUS) Adverse EventsNo drug interventionsNot AvailableNot Availablecompleted
NCT02426216
Molecular Effects of a Multi-carotenoids (MCS) New Agent on Prostate Cancer ChemopreventionNo drug interventionsNot AvailableNot Availableunknown_status
NCT02935816
Localising Occult Prostate Cancer Metastases With Advanced Imaging TEchniquesNo drug interventionsNot AvailableNot Availableunknown_status
NCT05681416
Prostate Cancer Prevention Clinic for Men With Risk of Familial Prostate CancerNo drug interventionsdiagnosticNot Availablenot_yet_recruiting
NCT05815316
18F-PSMA PET/MRI for the Diagnosis of Clinically Significant Prostate CancerNo drug interventionsdiagnostic2not_yet_recruiting
NCT02790216
Deformable Registration of Multi-parametric MRI to Intra-operative Transrectal Ultrasound for Prostate BrachytherapyNo drug interventionsNot AvailableNot Availableunknown_status
NCT03384316
Multi-Targeted Recombinant Ad5 (CEA/MUC1/Brachyury) Based Immunotherapy Vaccine Regimen in People With Advanced Cancertreatment1completed
NCT00447616
Prostatectomy Prospective DatabaseNo drug interventionsNot AvailableNot Availableterminated
NCT02834416
ADT Exercise Trial and Economic AnalysisNo drug interventionssupportive_care3completed
NCT00348816
Docetaxel, Radiation Therapy, and Prednisone in Treating Patients Who Have Undergone Surgery For Prostate Cancertreatment2terminated
NCT01547416
The Effect of Combined General/Epidural Anesthesia Versus General Anesthesia on Diaphragmatic Functiontreatment4completed
NCT00025116
ZD 1839 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapytreatment2completed
NCT01864096
The Metformin Active Surveillance Trial (MAST) Studytreatment3active_not_recruiting
NCT02745496
Advanced Magnetic Resonance Imaging (MRI) in Men With Suspected Prostate CancerNo drug interventionstreatmentNot Availablecompleted
NCT04662996
Search for Predictive Factors of Resistance to Treatment for Metastatic Castration-resistant Prostate Cancer by Studying the Expression of microRNAsNo drug interventionsotherNot Availableactive_not_recruiting
NCT04565496
Phase 2 Study of Neoadjuvant PEMbrolizumab Before Radical PROstatectomy in High-risk Prostate Cancer Patientstreatment2unknown_status
NCT02946996
Study of Pharmacologic Manipulation of AGE (Advanced Glycation Endproducts) Levels in Prostate Cancer Patients Receiving Androgen Deprivation Therapytreatment2terminated
NCT03674996
Safety and Security Evaluation of Patients Submitted to Minimally Invasive Radical ProstatectomyNo drug interventionssupportive_careNot Availablecompleted
NCT03836196
Optimizing Prostate Cancer Treatment in Men With Advanced Local DiseaseNo drug interventionshealth_services_researchNot Availablerecruiting
NCT06117696
Optimizing the Announcement of Advanced or Metastatic Prostate Cancer Using Animated Videos (CartDiag PROSTATE)No drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT00726596
Hydroxychloroquine in Treating Patients With Rising PSA Levels After Local Therapy for Prostate Cancertreatment2completed
NCT06489496
Prostate Cancer 18F-PSMA-1007 PET/CT Access TrialNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT02376296
Observational Study of Docetaxel Exposure in Metastatic Prostate Cancer PatientsNot AvailableNot Availablecompleted
NCT02488096
Improving Prostate Cancer Detection Using MRI-Targeted TRUS-Guided BiopsyNo drug interventionsdiagnosticNot Availablecompleted
NCT01414296
Extended Study of Prostate-specific Membrane Antigen Antibody-Drug Conjugate in Subjects With Prostate CancerNo drug interventionstreatment1completed
NCT06555796
Evaluation of Xaluritamig in High-Risk, Biochemically Recurrent, Non-metastatic Castrate-sensitive Prostate Cancertreatment1not_yet_recruiting
NCT00050596
Comparison Study of MDX-010 (CTLA-4) Alone and Combined With Docetaxel in the Treatment of Patients With Hormone Refractory Prostate Cancertreatment2completed
NCT06494696
68Ga-PSMA PET/MRI in Conjunction With mpMRI for Evaluating Prospective Prostate Cancer RiskNo drug interventionsNot AvailableNot Availablerecruiting
NCT05415696
Prostatic Artery Embolization for the Treatment of Lower Urinary Tract Symptoms in Prostate Cancer Patients Undergoing Radiation TherapyNo drug interventionssupportive_careNot Availablewithdrawn
NCT04068896
Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination TherapyNo drug interventionstreatment1 / 2completed
NCT00355758
UCI 03-72 Prostate Cancer Detection by Serum Proteomic ProfilingNo drug interventionsNot AvailableNot Availableterminated
NCT00451958
A Long-term Extension Study Evaluating a One-Month Dosing Regimen of Degarelix in Prostate Cancer Requiring Androgen Ablation Therapytreatment3completed
NCT00636558
Coxsackie Virus A21 Administered Intravenously (IV) for Solid Tumour Cancers (PSX-X04)treatment1completed
NCT03253458
Focal Prostate Imaging With CLE and OCTNo drug interventionsdiagnosticNot Availableunknown_status
NCT00598858
Neoadjuvant Docetaxel on Newly Diagnosed Intermediate and High Grade Cancer of the Prostatetreatment2withdrawn
NCT01706458
Provenge With or Without pTVG-HP DNA Booster Vaccine in Prostate Cancertreatment2completed
NCT01560858
Treatment Patterns Among Patients With Prostate Cancer Prior to Diagnosis of a Castration-resistant StateNo drug interventionsNot AvailableNot Availablecompleted
NCT04359758
Streamlined Genetic Testing in Prostate CancerNo drug interventionssupportive_careNot Availablecompleted
NCT02321358
Trial of a Behavior Change Intervention to Increase Aerobic and Resistance Exercise and Quality of Life in Older Prostate and Breast Cancer SurvivorsNo drug interventionssupportive_careNot Availablecompleted
NCT04604158
Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer PatientsNo drug interventionssupportive_careNot Availablecompleted
NCT00181558
Atrasentan and Zometa for Men With Prostate Cancer Metastatic to Bonetreatment2completed
NCT01686958
Safety Study of MRI-guided Transurethral Ultrasound Ablation of Prostate Tissue to Treat Localized Prostate CancerNo drug interventionstreatmentNot Availablecompleted
NCT00909558
Safety and Effectiveness Study of Autologous Natural Killer and Natural Killer T Cells on CancerNo drug interventionstreatment1suspended
NCT02307058
Randomized MRI-Guided Prostate Boosts Via Initial Lattice Stereotactic vs Daily Moderately Hypofractionated RadiotherapyNo drug interventionstreatmentNot Availablerecruiting
NCT00809458
Biomarker Study of Neoadjuvant Vitamin E in Patients With Locally Treatable Prostate Cancertreatment3terminated
NCT06145958
Radiotherapy and Androgen Deprivation In Combination After Local Surgery (RADICALS) Translational StudyNot AvailableNot Availablenot_yet_recruiting
NCT06200558
ARON-3 Study: International Multicentric Retrospective Study to Collect Global Experiences in the Treatment of Patients With Metastatic PCaNo drug interventionsNot AvailableNot Availablerecruiting
NCT06166758
Feasibility Study: Educational Genetic Test VideoNo drug interventionssupportive_careNot Availablecompleted
NCT01995058
Study of Cabozantinib in Combination With Abiraterone in Chemotherapy-Naïve Subjects With Bone-Metastatic Castration-Resistant Prostate Cancertreatment2terminated
NCT06482658
Evaluation of Transrectal Perilesional Biopsy in Diagnosis of Prostate CancerNo drug interventionsdiagnosticNot Availablerecruiting
NCT03075735
Prospective Multicentre Cohort Study PROREPAIR-B (mCRPC)No drug interventionsNot AvailableNot Availablecompleted
NCT03255135
Initial Experience in Brazilian Single Center With High Intensity Focalized Ultrasound (HIFU) Prostate Cancer Therapy: Morbidity, Oncological and Functional Outcomes.No drug interventionstreatmentNot Availableunknown_status
NCT00955435
Study of Blood and Urine Samples in Patients With Newly Diagnosed Localized Prostate Cancer Treated With Hormone Therapy and Radiation Therapy. ICORG 06-15No drug interventionsNot AvailableNot Availableunknown_status
NCT05709535
PSMA-PET/CT RegistryNo drug interventionsNot AvailableNot Availablerecruiting
NCT00012935
Treatment Decision Intervention for Veterans With Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT01864135
Improved Prostate Cancer Diagnosis - Combination of Magnetic Resonance Imaging and BiomarkersNo drug interventionsdiagnosticNot Availablecompleted
NCT04969835
A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid TumoursNo drug interventionstreatment1recruiting
NCT02077335
Study of High-dose Rate (HDR) Monotherapy for Low and Intermediate Risk Prostate CancerNo drug interventionstreatment2active_not_recruiting
NCT03225235
Prospective Evaluation of Hypofractionated Stereotactic RT Using CyberKnife for Patients With Prostate CancerNo drug interventionstreatmentNot Availablerecruiting
NCT00959335
Relative Bioavailability Study of Bicalutamide 50 mg Tablet and Casodex Following a 50 mg Dose in Healthy Subjects Under Fasting Conditionstreatment1completed
NCT00115635
Docetaxel and Gemcitabine in Hormonal Refractory Metastatic Prostate Cancertreatment1 / 2completed
NCT02761135
Does End-fire Technique Increase Detection Rate of Prostate Cancer at First Re-biopsy Compared to Side-fire Technique?No drug interventionsNot AvailableNot Availablecompleted
NCT01076335
Neoadjuvant Hormones + Docetaxel in Node-Positive Prostate Cancertreatment2completed
NCT00900835
Pain and Fatigue Management in Patients With Breast Cancer, Prostate Cancer, Colon Cancer, or Lung CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT00087035
Docetaxel and Erlotinib in Treating Older Patients With Prostate Cancertreatment2completed
NCT01649635
Study of Cabazitaxel Combined With Prednisone and Prophylaxis of Neutropenia Complications in the Treatment of Patients With Metastatic Castration-resistant Prostate Cancertreatment4completed
NCT00373035
Biomarkers in Patients Undergoing Transrectal Ultrasound Prostate BiopsyNo drug interventionsNot AvailableNot Availablecompleted
NCT04066335
Study to Evaluate the Safety of Nanoxel M Inj.No drug interventionsNot AvailableNot Availableunknown_status
NCT00392535
Intensity-Modulated Radiation Therapy in Treating Patients With Localized Prostate CancerNo drug interventionstreatmentNot Availableunknown_status
NCT02333435
Effects of EPA on Prostate Cancer Cells Proliferation and Quality of LifeNo drug interventionstreatment2active_not_recruiting
NCT02020135
An Open-label Extension Study of PSMA ADC 2301 in mCRPCNo drug interventionstreatment2completed
NCT05245435
Diagnostic and Prognostic Accuracy of FDHT-PET and Liquid Biopsies in Prostate CancerNo drug interventionsdiagnosticNot Availablewithdrawn
NCT03345563
Project HERO: Health Empowerment & Recovery OutcomesNo drug interventionssupportive_careNot Availableactive_not_recruiting
NCT05918263
Exercise for Tumor Suppressive Impact in Black Men With Prostate Cancer on Active Surveillance: The REMOVE TrialNo drug interventionssupportive_careNot Availablerecruiting
NCT02656563
Radium 223 Following Intermittent ADTNo drug interventionstreatment2withdrawn
NCT00024063
SU006668 in Treating Patients With Advanced Solid Tumorstreatment1unknown_status
NCT04879563
Artificial Intelligence Supporting CAncer Patients Across Europe - the ASCAPE ProjectNo drug interventionssupportive_care2active_not_recruiting
NCT05766163
Comparison of Outcomes of Multiple Platforms for Assisted Robotic - ProstateNo drug interventionsotherNot Availablerecruiting
NCT03970863
Focal Therapy for Localized Prostate CancerNo drug interventionsNot AvailableNot Availablewithdrawn
NCT00090363
ZD4054 (Zibotentan) in Pain-free or Mildly Symptomatic Patients With Prostate Cancer and Bone Metastases Who Have Rising Serum Prostate Specific Antigen (PSA)treatment2completed
NCT02425163
Shear Wave Elastography of Prostate CancerNo drug interventionsdiagnostic2completed
NCT02812186
Deep Versus Moderate Neuromuscular Blockade During Laparoscopic Surgerytreatment4completed
NCT00099086
Docetaxel, Radiation Therapy, and Hormone Therapy in Treating Patients With Locally Advanced Prostate Cancertreatment1completed
NCT01982786
Feasibility Trial Of Image Guided External Beam Radiotherapy With Or Without High Dose Rate Brachytherapy Boost In Men With Intermediate-Risk Prostate CancerNo drug interventionsotherNot Availablecompleted
NCT03199586
Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Treatment-Refractory Solid Tumor Malignanciestreatment1completed
NCT02411786
A Phase I Study of a DNA Vaccine Encoding Androgen Receptor Ligand-Binding Domain (AR LBD) +/-GMCSFtreatment1completed
NCT03412786
Bcl-XL_42-CAF09b Vaccination for Patients With Prostate Cancer With Lymph Node MetastasesNo drug interventionstreatment1completed
NCT05172986
Enhanced Recovery Program After a Robotic-assisted Surgery (RAAC) of Radical Prostatectomy. PROSTA-RAACNo drug interventionstreatmentNot Availablecompleted
NCT06258486
Ultrasound Guided Inguinal Indocyanine Green Injection to Identify and Pre-emptively Seal Lymphatic LeaksNo drug interventionstreatment4not_yet_recruiting
NCT02189486
Prostate Cancer Upgrading Reference SetNo drug interventionsNot AvailableNot Availablerecruiting
NCT04886986
Phase I/II 225Ac-J591 Plus 177Lu-PSMA-I&T for Progressive Metastatic Castration Resistant Prostate Cancertreatment1 / 2suspended
NCT00654186
Study Evaluating Toxicity & Efficacy of Lenalidomide(Revlimid®)in Chemotherapy-Naïve AIPC Patientstreatment2completed
NCT03137186
Repurposing Metformin as Anticancer Drug: in Advanced Prostate Cancertreatment2unknown_status
NCT00676286
Biological Investigations in Active Surveillance (BIAS) IGAR 2008 I 19 in Prostate Cancer Using High Field MRI (3 Tesla), PET, and BiomarkersNo drug interventionsscreening1completed
NCT06081686
Study of [177Lu] Lu-XT033 Injection in Patients With Metastatic Prostate Cancertreatment1 / 2recruiting
NCT00151086
Oral Estramustine and Oral Vinorelbine in the Treatment of Hormone-Refractory Prostate Cancertreatment1 / 2completed
NCT00459186
The Use of RAD001 With Docetaxel in the Treatment of Metastatic, Androgen Independent Prostate Cancertreatment1 / 2completed
NCT03027986
Evaluation of a Postural Rehabilitation Program Based on Sensory-motor Control in Men With Urinary Incontinence After ProstatectomyNo drug interventionstreatmentNot Availableunknown_status
NCT00554086
Open Label,Phase II Trial of MAB Dose Escalation OF Bicalutamide For Biochemical Failure In Prostate Cancer Patients.treatment2completed
NCT01529086
For Cause Prostate Biopsy in REDUCE Population TrialNo drug interventionsNot AvailableNot Availablecompleted
NCT01483586
Safety and Efficacy of Kanglaite Gelcaps in Prostate CancerNo drug interventionstreatment2terminated
NCT02803086
Longitudinal Evaluation of Intestinal, Haematological and Urinary Toxicity From Pelvic Irradiation for Prostate CancerNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT01326286
Comparative Effectiveness Analysis of Surgery and Radiation (CEASAR) for Localized Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT00165386
MRI-guided Bone Marrow Biopsies of Prostate Cancer PatientsNo drug interventionsdiagnosticNot Availablecompleted
NCT03879486
Infectious Outcomes of Povidone-iodine Rectal Cleansing Plus Formalin Disinfection of Needle During Prostate BiopsyNo drug interventionspreventionNot Availablecompleted
NCT02057939
Salvage Therapeutic Radiation With Enzalutamide and ADT in Men With Recurrent Prostate Cancer (STREAM)treatment2completed
NCT02121639
Open Label Phase I/Randomised,Double Blind Phase II Study in mCRPC of AZD5363 In Combination With DP Chemotherapytreatment1 / 2completed
NCT00005939
Brachytherapy in Treating Patients With Recurrent Prostate CancerNo drug interventionstreatment1 / 2unknown_status
NCT00195039
Treatment With Radiolabeled Monoclonal Antibody HuJ591-GS (177Lu-J591) in Patients With Metastatic Prostate Cancertreatment2completed
NCT00384839
Vidaza to Restore Hormone Thx Prostatetreatment2completed
NCT00406939
Vector Delivery of the IL-12 Gene in Men With Prostate CancerNo drug interventionstreatment1completed
NCT02453139
Exercise, Prostate Cancer and Circulating Tumour CellsNo drug interventionstreatmentNot Availablecompleted
NCT06398639
Polygenic Risk Stratification Combined With mpMRI to Identify Clinically Relevant Prostate CancerNo drug interventionsscreeningNot Availablerecruiting
NCT00494039
I-125 Versus Pd-103 for Low Risk Prostate CancerNo drug interventionstreatment3unknown_status
NCT00741039
Prospective Trial of Vaccine Responses Against Pneumococcus and Influenza in Adult Cancer Patients 65 Years of Age and Olderprevention2completed
NCT02649439
Prostvac in Patients With Biochemically Recurrent Prostate CancerNo drug interventionstreatment2completed
NCT04804839
Comparison of the Effectiveness of Different Conservative Treatment Protocols in Postprostatectomy Urinary IncontinenceNo drug interventionstreatmentNot Availablecompleted
NCT03580239
Everolimus in Castrated Resistant Prostate Cancer(CRPC)Patients With PI3K-AKT-mTOR Signaling Pathway Deficiencytreatment3unknown_status
NCT02437539
Evaluation of a New Radiotracer (68Ga-NOTA-AE105) for Diagnosing Aggressive Cancer With Positron Emission TomographyNo drug interventionsdiagnostic1completed
NCT00547339
Stereotactic Body Radiation Therapy in Treating Patients With Prostate CancerNo drug interventionstreatment1 / 2completed
NCT00341939
Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics DataNo drug interventionsNot AvailableNot Availablecompleted
NCT05200039
Health Status, Quality of Life and Function in Survivors After Radical Treatment for Prostate Cancer. Part IIBNo drug interventionsNot AvailableNot Availablecompleted
NCT00054522
Calcitriol and Dexamethasone in Treating Patients With Prostate Cancer Who Have Undergone Surgery or Radiation Therapytreatment2completed
NCT05678322
Optimizing Timing of rhPSMA-7.3 (18F) for Assessing Site(s) of Recurrent Disease Following Radical ProstatectomyNo drug interventionsdiagnostic3recruiting
NCT00651222
Influence of Hormone Therapy on Heart Attack Incidence in Men Undergoing Prostate BrachytherapyNo drug interventionsNot AvailableNot Availablecompleted
NCT00072722
Safety and Efficacy of CC-4047 in Subjects With Metastatic Hormone Refractory Prostate Cancer (HRPC)treatment2completed
NCT02960022
A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Studytreatment2recruiting
NCT03158922
The BARCODE 1 Pilot StudyNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT03225222
MRI in PROstate Cancer Diagnosis With Prior Risk AssessmentNo drug interventionsNot AvailableNot Availablecompleted
NCT05957822
Goal-directed vs Preemptive Tranexamic Acid Administration in Non-cardiac SurgeryNo drug interventionstreatment4recruiting
NCT04577222
The Ability of Adipose Flap Over the NVB to Improve Sexual and Urinary Function Following Radical ProstatectomyNo drug interventionsotherNot Availableunknown_status
NCT02182622
LDE225 + Docetaxel/Prednisone for Adv/Met Castrate Resistant Prostate Cancer w/ Disease Progression After Docetaxeltreatment1withdrawn
NCT00003622
Vinorelbine Plus Paclitaxel in Treating Patients With Metastatic Prostate Cancer That Is Refractory to Hormone Therapytreatment2withdrawn
NCT02710422
Miami Membrane for Potency (MMEP) TrialNo drug interventionstreatment2terminated
NCT00132522
EMD 273066 in Patients With Recurrent EpCAM Positive Ovarian, Prostate, Colorectal or Non-small Cell Lung Cancers When First Given CyclophosphamideNo drug interventionstreatment1completed
NCT01562522
Evaluation of the Effect of Psycho-oncological Intervention on Well-being of Patients With Advanced Prostate Cancer on LHRH Analogs and Their Partners. A Randomized Controlled Pilot Study.No drug interventionssupportive_care2terminated
NCT00919022
Androcur Non-interventional Study Among Patients With Carcinoma of the ProstateNot AvailableNot Availableterminated
NCT03665922
Biomarkers of Sulforaphane/Broccoli Sprout Extract in Prostate CancerNo drug interventionsbasic_scienceNot Availableactive_not_recruiting
NCT01085422
A Study Combining ABT-888, Oral PARP Inhibitor, With Temozolomide in Patients With Metastatic Prostate Cancertreatment1completed
NCT00214422
Intensity Modulated Radiation Therapy for Prostate CancerNo drug interventionstreatment0completed
NCT02597725
Salvage Radiotherapy After Radical ProstatectomyNo drug interventionsNot AvailableNot Availableunknown_status
NCT02749825
Comparison of Trelstar Versus Lupron or Zoladex in Advanced Prostate Cancertreatment4terminated
NCT04560725
PSMA Specific [68Ga]-P137 Peptide Probe for PET Imaging in Prostate CancerdiagnosticNot Availableactive_not_recruiting
NCT00166725
Effects of Octreotide Acetate on Circulating Levels of Chromogranin A in Advanced Prostate Cancer Patientstreatment2completed
NCT00881725
A Study of Pre-operative Metformin in Prostate Cancertreatment2terminated
NCT04541225
Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid TumorsNo drug interventionstreatment1terminated
NCT00551525
Samarium Sm 153 Lexidronam Pentasodium and 3-Dimensional Conformal Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Rising Prostate-Specific Antigen Levels After Radical Prostatectomy for Prostate Cancertreatment2completed
NCT06040125
Debunking the Frailty-sarcopenIa-ADT Axis in mEtastatic Prostate canceR With multiComponent Exercise: The FIERCE TrialNo drug interventionssupportive_careNot Availablerecruiting
NCT06536725
Observation of Clinical Consistency of Organoid-chips Drug Sensitivity in Chemotherapy for PCa With Visceral MetastasisNo drug interventionsNot AvailableNot Availablerecruiting
NCT04346225
Magnetic Resonance Imaging (MRI) With Hyperpolarized Pyruvate (13C) as Diagnostic Tool in Advanced Prostate CancerNo drug interventionstreatment2recruiting
NCT00465725
A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumorstreatment1completed
NCT01353625
Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, and Hematologic Malignancies.treatment1completed
NCT02225925
Intraoperative Dosimetry for Prostate Brachytherapy Using Fluoroscopy and UltrasoundNo drug interventionstreatmentNot Availablecompleted
NCT04357925
Quality of Life in Prostate Cancer PatientsNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT03232125
Effect of Ramosetron on Heart Rate-corrected QT Interval During Robot-assisted Laparoscopic Prostatectomy With Steep Trendelenburg PositionpreventionNot Availablecompleted
NCT00155025
Family History in Prostate Cancer Patients in TaiwanNo drug interventionsNot AvailableNot Availableunknown_status
NCT04305925
Focal Laser Ablation of Prostate CancerNo drug interventionstreatment0active_not_recruiting
NCT03623425
Comparison of PET With 68GA-PSMA-11 and 18F-Fluorocholine for Recurrence in Men With Prostate Cancerdiagnostic3unknown_status
NCT05722925
Evaluating Fluciclovine PET in Patients With Biochemical Recurrence of Prostate Cancer and a Negative PSMA PETdiagnostic4recruiting
NCT00084825
Docetaxel and Imatinib Mesylate in Treating Patients With Androgen-Independent Prostate Cancer and Bone Metastases That Progressed on the Docetaxel and Placebo Group of MDA-ID-030008treatment2completed
NCT01013025
Vantas Implant Retrieval StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT00953225
Vitamin D Supplementation in Veterans With Early-Stage Prostate Cancertreatment2completed
NCT02107430
Phase II Study of DCVAC/PCa After Primary Radiotherapy for Patients With High Risk Localized Prostate CancerNo drug interventionstreatment2completed
NCT00988130
High-Intensity Focused Ultrasound Focal Ablation in Treating Patients With Progressive Prostate CancerNo drug interventionstreatment2unknown_status
NCT05856630
Pharmacokinetics Pharmacodynamics and Safety of LY01022 in Patients With Prostate Cancer Compared With Zoladex® 10.8mgtreatment1not_yet_recruiting
NCT00582530
Men Undergoing Radical ProstatectomyNo drug interventionsNot AvailableNot Availablecompleted
NCT05720130
Phase Ib/IIa Dose Escalation and Expansion Study of [²¹²Pb]Pb-ADVC001 in Metastatic Castration Resistant Prostate Cancer (TheraPb - Phase I/II Study).No drug interventionstreatment1 / 2recruiting
NCT04175730
Prostate Cancer Detection Screening MRI ProtocolNo drug interventionsscreeningNot Availablecompleted
NCT04356430
Neoadjuvant Therapy of Abiraterone Plus ADT for High Risk Prostate Cancertreatment2unknown_status
NCT01424930
A Study to Determine the Short-Term Safety of Continuous Dosing of Abiraterone Acetate and Prednisone in Modified Fasting and Fed States to Patients With Metastatic Castration-Resistant Prostate Cancertreatment2completed
NCT00006430
A Safety and Feasibility Study of Active Immunotherapy in Patients With Metastatic Prostate Carcinoma Using Autologous Dendritic Cells Pulsed With Antigen Encoded in Amplified Autologous Tumor RNANo drug interventionstreatment1unknown_status
NCT01105130
L-Arginine Supplementation With or Without Enzyme Inhibitors Treating Erectile Function of Prostate Cancer Survivorssupportive_care2completed
NCT00104130
Study of KOS-862 (Epothilone D) in Metastatic Prostate Cancertreatment2terminated
NCT01501630
Role of PET/CT With Fluorine-18 Tracers of Bone Metastases in Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT01393730
Abiraterone Acetate Combined With Dutasteride for Metastatic Castrate Resistant Prostate Cancertreatment2completed
NCT05799248
Role of rhPSMA-7.3 PET/CT Imaging in Men With High-Risk Prostate Cancer Following Conventional Imaging and Associated Changes in Medical ManagementNo drug interventionsdiagnostic3recruiting
NCT05732948
PD-1 Silent PSMA/PSCA Targeted CAR-T for the Treatment of Prostate Cancertreatment1recruiting
NCT00731848
Open-label Extension Study of the Effects of Pomegranate Extract on Rising PSA After Primary Therapy for Prostate CancerNo drug interventionstreatment2unknown_status
NCT01194648
Focal Therapy for Prostate Cancer Using HIFUNo drug interventionstreatmentNot Availablerecruiting
NCT02651948
Transperineal, MRI-guided, Prostate BiopsyNo drug interventionsdiagnostic4completed
NCT03152448
Prospective Prolaris Value and EfficacyNo drug interventionsNot AvailableNot Availableterminated
NCT00005048
Estramustine and Paclitaxel in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapytreatment1completed
NCT02016248
Evaluation of CyberKnife Stereotactic Radiotherapy in Prostate CancerNo drug interventionstreatmentNot Availablerecruiting
NCT05346848
Randomized Phase II Trial on Short Term Darolutamide Concomitant to Radiation Therapy for Patients With Intermediate Unfavorable Risk Prostate Cancertreatment2recruiting
NCT02503748
Prostate Cancer E-Health-TutorialNo drug interventionshealth_services_researchNot Availablecompleted
NCT04633148
Dose-escalating Trial With UniCAR02-T Cells and PSMA Target Module (TMpPSMA) in Patients With Progressive Disease After Standard Systemic Therapy in Cancers With Positive PSMA Markertreatment1terminated
NCT01242748
A Degarelix Trial in Patients With Prostate Cancertreatment3terminated
NCT01163448
Feasibility and Safety Study Using Preoperative High-Dose Single-Fraction Image-Guided Radiotherapy for Men Undergoing Radical Prostatectomy at High-Risk for Extraprostatic CancerNo drug interventionstreatment1withdrawn
NCT02653248
SBRT for Organ Confined Prostate CancerNo drug interventionstreatment1completed
NCT01000948
A Safety Study of ZD4054 in Prior Chemotherapy Treated Patients With Metastatic Hormone-resistant Prostate Cancertreatment2terminated
NCT03396848
Sexual Health and Rehabilitation eClinic (SHAReClinic)No drug interventionssupportive_careNot Availableunknown_status
NCT01045148
CyberKnife Radiosurgery for Localized Prostatic CarcinomaNo drug interventionstreatment2unknown_status
NCT03558048
The Effect of IBD Flares on Serum PSANo drug interventionsNot AvailableNot Availablerecruiting
NCT02739048
Changes of Immunologic Function in Patients of Prostate Cancer Induced After Cryoablation.No drug interventionsNot AvailableNot Availableunknown_status
NCT00243048
Isoflavones and Radiation Therapy in Treating Patients With Localized Prostate CancerNo drug interventionstreatment2completed
NCT00653848
Adjuvant Treatment of Prostate Cancer With Docetaxel or Not After Radical Radiotherapytreatment3unknown_status
NCT03786848
Personalized Mini-PDX for Metastatic CRPCNo drug interventionstreatmentNot Availableunknown_status
NCT00482157
Calcitriol or Placebo in Men for Prostate Cancer Active SurveillancetreatmentNot Availablewithdrawn
NCT02113657
T-Cell Responses to Neoantigens Post Treatment With Ipilimumab in Men With Metastatic Castration-Resistant Prostate Cancertreatment0completed
NCT05948657
Evaluation of Prostate Specific Membrane Antigen Positron Emission Tomography-Computed Tomography in Active Surveillance for Prostate CancErNo drug interventionsdiagnosticNot Availablerecruiting
NCT03998657
Continued Access of Focal MR-Guided Focused Ultrasound for Localized Intermediate Risk Prostate LesionsNo drug interventionstreatmentNot Availableunknown_status
NCT00653757
Intensity-Modulated Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Prostate Cancertreatment1 / 2completed
NCT00450957
Lycopene in Healthy Male ParticipantsNo drug interventionsprevention1completed
NCT01398657
Cryotherapy With or Without Short-term Adjuvant Androgen-Deprivation Therapy in Prostate CancerNo drug interventionstreatment3unknown_status
NCT02325557
ADXS31-142 Alone and in Combination With Pembrolizumab (MK-3475) in Participants With Previously Treated Metastatic Castration-Resistant Prostate Cancer (mCRPC)treatment1 / 2completed
NCT00049257
Paclitaxel and Carboplatin in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapytreatment2completed
NCT06542757
Evaluation of Tumor Control Based on Serial Multiparametric MRI and Post-Treatment Biopsies For Patients Treated With Dose Intensification to the Dominant Intra-Prostatic Lesion (DIL) Using Ultra-Hypofractionated, MR-Guided RadiotherapyNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT00872157
BMTP-11 in Patients With Castrate-Resistant Prostate Cancer With Bone MetsNo drug interventionstreatment1completed
NCT02985957
A Study of Nivolumab Plus Ipilimumab, Ipilimumab Alone, or Cabazitaxel in Men With Metastatic Castration-Resistant Prostate Cancer (CheckMate 650)treatment2active_not_recruiting
NCT05197257
68Ga-PSMA-11 PET in Patients With Prostate CancerNo drug interventionsdiagnostic3completed
NCT01784757
Bioavailability Study of ODM-201 in Subjects With Metastatic Chemotherapy-naive Castration-resistant Prostate Cancerbasic_science1completed
NCT00757757
A Phase I/II Open-label Study of MCS110 in Patients With Prostate Cancer and Bone Metastasestreatment1 / 2terminated
NCT00977457
Genetic Testing in Predicting Biomarkers of Recurrence in Patients With Prostate Cancer Undergoing SurgeryNo drug interventionsdiagnostic1active_not_recruiting
NCT01193257
Study Comparing Orteronel Plus Prednisone in Participants With Metastatic Castration-Resistant Prostate Cancer.treatment3completed
NCT03235557
CyberKnife for Prostate Cancer Patients Aged 70 y or MoreNo drug interventionsNot AvailableNot Availablecompleted
NCT02388126
Prostate Magnetic Resonance Imaging in Patient With Previous Negative BiopsiesNo drug interventionsdiagnosticNot Availablecompleted
NCT00046826
Docetaxel, Estramustine, and Thalidomide in Treating Patients With Prostate Cancer Previously Treated With Hormone Therapytreatment2completed
NCT00003026
Hormone Therapy in Treating Patients With Advanced Prostate Cancertreatment3completed
NCT02346526
A Biomarker Study of Standard-of-care Radium-223 Chloride for Metastatic Castration-resistant Prostate Cancertreatment2completed
NCT01136226
Evaluate Recovery of Testosterone for Patients Using Eligardtreatment4completed
NCT01045226
Proton Radiation Therapy in Treating Patients With Prostate CancerNo drug interventionstreatmentNot Availableterminated
NCT00933426
Lenalidomide and Paclitaxel in Prostate Cancertreatment1terminated
NCT00604526
High Dose Rate Prostate Brachytherapy as Salvage for Locally Recurrent Prostate Cancer Previously Treated With External Beam RadiotherapyNo drug interventionstreatment1completed
NCT00651326
Androgen Suppression and Radiation With/Out Docetaxel in High-Risk Localized Prostate Cancertreatment3terminated
NCT01176526
The Role of Social Comparisons in Coping and Quality of Life Following a Prostate Cancer DiagnosisNo drug interventionsNot AvailableNot Availablecompleted
NCT04462926
Evaluation of Diagnostic Accuracy of [68Ga]Ga-PSMA-11 PET/CT in Primary Staging of Intermediate and High Risk Prostatic Cancer in Men Newly DiagnosedNo drug interventionsdiagnosticNot Availablerecruiting
NCT00003626
Dolastatin 10 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Previous Hormone Therapytreatment2completed
NCT02871726
Transrectal Ultrasound Robot-Assisted Prostate BiopsyNo drug interventionsdiagnosticNot Availablerecruiting
NCT03237026
Predictive and Prognostic Markers for Treatment Outcomes in Prostate Cancer PatientsNo drug interventionsNot AvailableNot Availableunknown_status
NCT03313726
The Effect of ADT on PSMA-PET.diagnosticNot Availableunknown_status
NCT00898326
PSA Levels and Biopsy Samples After Implant Radiation and Hormone Therapy in Patients With Stage I or Stage II Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT05258526
Home Based Exercise for Patients With Breast or Prostate Cancer (The BENEFIT-CA Study)No drug interventionstreatmentNot Availableunknown_status
NCT01516866
Sodium Fluoride (NaF) Positron Emission Tomography/Computed Tomography (PET/CT) in Patients With Metastatic Castrate-resistant Prostate Cancer (CRPC) With Microtubule Directed Chemo or AR-directed TherapyNo drug interventionsNot AvailableNot Availablecompleted
NCT00085566
Everolimus and Gefitinib in Treating Patients With Progressive Glioblastoma Multiforme or Progressive Metastatic Prostate Cancertreatment1 / 2completed
NCT04063566
ReIMAGINE Prostate Cancer ScreeningNo drug interventionsscreeningNot Availablecompleted
NCT00952666
Transrectal Ultrasound Imaging of the Prostate Gland and Neurovascular Bundles During Robot-Assisted Laparoscopic Radical ProstatectomyNo drug interventionstreatment0terminated
NCT00782366
Predictive Genetic Risk Assessment TrialNo drug interventionsNot AvailableNot Availablecompleted
NCT00118066
Calcitriol in Preventing Prostate Cancer in Patients With Prostatic Intraepithelial NeoplasiaNo drug interventionsprevention2terminated
NCT00270166
The Effect of Epoetin Alfa on the Anemia of Patients With Selected Cancers Receiving Chemotherapytreatment3completed
NCT01707966
Orteronel Maintenance Therapy in Patients With Metastatic Castration Resistant Prostate Cancer and Non-progressive Disease After First-line Docetaxel Therapytreatment3completed
NCT01744366
One Month Degarelix/Comparator Treatment for Prostate Cancer in Chinese Populationtreatment3completed
NCT01100866
Study of POMELLA™ Extract to Treat Prostate CancerNo drug interventionstreatmentNot Availableterminated
NCT02450266
Study Comparing MRI/Ultrasound Fusion-guided Prostate Biopsy Versus Systematic Transrectal Ultrasound-guided BiopsyNo drug interventionsdiagnosticNot Availableunknown_status
NCT01230866
Study of Hypo-fractionated Proton Radiation for Low Risk Prostate CancerNo drug interventionstreatment3active_not_recruiting
NCT04558866
Extreme Bipolar Androgen Therapy With Darolutamide and Testosterone Cypionate in Patients With Metastatic Castration-Resistant Prostate Cancer (ExBAT Trial)treatment2active_not_recruiting
NCT02376166
Metformin for Rising PSA Remote TrialotherNot Availablecompleted
NCT03635866
PET/MRI Study of Men With Highly Suspicious MRI Lesions That Showed no Clinically Significant Prostate Cancer Following MRI Fusion Targeted BiopsyNo drug interventionsdiagnosticNot Availablecompleted
NCT00895466
Efficacy and Safety Study of the Therapeutic Vaccine PEP223 in Prostate Cancer PatientsNo drug interventionsNot Available1 / 2unknown_status
NCT00381966
Study of Robotic Template Guidance for Needle Placement in Transperineal Prostate BrachytherapyNo drug interventionsdevice_feasibilityNot Availablecompleted
NCT00245466
Study Investigating the Long-Term Safety and Tolerability of Repeated Doses of Degarelix in Prostate Cancer Patientstreatment2terminated
NCT00258466
Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Prostate CancerNo drug interventionstreatment3withdrawn
NCT00124566
Study of Irofulven in Patients With Hormone-refractory Prostate Cancertreatment2completed
NCT00771966
Radical Prostatectomy and Perioperative Fluid TherapyNo drug interventionstreatment4completed
NCT02883166
Improving Bio-availability of the Expensive Oral Oncolytic Drug Abiraterone by Food Intaketreatment1completed
NCT05847166
A Phase 2/3,PSMA-T4, Prostate CancerNo drug interventionsdiagnosticNot Availablerecruiting
NCT05753566
Rezvilutamide in Patients With Biochemical Recurrence After Radical Prostatectomy for Prostate Cancertreatment2recruiting
NCT01804465
Sipuleucel-T With Immediate vs. Delayed Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA-4) Blockade for Prostate Cancertreatment2completed
NCT00004065
Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancertreatment1completed
NCT03160365
Innovative Planning and Guidance System for Prostate Focal BrachytherapyNo drug interventionsotherNot Availablecompleted
NCT00087165
GTI-2040, Docetaxel, and Prednisone in Treating Patients With Prostate Cancertreatment2completed
NCT00899665
Proteases in Patients With Prostate Cancer That Has Spread to the BoneNo drug interventionsNot AvailableNot Availablecompleted
NCT02229565
Molecular Mechanisms Underlying Prostate Cancer DisparitiesNo drug interventionsNot AvailableNot Availablecompleted
NCT05851365
Magnetic Resonance (MR) Imaging With Hyperpolarized Bicarbonate (13C) to Measure Tissue pH in Prostate CancerNo drug interventionsdiagnostic0recruiting
NCT01094665
MRI Targeted Focal Laser Thermal Therapy of Prostate CancerNo drug interventionstreatmentNot Availablecompleted
NCT05739565
Impact of a Physical Activity Intervention With Motivational Support From Peers for Prostate Cancer PatientsNo drug interventionspreventionNot Availablerecruiting
NCT05002465
Clinical Use of 68Ga PSMA-11 PET/CT in Diagnosing, Staging and Restaging Prostate CancerNot AvailableNot Availableno_longer_available
NCT03545165
177Lu-J591 and 177Lu-PSMA-617 Combination for mCRPCtreatment1 / 2terminated
NCT00223665
Effects of IAS in Men With Localized Biochemical Relapsed Prostate Cancertreatment2completed
NCT00126165
Short-course Hypofractionated Radiotherapy for Localized Prostate CancerNo drug interventionstreatment1 / 2completed
NCT03536065
Post-Discharge Opioid Reduction Intervention for Open, Laparoscopic, and Endoscopic SurgeryNo drug interventionspreventionNot Availablecompleted
NCT00006365
External-Beam Radiation Therapy Plus Implanted Radiation Therapy in Treating Patients With Prostate CancerNo drug interventionstreatment2completed
NCT00348465
Prostate Volume Changes Following Prostate Brachytherapy With Iodine-125 SeedsNo drug interventionsNot AvailableNot Availablecompleted
NCT04655365
Detecting Metastases by PyL PET/CT in Subjects Starting Enzalutamide for Untreated Castration Resistant Prostate Cancer.treatment2recruiting
NCT00375765
Effects On Dihydrotestosterone Regulated Gene Expression In Benign Prostatic Hyperplasia Or Prostate Cancertreatment4completed
NCT01090765
A Phase I/II Study of TRC105 in Metastatic Castrate Resistant Prostate Cancer (CRPC)treatment1 / 2completed
NCT01838265
Trial of Prostate Cancer Patients Undergoing Active Surveillance With or Without MRI-Guided ManagementNo drug interventionsNot AvailableNot Availablewithdrawn
NCT05246774
Study of Serum and Urinary Biomarkers and Radiation Cystitis in Patients Treated With Radiotherapy for Localized Prostate CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT00898274
Study of Blood Samples From Older Patients at High Risk of Developing Prostate Cancer and From Healthy Male ParticipantsNo drug interventionsNot AvailableNot Availablecompleted
NCT01511874
Efficacy and Safety Study of ELIGARD 22.5mg With Prostate Cancertreatment4completed
NCT00692874
Quality of Life Analysis of Treatment in Patients With Prostate Cancer on Adjuvant Zoladex TherapyNo drug interventionsNot AvailableNot Availablecompleted
NCT03082274
Prospective Validation of Prostate Biomarkers for Repeat BiopsyNo drug interventionsNot AvailableNot Availableunknown_status
NCT05974774
Intermittent Androgen Deprivation Therapy in the Era of AR Pathway InhibitorsNo drug interventionstreatment3not_yet_recruiting
NCT04781374
Neratinib in Patients With Metastatic Castration-Resistant Prostate Cancertreatment2withdrawn
NCT00089674
AMG 162 in the Treatment of Bone Loss in Subjects Undergoing Androgen-Deprivation Therapy for Non-metastatic Prostate Cancertreatment3completed
NCT00002874
Radiation Therapy With or Without Bicalutamide for Recurrent pT3N0 Prostate Cancer After Radical Prostatectomytreatment3completed
NCT00140374
Vaccination Priming and Vaccine Boosting Trial of Allogeneic Human GM-CSF Gene Transduced Irradiated Prostate Cancer Cell Vaccines (GVAX® Vaccine for Prostate Cancer)No drug interventionstreatment1 / 2completed
NCT05712174
A Study of [18]F-PSMA-1007 in Patients With Known or Suspected Metastatic Prostate CancerNo drug interventionsdiagnostic2recruiting
NCT01376674
T-cell-immunity During Standard Radiotherapy in Localised Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT01654874
99mTc-MIP-1404 for Imaging Prostate Cancer: Phase I Clinical Study to Assess the Image Quality of a Simplified Kit Formulation Compared to a Multi-step Preparation of 99mTc-MIP-1404diagnostic1completed
NCT00054574
Monoclonal Antibody Therapy in Treating Patients With Prostate Cancertreatment2completed
NCT04009174
Multi-modality Prostate Cancer Image Guided InterventionsNo drug interventionsdiagnosticNot Availablecompleted
NCT03480074
Staple vs. Suture in Robotic ProstatectomyNo drug interventionstreatmentNot Availablecompleted
NCT04647474
Mental Wellbeing and Quality of Life in Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT01444820
Hypofractionated, Dose Escalation Radiotherapy for High Risk Adenocarcinoma of the ProstateNo drug interventionstreatment3unknown_status
NCT00186420
Adjuvant Taxotere in Patients With High Risk Prostate Cancer Post Prostatectomy and Radiationprevention2completed
NCT02564120
North Carolina Prostate Cancer Comparative Effectiveness & Survivorship Study (NC ProCESS)No drug interventionsNot AvailableNot Availablecompleted
NCT02678520
Clinical Trial Comparing 3-D RT vs. IMRT in Post- Prostatectomy Prostate Cancer PatientsNot Available2withdrawn
NCT02432820
Assessment of 3D Transperineal Ultrasound Imaging w/ Matrix Array Transducers in Prostate RadiotherapyNo drug interventionsNot AvailableNot Availableterminated
NCT05179720
The Application Research of Ultrasound Guided Puncture Stent Assisted Transperineal Prostate BiopsyNo drug interventionsdiagnosticNot Availableunknown_status
NCT00244920
Hormone Therapy With or Without Squalamine Lactate in Treating Patients Who Are Undergoing a Radical Prostatectomy for Locally Advanced Prostate Cancertreatment2withdrawn
NCT00901420
Urodynamic Evaluation in Post-radiation Salvage Prostatectomy PatientsNo drug interventionsNot AvailableNot Availableterminated
NCT00946920
A Trial of Degarelix in Patients With Prostate Cancertreatment3completed
NCT02867020
Study of Abiraterone Acetate Plus ADT Versus APALUTAMIDE Versus Abiraterone and APALUTAMIDE in Patients With Advanced Prostate Cancer With Non-castrate Testosterone Levelstreatment2completed
NCT03002220
Trial of Rad-223 Activity in Asymptomatic Patients With mCRPC While on Abiraterone or Enzalutamide Besides AR-V7 Statustreatment2completed
NCT01284920
A Study of MDV3100 to Evaluate Safety, Tolerability, Pharmacokinetics and Efficacy of in Prostate Cancer Patientstreatment1 / 2completed
NCT00116220
Study of External Beam Radiation Therapy With and Without Hormonal Therapy to Treat Prostate Cancertreatment3completed
NCT06202820
CV CARE: CardioVascular Care in PC PatientsNo drug interventionshealth_services_researchNot Availablerecruiting
NCT01603420
External Beam Radiation With or Without Chemotherapy to Treat High Risk Prostate Cancertreatment2 / 3terminated
NCT00589420
Sorafenib and Docetaxel in Patients With Prostate Cancer That Did Not Respond to Previous Hormone Therapytreatment2completed
NCT00002520
Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage CancerotherNot Availablecompleted
NCT00594620
Soy Derivatives for Control of Hot Flashes in Men on Androgen Deprivation TherapyNo drug interventionstreatment2terminated
NCT00264420
Safety and Efficacy Study of Concomitant Radiotherapy and Zoledronic Acid for Bone Metastases Palliationtreatment1completed
NCT00807820
Phase I Targeting Dominant Intraprostatic Lesion Using MR Spectroscopy and HDR BrachytherapyNo drug interventionsNot AvailableNot Availablecompleted
NCT00657982
Phase II Study of RAD001 in a Neoadjuvant Setting in Men With Intermediate or High Risk Prostate Cancertreatment2unknown_status
NCT02869282
STUDY OF THE EXPRESSION OF CIRCULATING AND INTRA-TUMORAL CHEMOKINES IN PATIENTS WITH PROSTATE CANCERNo drug interventionsNot AvailableNot Availableunknown_status
NCT00786682
Docetaxel and Hydroxychloroquine in Treating Patients With Metastatic Prostate Cancertreatment2terminated
NCT05248282
Clinical Validation of the Prognostic Value of the PrTS on Prostate Cancer PatientsNo drug interventionsNot AvailableNot Availableunknown_status
NCT04110782
Radical Prostatectomy and External Beam Radiotherapy in mCRPC With 223Radium-dicloride (RaProRad)No drug interventionsNot AvailableNot Availableunknown_status
NCT00849082
Radiation Therapy With or Without Goserelin and Cyproterone in Treating Patients With Prostate Cancertreatment3completed
NCT05382182
Outcome Of Treatment Of Prostate Cancer at Sohag University Hospital Between 2017 to 2021No drug interventionsNot AvailableNot Availableunknown_status
NCT00080782
Doxorubicin and Strontium-89 With or Without Celecoxib in Treating Patients With Progressive Androgen-Independent Prostate Cancer and Bone Metastasestreatment2terminated
NCT00560482
Efficacy Study of ABR-215050 to Treat Prostate Cancertreatment2completed
NCT02611882
Evaluation of Gallium-68-HBED-CC-PSMA Imaging in Prostate Cancer Patientsdiagnostic2completed
NCT05540782
A Study of Cognitive Health in Survivors of Prostate CancerNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT02269982
Prospective CiRculating prOstate Cancer Predictors in HighEr Risk mCRPC studYNo drug interventionsNot AvailableNot Availablecompleted
NCT03689582
Radiolabeled Gallium-68 (68Ga-PSMA) for PET/CT Imaging to Detect Prostate Cancerdiagnostic2terminated
NCT05326282
Evaluating the Role of Ultrasound in Prostate CancerNo drug interventionsdiagnosticNot Availablecompleted
NCT02826382
Preliminary Evaluation of Uptake in Bone Metastases and Biodistribution of [68Ga]P15-041No drug interventionsdiagnostic0completed
NCT00063882
Interstitial Brachytherapy With or Without External-Beam Radiation Therapy in Treating Patients With Prostate CancerNo drug interventionstreatment3completed
NCT01792882
Prospective Collection of Surplus Surgical Tumor Tissues and Pre-surgical Blood SamplesNo drug interventionsNot AvailableNot Availablewithdrawn
NCT00526331
Evaluation of Arterial Pressure Based Cardiac Output for Goal-Directed Perioperative TherapyNo drug interventionstreatment4completed
NCT00242931
Flu/TBI in Treating Patients Not Responding to Previous Hormone TherapyNo drug interventionstreatment2withdrawn
NCT00915031
Use of Hypothermia During Robotic ProstatectomyNo drug interventionspreventionNot Availablecompleted
NCT00059631
Phase I Study of Weekly Intravenous PS-341 (Bortezomib) Plus Mitoxantronetreatment1completed
NCT00623831
A Phase 1 Study of Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 AntigenNo drug interventionstreatment1completed
NCT00042731
Isoflavones & Lycopene in Localized Prostate Ca:Prior to Radical ProstatectomyNo drug interventionssupportive_careNot Availablecompleted
NCT03615131
Accuracy of mpMRI and MRI-targeted, Ultrasound-navigated Prostate Fusion Biopsy in Detection of Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT00076531
Clinical Trial for Prostate Cancertreatment3completed
NCT01804231
Prospective Study Using Hybrid PET/MRI to Evaluate Men With Suspected Recurrence Following Treatment for Prostate CancerNo drug interventionsdiagnosticNot Availablecompleted
NCT00460031
Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapytreatment2completed
NCT00811031
Preoperative Docetaxel for Localized Progressive Castration-resistant Prostate Cancer (CRPC)treatment2withdrawn
NCT00055731
Hormone Therapy With or Without Docetaxel And Estramustine in Treating Patients With Prostate Cancer That is Locally Advanced or At High Risk of Relapsetreatment3completed
NCT03091231
Multiparametric Ultrasound-Study for the Detection of Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT00215631
Can Tadalafil Maintain Erectile Function In Patients Treated With Radiotherapy For Prostate Cancer?prevention3terminated
NCT02913131
Hyperpolarized C-13 Pyruvate as a Biomarker in Patients With Advanced Solid Tumor MalignanciesNo drug interventionsdiagnostic1 / 2terminated
NCT01283373
A Study of the Safety and Pharmacokinetics of Escalating Doses of DSTP3086S in Patients With Metastatic Castration-Resistant Prostate CancerNo drug interventionstreatment1completed
NCT01878773
Prostate Delineation: High Quality Volume CTNo drug interventionsdiagnosticNot Availablecompleted
NCT03927573
Study With Bispecific Antibody Engaging T-cells, in Patients With Progressive Cancer Diseases With Positive PSCA MarkerNo drug interventionstreatment1terminated
NCT01978873
Efficacy Study Evaluating Chemotherapy in Prostate Cancertreatment3unknown_status
NCT00773773
Combination of Serum Measurements of Molecular Biomarkers and Serum Protein Profiling Can be Used to Predict Which Patients Undergoing Prostatic Biopsy Will be Diagnosed With CancerNo drug interventionsdiagnosticNot Availableterminated
NCT01409473
Stereotactic Body Radiotherapy (SBRT) With Concurrent Boost for Low- and Intermediate-Risk Prostate CancerNo drug interventionstreatment2withdrawn
NCT00381173
A Study of ZYC300 Administered With Cyclophosphamide Pre-Dosingtreatment1completed
NCT00738673
Degarelix as Second-Line Hormonal Treatment After Prostate-specific Antigen (PSA)-Failure in GnRH Agonist Treated Patients With Prostate Cancertreatment2completed
NCT01220973
Atorvastatin Calcium and Celecoxib in Treating Patients With Rising PSA Levels After Local Therapy for Prostate Cancertreatment2completed
NCT00758173
Study of Genes and the Environment in Patients With Prostate Cancer Residing in the East Anglia, Trent, or West Midlands Regions of the United KingdomNo drug interventionsNot AvailableNot Availableunknown_status
NCT02242773
MRI Based Active Selection for Treatment TrialNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT06236373
The Unmet Needs of Cancer Survivors in Ausl IRCCS Reggio EmiliaNo drug interventionsNot AvailableNot Availablerecruiting
NCT05900973
A Phase 2 Trial of Darolutamide as a Prostate-Specific Membrane Antigen (PSMA) Expression Enhancer in Patients With Localized Prostate Cancerdiagnostic2recruiting
NCT00331773
Radiation Therapy in Treating Patients With Stage II Prostate CancerNo drug interventionstreatment3completed
NCT02914873
SPCG17: Prostate Cancer Active Surveillance Trigger TrialNo drug interventionstreatmentNot Availablerecruiting
NCT04903873
A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid TumorsNo drug interventionstreatment1 / 2recruiting
NCT05120973
Multispectral Fluorescence as a Tool to Separate Healthy and Disease Related Lymphatic Anatomies in Prostate Cancer.No drug interventionsNot AvailableNot Availablecompleted
NCT02577627
Multi-Indication, Retrospective Oncological Study to Validate the Accuracy in Predicting TTP by PrediCare in Patients Under SOCNo drug interventionsNot AvailableNot Availableunknown_status
NCT02659527
PET/MRI in Patients With Suspected Prostate Cancerdiagnostic3completed
NCT03134027
Reconstitution of a Human Immune System in a Patient Derived Xenograft (PDX) Model of Genitourinary (GU) CancersNo drug interventionsNot AvailableNot Availableterminated
NCT06484127
Heterogeneity of Tertiary Lymphoid Structures Predicts Distinct Malignancy and Immune Microenvironment in Prostate Cancer: a Retrospective Cohort StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT05025527
Biparametric MRI in Prostate Cancer Screening: a Noninferior Randomized Controlled StudyNo drug interventionsscreeningNot Availablenot_yet_recruiting
NCT00670527
[18F] Fluorocholine FCH Positron Emission Tomography (PET)/Computed Tomography (CT) for Detection of Prostate Cancer Lymph Nodes MetastasesNo drug interventionsdiagnosticNot Availableunknown_status
NCT00045227
Vaccine Therapy With or Without Docetaxel in Treating Patients With Metastatic Prostate Cancertreatment2completed
NCT00565227
Phase I Study of Vorinostat in Combination With Docetaxel in Patients With Advanced and Relapsed Solid Malignancies.treatment1terminated
NCT02785627
Assessment of Bone Loss in Men Receiving Treatment for Prostate CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT00924027
A Study of Patients Receiving High-Dose Rate BrachytherapyNo drug interventionstreatment2active_not_recruiting
NCT00911027
SonoVue Guided Prostate Biopsydiagnostic3terminated
NCT04873427
In Situ Clonal Heterogeneity in Prostatic Diagnostic BiopsiesNo drug interventionsNot AvailableNot Availableterminated
NCT02006927
A Pilot Study of the Feasibility of Chronic Cavernous Nerve Stimulation to Promote Regeneration and Erectile FunctionNo drug interventionstreatmentNot Availableterminated
NCT03936127
Comparison of a Novel Transperineal Targeted Fusion Biopsy System to Conventional Transrectal Targeted Fusion BiopsyNo drug interventionsdiagnosticNot Availablerecruiting
NCT04271527
Non-inferiority Randomized Controlled Trial of Cognitive Targeted Biopsy Versus Software Targeted BiopsyNo drug interventionsdiagnosticNot Availablerecruiting
NCT05098327
Pioglitazone and Insulin Resistance in ADTtreatment3withdrawn
NCT05553327
Impact of a Multimodal Prehabilitation Program Before Robotic-assisted Radical Prostatectomy.No drug interventionstreatmentNot Availablerecruiting
NCT00005827
Genistein in Treating Patients With Stage II, Stage III, or Stage IV Prostate CancerNo drug interventionstreatment1withdrawn
NCT03495427
PSMA-PET Imaging for Detecting Early Metastatic Prostate Cancer in Men w/ High Decipher Test ScoresNo drug interventionsdiagnostic2 / 3recruiting
NCT01220427
Micro-RNA Expression Profiles in High Risk Prostate CancerNo drug interventionsNot AvailableNot Availableterminated
NCT00316927
Dexamethasone, Aspirin, and Diethylstilbestrol in Treating Patients With Locally Advanced or Metastatic Prostate Cancertreatment3completed
NCT05355727
PROSAIC-DS Study (PROState AI in Cancer - Decision Support)No drug interventionsotherNot Availableunknown_status
NCT00631527
Sunitinib Malate, Hormone Ablation and Radiation Therapy in Patients With Prostate Cancertreatment1completed
NCT05797727
Real-Life Pilot Feasibility Study (LC_RLP)No drug interventionsotherNot Availablecompleted
NCT03348527
A Study to Evaluate the Safety, Tolerability and Efficacy of a Liproca® Depot Injection in Patients With Prostate CancerNo drug interventionstreatment2completed
NCT06546527
Study of [177Lu]Lu-PSMA-137 In Metastatic Castrate Resistant Prostate Cancer(mCRPC)treatment0not_yet_recruiting
NCT05000827
Dutch National Randomized Study: PSMA-PET/CT as a Triage Tool for Pelvic Lymph Node Dissection in Prostatectomy PatientsNo drug interventionsdiagnosticNot Availablerecruiting
NCT05467176
A Multi-Center, Prospective, Observational Study of Patients Being Treated With ORGOVYXNot AvailableNot Availablerecruiting
NCT02887976
Extension of SoluMatrix TM Abiraterone Acetate in Patients Who Completed Study Number CHL-AA-201treatment3completed
NCT04661176
Evaluation of the Sentinel™ PCC4 Assay for Diagnosis, Prognosis and Monitoring of Prostate Cancer in Puerto RicoNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT01940276
Abiraterone Race in Metastatic Castrate-resistant Prostate Cancertreatment2completed
NCT00511576
Study to Evaluate Combination Treatment of MGCD0103 and Docetaxel (Taxotere®) for Subjects With Advanced Cancer Tumorstreatment1terminated
NCT02431676
Survivorship Promotion In Reducing IGF-1 Trialprevention2completed
NCT04605276
Threedimensional Multiparametric Ultrasound for Prostate Cancer DetectionNo drug interventionsNot AvailableNot Availablecompleted
NCT00580476
Assessing Depression in a Geriatric Cancer PopulationNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT00544076
ED Recovery in Men Age </=65 Treated With Bilateral Nerve Sparing Robotic Assisted Prostatectomy for Prostate Cancersupportive_care3terminated
NCT06516276
Technologies to Improve QoL of Prostate CancerNo drug interventionssupportive_careNot Availablenot_yet_recruiting
NCT00169676
Registry and Database Lap ProstatectomyNo drug interventionsNot AvailableNot Availablecompleted
NCT02534376
Cellular Effect of Cholesterol-Lowering Prior to Prostate Removalsupportive_care0completed
NCT00987376
Novel PET/CT Agents and MRS/MRI in Prostate CA and High Risk Prostate Cancer: An Inter-SPORE CollaborationNo drug interventionsdiagnostic1completed
NCT01691976
Mild Cognitive Impairment in Men Following Androgen DeprivationNo drug interventionsotherNot Availablewithdrawn
NCT03101176
Multiparametric Ultrasound Imaging in Prostate CancerdiagnosticNot Availableunknown_status
NCT02375776
Improving Outcomes in Cancer Patients on Oral Anti-Cancer Medications Using a Multi-modal Mobile Health InterventionNo drug interventionssupportive_careNot Availablecompleted
NCT00811876
Retrospective, Non-interventional Study of Depo-Eligard®.No drug interventionsNot AvailableNot Availablecompleted
NCT01828476
Navitoclax and Abiraterone Acetate With or Without Hydroxychloroquine in Treating Patients With Progressive Metastatic Castrate Refractory Prostate Cancertreatment2terminated
NCT00953576
Ketoconazole, Hydrocortisone, Dutasteride and Lapatinib (KHAD-L) in Prostate Cancertreatment1 / 2terminated
NCT03205176
AZD5153 in Patients With Relapsed or Refractory Solid Tumors, Including Lymphomastreatment1completed
NCT04393376
PSA Glycomics Assay for Early Detection of Prostate CancerNo drug interventionsdiagnosticNot Availablerecruiting
NCT00846976
Treatment Protocol to Monitor the Safety of a 200 mg Dose of Bicalutamide in Patients With Advanced Prostate Cancertreatment3completed
NCT04394676
The Impact of Low Pressure Pneumo in RARP IINo drug interventionssupportive_careNot Availablerecruiting
NCT02020876
Decision Impact Study to Measure the Influence of DECIPHER on Treatment RecommendationsNo drug interventionsNot AvailableNot Availablecompleted
NCT01417676
DAPROCA Pelvic Lymph Node Irradiation to Prostate for High Risk Prostate Cancer: Phase I/II StudyNo drug interventionstreatmentNot Availablecompleted
NCT02972060
ODM-201 vs Androgen Deprivation Therapy in Hormone naïve Prostate Cancertreatment2active_not_recruiting
NCT03910660
A Trial of BXCL701 and Pembrolizumab in Patients With mCRPC Either Small Cell Neuroendocrine Prostate Cancer or Adenocarcinoma Phenotype.treatment1 / 2active_not_recruiting
NCT02524860
Targeted Prostate Biopsy Using a Novel MRI-Ultrasound Fusion DeviceNo drug interventionsdiagnosticNot Availableunknown_status
NCT03761160
Mobile Health App to Mitigate the Metabolic Effects of Androgen Deprivation TherapyNo drug interventionssupportive_careNot Availablecompleted
NCT05586360
T-reg Function Changes: a Novel Immune Regulatory Effect Underlying Benefit of Statin Use on Lethal Prostate Cancertreatment2recruiting
NCT03594760
PSMA-PET: Deep Radiomic Biomarkers of Progression and Response Prediction in Prostate CancerNo drug interventionsdiagnostic3recruiting
NCT06279260
National Robotics-Assisted Radical Prostatectomy DatabaseNo drug interventionsNot AvailableNot Availablerecruiting
NCT02138760
Comparison of MRI Fusion Biopsy Techniques in Men With Elevated PSA and Prior Negative Prostate BiopsyNo drug interventionsdiagnosticNot Availableunknown_status
NCT01993160
18F-FCH (Fluorocholine)-PET/MR in Staging of High-Risk Prostate CancerdiagnosticNot Availablecompleted
NCT06380660
Study of ACE-86225106 to Treat Patients With Advanced Solid TumorsNo drug interventionstreatment1 / 2recruiting
NCT00242060
Functional and Morphologic MRI in the Detection of Prostate Cancer in Patients With Prior Negative BiopsyNo drug interventionsdiagnosticNot Availablecompleted
NCT03679260
Carbohydrate Restricted Diet Intervention for Men on Prostate Cancer Active SurveillanceNo drug interventionstreatment2completed
NCT02903160
Prostate Cancer Intensive, Non-Cross Reactive Therapy (PRINT) for Castration Resistant Prostate Cancer (CRPC)treatment2completed
NCT05141760
18F-PSMA PET and MRI in the Primary Staging of Prostate Cancer PatientsNo drug interventionsdiagnostic2completed
NCT03203460
Exercise During Active Surveillance for Prostate CancerNo drug interventionssupportive_careNot Availablecompleted
NCT03585660
Developing an Imaging-Based Tool to Identify Areas for Prostate Cancer BiopsyNo drug interventionsdiagnosticNot Availablerecruiting
NCT00005960
Combination Chemotherapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapytreatment2unknown_status
NCT03061760
Effects of Urinary Bladder Hypertrophy on Urge Urine Incontinence After Radical ProstatectomyNo drug interventionsNot AvailableNot Availableunknown_status
NCT05917860
Neoadjuvant ADT With TULSA in the Treatment of Intermediate Risk Prostate Cancertreatment1recruiting
NCT02382094
Clinical Trial to Study Quality of Life in Prostate Cancer Patients by Randomizing Anti-androgen Versus Total Androgen Blockage Prior to Curative Intended Radiation Therapyhealth_services_research3completed
NCT03017794
Evaluation of Neuroendocrine Differentiation as a Potential Mechanism of Tumor Recurrence Following RadiotherapyNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT05179694
The TRANSLATE TrialNo drug interventionsdiagnosticNot Availableunknown_status
NCT04100694
Early Access Program Providing HER2/HER3 Bispecific Antibody, MCLA-128, for a Patient With Advanced NRG1-Fusion Positive Solid TumorNot AvailableNot Availableavailable
NCT06540794
Evaluating Respiratory Effects of Driving Pressure Guided Mechanical Ventilation Using Electrical Impedance Tomography in Patients Undergoing Robot-Assisted Laparoscopic Radical ProstatectomyNo drug interventionsotherNot Availableenrolling_by_invitation
NCT05736094
Ultrasound for Detection of Prostate CancerNo drug interventionsdiagnosticNot Availablecompleted
NCT04404894
Long-Term Prospective Registry in Prostate Cancer Patients From Diverse Urology Practice Settings Following Prolaris® TestingNo drug interventionsNot AvailableNot Availablerecruiting
NCT04615494
Internal Carotid Artery Blood Flow in Robot-Assisted Laparoscopic ProstatectomyNo drug interventionsNot AvailableNot Availablecompleted
NCT03424694
HDR Brachytherapy as Monotherapy for Low and Intermediate Risk Prostate CancerNo drug interventionstreatmentNot Availablecompleted
NCT05671094
Implementation of a Multimodal Prehabilitation Program in Robotic Oncological SurgeryNo drug interventionssupportive_careNot Availableactive_not_recruiting
NCT03744494
Cosmetic Appeal, HRQoL and Effectiveness of Simple and Pseudotesticular Techniques of Orchidectomy in Prostate CancerNo drug interventionsotherNot Availablecompleted
NCT01726894
Focal Therapy for Localised Prostate Cancer Using Irreversible ElectroporationNo drug interventionsNot AvailableNot Availableunknown_status
NCT00038194
Phase I Trial of Fixed Dose STI571 (Imatinib Mesylate) With Escalating Doses of Docetaxel in Patients With Metastatic Androgen-Independent Prostate Cancertreatment1completed
NCT00309894
Ketoconazole, Hydrocortisone, and GM-CSF in Treating Patients With Progressive Prostate Cancer After Hormone Therapytreatment2completed
NCT00681694
Long-Term Outcomes of Alternative Brachytherapy Techniques for Early Prostate CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT00672594
Study of Sunitinib Malate in Patients With Newly Diagnosed Prostate Cancer Prior to Prostatectomytreatment2completed
NCT05893394
Core Stability as a Prognostic Factor of Urinary Incontinence in Patients Undergoing Robot-assisted Laparoscopic ProstatectomyNo drug interventionsNot AvailableNot Availablerecruiting
NCT00064194
Vitamin E, Selenium, and Soy Protein in Preventing Cancer in Patients With High-Grade Prostate NeoplasiaNo drug interventionsprevention3completed
NCT00244894
Acupuncture in Treating Hot Flashes in Patients With Prostate CancerNo drug interventionssupportive_careNot Availableterminated
NCT04021394
Influence of EMT on CTCs and Disease Progression in Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT04182594
Cardiovascular Events in GnRH Agonist vs. Antagonisttreatment2unknown_status
NCT05629494
Anti-inflammatory Drugs and Serum Prostate-Specific Antigen Testtreatment4recruiting
NCT06441994
Clinical Trial of Targeted Alpha Therapy Using [At-211]PSMA-5 for Prostate CancerNo drug interventionstreatment1recruiting
NCT04861194
EREctile Function Preservation for Prostate Cancer Radiation Therapy (ERECT)No drug interventionstreatmentNot Availablerecruiting
NCT02805894
NBTXR3 Nanoparticles and EBRT or EBRT With Brachytherapy in the Treatment of Prostate Adenocarcinomatreatment1 / 2terminated
NCT03207594
Improving Evidence-Based Care for Cancer PatientsNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT01899391
Periperal Blood Lymphocytes During Prostate RTNo drug interventionsNot AvailableNot Availablewithdrawn
NCT00809991
Hypofractionated Adaptive Image-Guided Radiation Therapy for Localized Adenocarcinoma of the ProstateNo drug interventionstreatment2active_not_recruiting
NCT04085991
Two TraCer PositROn EmiSSion Tomography ComBination for Efficacy EstimatiOn of Prostate Specific Membrane Antigen Radioligand Therapy in Patients With Metastatic Prostate CancerNo drug interventionstreatment2terminated
NCT02020291
Phase I Study to Evaluate Safety, Tolerability, Anti-Tumour Activity and PK Profiles of Foxy-5 in Metastatic Breast, Colon or Prostate Cancertreatment1completed
NCT01292291
MRI in Diagnosing Prostate CancerNo drug interventionsdiagnosticNot Availableunknown_status
NCT00694291
Sorafenib in Hormone Naïve Biochemical Recurrence of Prostate Cancertreatment2withdrawn
NCT02645591
Randomized AmnioFix Study During Radical ProstatectomyNo drug interventionstreatment2withdrawn
NCT02770391
Apalutamide and Leuprolide in Intermediate and High-risk Prostate Cancertreatment2completed
NCT01446991
Feasibility and Toxicity of Degarelix for Prostate Downsizing Prior to Permanent Seed Prostate Brachytherapytreatment2completed
NCT00335491
Exercise in Improving Mobility and Reducing Fatigue and/or Weakness in Older Cancer SurvivorsNo drug interventionssupportive_careNot Availablecompleted
NCT06362291
Comparison of MRI AI-cTB Versus Routine cTB in Prostate Cancer Diagnosis: a Prospective Randomized Controlled TrialNo drug interventionsdiagnosticNot Availablerecruiting
NCT02107391
Phase II Study of DCVAC/PCa Added to Hormone Therapy for Men With Metastatic Prostate Cancertreatment2completed
NCT03971591
Men Moving Forward: A Lifestyle Program for African-American Prostate Cancer SurvivorsNo drug interventionssupportive_careNot Availablerecruiting
NCT03477591
Evaluating the Impact of Evidence-based Information About PSA Testing on Prostate Cancer Screening DecisionsNo drug interventionsscreeningNot Availablecompleted
NCT01378091
Study of Lenalidomide and Docetaxel in Subjects With Androgen Independent Prostate Cancertreatment1completed
NCT00020891
CT Scans in Guiding the Treatment of Patients With Prostate Cancer Who Are Undergoing Radiation TherapyNo drug interventionsdiagnostic2completed
NCT05313191
Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated TumorsNo drug interventionstreatmentNot Availablerecruiting
NCT01431391
Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancertreatment2completed
NCT00003391
Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone TherapyNo drug interventionstreatment1completed
NCT03322891
Improving Health Literacy in African-American Prostate Cancer PatientsNo drug interventionsotherNot Availablecompleted
NCT01588262
Early Rehabilitation of Cancer PatientsNo drug interventionssupportive_careNot Availablecompleted
NCT02585362
Whey Protein Supplement in Combination With Physical Exercise and Nutrition ProgramNo drug interventionssupportive_careNot Availablecompleted
NCT02279862
Safety and Efficacy Study of Ipilimumab 3 mg/kg Versus Ipilimumab 10 mg/kg in Subjects With Metastatic Castration Resistant Prostate Cancer Who Are Chemotherapy Naivetreatment2completed
NCT03005262
MLN8237 for a Subject With Adenocarcinoma of the ProstateNot AvailableNot Availableno_longer_available
NCT00086762
Mindfulness Relaxation Compared With Relaxing Music and Standard Symptom Management Education in Treating Patients Who Are Undergoing Chemotherapy For Newly Diagnosed Solid TumorsNo drug interventionsotherNot Availablecompleted
NCT06051162
HPI Effect in Robotic Urological Surgery on AKINo drug interventionspreventionNot Availablerecruiting
NCT00949962
Post-operative or Early Salvage XRT and ADT for High Risk PCatreatment3terminated
NCT04571762
Adaptive MR-guided SBRT for Localized Prostate CancerNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT01120262
S9346A Blood Samples From Patients With Metastatic Prostate Cancer Previously Treated With Bicalutamide and GoserelinNo drug interventionsNot AvailableNot Availablecompleted
NCT05154162
PSMA PET Additive Value for Prostate Cancer Diagnosis in Men With Negative/Equivocal MRINo drug interventionsdiagnostic3recruiting
NCT04869462
DS Titanium Ligation Clip in Urology (Prostatectomy and Nephrectomy)No drug interventionsNot AvailableNot Availablecompleted
NCT05024162
Can MRI of the Prostate Combined With a Radiomics Evaluation Determine the Invasive Capacity of a TumourNo drug interventionsdiagnosticNot Availablerecruiting
NCT01744262
A Comparison of Totally Intravenous and Inhalation Anesthesia for Intraocular Pressure During Robot-Assisted Laparoscopic Radical ProstatectomyNo drug interventionspreventionNot Availablecompleted
NCT02123862
Cultured Circulating Tumor Cells in Prostate and Other CancersNo drug interventionsNot AvailableNot Availableunknown_status
NCT05622162
Prospective Comparative Study for Patients With Biochemical Recurrence Prostate Cancer Detecting by 18F-JK-PSMA-7No drug interventionstreatment3active_not_recruiting
NCT00585962
Proton Beam Radiation Therapy for Early Stage Adenocarcinoma of the ProstateNo drug interventionstreatment2completed
NCT05297162
PSMA PET/CT vs. mpMRI in Patients With a High Suspicion of Prostate Cancer: a Head to Head, Parallel, Prospective TrialNo drug interventionsdiagnosticNot Availablerecruiting
NCT00006380
Monoclonal Antibody Therapy in Treating Patients With Prostate CancerNo drug interventionstreatment1completed
NCT02430480
Using Multiparametric MRI to Evaluate Intraprostatic Tumor Responses and Androgen Resistance Patterns in Newly Diagnosed Prostate Cancerdiagnostic2active_not_recruiting
NCT02391480
A Study Evaluating the Safety and Pharmacokinetics of ABBV-075 in Subjects With Cancertreatment1completed
NCT00818480
An Extension Study Administering YM155 to Subjects Previously Enrolled in Another Protocol Administering YM155treatment2completed
NCT00002480
Radiation Therapy in Treating Patients With Prostate CancerNo drug interventionstreatment1completed
NCT03201380
Evaluation of the Practice of the TEP Choline at Patients With Prostate CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT04925180
A Study to Learn About the Awareness and Knowledge That Doctors Have About the Safety and Safe Use Information for Androcur and Other Cyproterone Acetate Treatments in EuropeNot AvailableNot Availablecompleted
NCT02058680
Phase 1A/1B Study of PSA/IL-2/GM-CSF Vaccine for Recurrent Prostate Cancer in Hormone Naive and Hormone Independent PatientsNo drug interventionstreatment1unknown_status
NCT02759380
Can Dietary Phytoestrogens Slow Down Prostate Tumor Proliferation?No drug interventionspreventionNot Availablerecruiting
NCT02694380
Measuring the Effect of Radiation Therapy on Patient Activity LevelsNo drug interventionsNot AvailableNot Availableterminated
NCT04896580
IIT2020-20-SHIRAZIP-WALK: Nature WalksNo drug interventionssupportive_careNot Availableactive_not_recruiting
NCT00577980
Testosterone in Castration-Resistant Prostate Cancertreatment2withdrawn
NCT04986280
Diagnostic Accuracy and Performance of 18F-PSMA-1007No drug interventionsNot AvailableNot Availablecompleted
NCT00044980
Diet and Exercise-Based Counseling Program Compared With a Standard Counseling Program in Patients With Early-Stage Prostate CancerNo drug interventionsotherNot Availablecompleted
NCT03619980
A Non-Interventional Study to Evaluate Time to Event and Healthcare Resource Utilisation for Prostate Cancer Participants Throughout the Disease Trajectories Until Progression or DeathNo drug interventionsNot AvailableNot Availablecompleted
NCT00332280
Study to Evaluate the Clinical Benefit Response in Cancer Patients With Advanced Disease With AMT2003 Versus PlaceboNo drug interventionstreatment2 / 3terminated
NCT00567580
Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancertreatment3active_not_recruiting
NCT02923180
Neoadjuvant Enoblituzumab (MGA271) in Men With Localized Intermediate and High-Risk Prostate Cancertreatment2active_not_recruiting
NCT00524680
Vitamin D in Treating Patients With Prostate CancerNo drug interventionstreatment2completed
NCT04337580
Fatty Acid Synthase Inhibition in Castration Refractory Prostate Cancertreatment2recruiting
NCT02920229
68Ga-PSMA HBED-PET/CT in the Evaluation of the Biochemical Relapse in Patients With a History of Prostate Cancer Radically TreatedNo drug interventionsdiagnosticNot Availableactive_not_recruiting
NCT03600129
Qudratus Lumborum Block for Postoperative Pain After Endoscopic Prostatectomy.supportive_careNot Availablecompleted
NCT05910229
Telephone Paramedical Support Prior to the Radiotherapy Simulation Scanner for Patients With Prostate CancerNo drug interventionsotherNot Availablerecruiting
NCT00975429
Study Using WST11 in Patients With Localized Prostate Cancertreatment2completed
NCT05364229
MR-guided Tumour BoostNo drug interventionstreatmentNot Availablerecruiting
NCT03893929
The Investigation of New Biological Markers for Prostate Cancer Diagnosis and Management in Chinese PopulationNo drug interventionsNot AvailableNot Availablerecruiting
NCT00003329
Identification of Genes Associated With Cancer in Patients and Siblings Who Have CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT00859729
Dose Finding Study of a DNA Vaccine Delivered With Intradermal Electroporation in Patients With Prostate CancerNo drug interventionstreatment1 / 2completed
NCT00004929
Vaccine Therapy Plus QS21 in Treating Patients With Progressive Prostate CancerNo drug interventionstreatment1completed
NCT04751929
Abemaciclib With or Without Atezolizumab for mCRPCtreatment2active_not_recruiting
NCT00450229
Diindolylmethane in Treating Patients Undergoing Surgery for Stage I or Stage II Prostate Cancertreatment1completed
NCT00918229
Pilot Study to Assess the Safety and Efficacy of